	Gene name	Gene	Cancer	High	Medium	Low	Not detected	prognostic - favorable	unprognostic - favorable	prognostic - unfavorable	unprognostic - unfavorable
0	PDCD5	ENSG00000105185	breast cancer	1.0	6.0	3.0	2.0		0.1041		
1	PDCD5	ENSG00000105185	carcinoid	2.0	0.0	0.0	2.0				
2	PDCD5	ENSG00000105185	cervical cancer	0.0	2.0	3.0	6.0		0.2084		
3	PDCD5	ENSG00000105185	colorectal cancer	0.0	6.0	2.0	4.0		0.09646		
4	PDCD5	ENSG00000105185	endometrial cancer	0.0	2.0	1.0	8.0			0.0002595	
5	PDCD5	ENSG00000105185	glioma	0.0	3.0	4.0	3.0		0.2023		
6	PDCD5	ENSG00000105185	head and neck cancer	2.0	1.0	0.0	1.0				0.08639
7	PDCD5	ENSG00000105185	liver cancer	0.0	1.0	2.0	9.0				0.003637
8	PDCD5	ENSG00000105185	lung cancer	0.0	0.0	3.0	8.0				0.02427
9	PDCD5	ENSG00000105185	lymphoma	0.0	8.0	1.0	3.0				
10	PDCD5	ENSG00000105185	melanoma	0.0	7.0	3.0	1.0				0.06216
11	PDCD5	ENSG00000105185	ovarian cancer	1.0	1.0	4.0	6.0		0.08494		
12	PDCD5	ENSG00000105185	pancreatic cancer	0.0	8.0	0.0	3.0				0.03866
13	PDCD5	ENSG00000105185	prostate cancer	1.0	7.0	4.0	0.0				0.01932
14	PDCD5	ENSG00000105185	renal cancer	0.0	3.0	3.0	5.0			0.0	
15	PDCD5	ENSG00000105185	skin cancer	0.0	5.0	4.0	2.0				
16	PDCD5	ENSG00000105185	stomach cancer	0.0	7.0	2.0	2.0		0.06001		
17	PDCD5	ENSG00000105185	testis cancer	4.0	4.0	1.0	3.0		0.03347		
18	PDCD5	ENSG00000105185	thyroid cancer	0.0	2.0	2.0	0.0		0.1098		
19	PDCD5	ENSG00000105185	urothelial cancer	2.0	3.0	4.0	3.0		0.09542		
20	AURKA	ENSG00000087586	breast cancer	0.0	0.0	5.0	7.0				0.07728
21	AURKA	ENSG00000087586	carcinoid	0.0	0.0	0.0	4.0				
22	AURKA	ENSG00000087586	cervical cancer	0.0	1.0	6.0	5.0				0.02459
23	AURKA	ENSG00000087586	colorectal cancer	2.0	2.0	2.0	6.0		0.02762		
24	AURKA	ENSG00000087586	endometrial cancer	0.0	0.0	2.0	10.0			9.404e-05	
25	AURKA	ENSG00000087586	glioma	0.0	0.0	3.0	9.0				0.1921
26	AURKA	ENSG00000087586	head and neck cancer	0.0	0.0	3.0	1.0				0.02114
27	AURKA	ENSG00000087586	liver cancer	0.0	0.0	4.0	7.0			0.0001494	
28	AURKA	ENSG00000087586	lung cancer	0.0	1.0	5.0	5.0				0.004692
29	AURKA	ENSG00000087586	lymphoma	2.0	3.0	3.0	4.0				
30	AURKA	ENSG00000087586	melanoma	0.0	0.0	5.0	4.0				0.2424
31	AURKA	ENSG00000087586	ovarian cancer	1.0	1.0	3.0	7.0		0.06883		
32	AURKA	ENSG00000087586	pancreatic cancer	0.0	0.0	2.0	8.0			0.000613	
33	AURKA	ENSG00000087586	prostate cancer	0.0	0.0	1.0	11.0				0.1403
34	AURKA	ENSG00000087586	renal cancer	0.0	0.0	1.0	11.0			1.475e-08	
35	AURKA	ENSG00000087586	skin cancer	0.0	0.0	3.0	7.0				
36	AURKA	ENSG00000087586	stomach cancer	0.0	2.0	5.0	5.0		0.1673		
37	AURKA	ENSG00000087586	testis cancer	0.0	1.0	6.0	5.0				0.06828
38	AURKA	ENSG00000087586	thyroid cancer	0.0	0.0	0.0	4.0				0.09003
39	AURKA	ENSG00000087586	urothelial cancer	0.0	2.0	6.0	4.0				0.05137
40	HNRNPA2B1	ENSG00000122566	breast cancer	12.0	0.0	0.0	0.0		0.1193		
41	HNRNPA2B1	ENSG00000122566	carcinoid	2.0	1.0	1.0	0.0				
42	HNRNPA2B1	ENSG00000122566	cervical cancer	10.0	2.0	0.0	0.0				0.4449
43	HNRNPA2B1	ENSG00000122566	colorectal cancer	9.0	3.0	0.0	0.0		0.2334		
44	HNRNPA2B1	ENSG00000122566	endometrial cancer	6.0	3.0	2.0	0.0		0.06392		
45	HNRNPA2B1	ENSG00000122566	glioma	11.0	1.0	0.0	0.0		0.05638		
46	HNRNPA2B1	ENSG00000122566	head and neck cancer	2.0	2.0	0.0	0.0				0.008044
47	HNRNPA2B1	ENSG00000122566	liver cancer	8.0	1.0	0.0	3.0			1.028e-06	
48	HNRNPA2B1	ENSG00000122566	lung cancer	8.0	1.0	1.0	1.0				0.01246
49	HNRNPA2B1	ENSG00000122566	lymphoma	11.0	1.0	0.0	0.0				
50	HNRNPA2B1	ENSG00000122566	melanoma	10.0	2.0	0.0	0.0				0.009122
51	HNRNPA2B1	ENSG00000122566	ovarian cancer	7.0	5.0	0.0	0.0		0.004349		
52	HNRNPA2B1	ENSG00000122566	pancreatic cancer	11.0	1.0	0.0	0.0				0.1307
53	HNRNPA2B1	ENSG00000122566	prostate cancer	12.0	0.0	0.0	0.0			0.0005118	
54	HNRNPA2B1	ENSG00000122566	renal cancer	2.0	6.0	1.0	3.0			8.008e-05	
55	HNRNPA2B1	ENSG00000122566	skin cancer	9.0	3.0	0.0	0.0				
56	HNRNPA2B1	ENSG00000122566	stomach cancer	10.0	1.0	0.0	0.0		0.06741		
57	HNRNPA2B1	ENSG00000122566	testis cancer	2.0	5.0	5.0	0.0		0.03356		
58	HNRNPA2B1	ENSG00000122566	thyroid cancer	2.0	1.0	0.0	0.0		0.2023		
59	HNRNPA2B1	ENSG00000122566	urothelial cancer	5.0	4.0	1.0	2.0		0.01564		
60	ADRB2	ENSG00000169252	breast cancer	0.0	0.0	2.0	7.0		0.02283		
61	ADRB2	ENSG00000169252	carcinoid	0.0	0.0	2.0	2.0				
62	ADRB2	ENSG00000169252	cervical cancer	0.0	0.0	1.0	10.0		0.1498		
63	ADRB2	ENSG00000169252	colorectal cancer	0.0	0.0	5.0	5.0				0.1212
64	ADRB2	ENSG00000169252	endometrial cancer	0.0	0.0	0.0	12.0		0.01166		
65	ADRB2	ENSG00000169252	glioma	0.0	0.0	0.0	12.0		0.1689		
66	ADRB2	ENSG00000169252	head and neck cancer	0.0	0.0	0.0	3.0		0.117		
67	ADRB2	ENSG00000169252	liver cancer	0.0	0.0	0.0	12.0		0.009352		
68	ADRB2	ENSG00000169252	lung cancer	0.0	0.0	0.0	12.0		0.05543		
69	ADRB2	ENSG00000169252	lymphoma	0.0	0.0	1.0	11.0				
70	ADRB2	ENSG00000169252	melanoma	0.0	0.0	0.0	12.0				0.2337
71	ADRB2	ENSG00000169252	ovarian cancer	0.0	0.0	0.0	11.0				0.09852
72	ADRB2	ENSG00000169252	pancreatic cancer	1.0	0.0	0.0	11.0		0.03173		
73	ADRB2	ENSG00000169252	prostate cancer	0.0	6.0	5.0	0.0				0.2234
74	ADRB2	ENSG00000169252	renal cancer	0.0	1.0	0.0	10.0	3.15e-09			
75	ADRB2	ENSG00000169252	skin cancer	0.0	0.0	0.0	12.0				
76	ADRB2	ENSG00000169252	stomach cancer	0.0	0.0	0.0	11.0				0.01553
77	ADRB2	ENSG00000169252	testis cancer	0.0	0.0	2.0	10.0				0.1455
78	ADRB2	ENSG00000169252	thyroid cancer	0.0	0.0	0.0	4.0		0.1491		
79	ADRB2	ENSG00000169252	urothelial cancer	0.0	1.0	0.0	11.0		0.07648		
80	UXT	ENSG00000126756	breast cancer	2.0	10.0	0.0	0.0		0.112		
81	UXT	ENSG00000126756	carcinoid	0.0	3.0	0.0	1.0				
82	UXT	ENSG00000126756	cervical cancer	1.0	3.0	6.0	1.0		0.003849		
83	UXT	ENSG00000126756	colorectal cancer	1.0	6.0	3.0	0.0		0.09077		
84	UXT	ENSG00000126756	endometrial cancer	0.0	1.0	2.0	9.0		0.02093		
85	UXT	ENSG00000126756	glioma	1.0	6.0	2.0	3.0		0.21		
86	UXT	ENSG00000126756	head and neck cancer	0.0	4.0	0.0	0.0		0.223		
87	UXT	ENSG00000126756	liver cancer	0.0	7.0	2.0	3.0				0.04489
88	UXT	ENSG00000126756	lung cancer	3.0	5.0	3.0	0.0		0.1238		
89	UXT	ENSG00000126756	lymphoma	8.0	1.0	2.0	1.0				
90	UXT	ENSG00000126756	melanoma	3.0	5.0	1.0	2.0		0.1973		
91	UXT	ENSG00000126756	ovarian cancer	1.0	7.0	3.0	0.0		0.00231		
92	UXT	ENSG00000126756	pancreatic cancer	1.0	8.0	0.0	1.0		0.01123		
93	UXT	ENSG00000126756	prostate cancer	0.0	5.0	4.0	2.0		0.1167		
94	UXT	ENSG00000126756	renal cancer	2.0	8.0	2.0	0.0				0.02557
95	UXT	ENSG00000126756	skin cancer	1.0	8.0	1.0	1.0				
96	UXT	ENSG00000126756	stomach cancer	0.0	10.0	1.0	1.0				0.1438
97	UXT	ENSG00000126756	testis cancer	2.0	5.0	3.0	2.0		0.08113		
98	UXT	ENSG00000126756	thyroid cancer	2.0	2.0	0.0	0.0		0.08635		
99	UXT	ENSG00000126756	urothelial cancer	3.0	9.0	0.0	0.0		0.00409		
100	HNRNPD	ENSG00000138668	breast cancer	7.0	1.0	2.0	0.0		0.009595		
101	HNRNPD	ENSG00000138668	carcinoid	1.0	1.0	1.0	0.0				
102	HNRNPD	ENSG00000138668	cervical cancer	10.0	2.0	0.0	0.0		0.01011		
103	HNRNPD	ENSG00000138668	colorectal cancer	11.0	1.0	0.0	0.0		0.09089		
104	HNRNPD	ENSG00000138668	endometrial cancer	8.0	2.0	1.0	0.0				0.2655
105	HNRNPD	ENSG00000138668	glioma	8.0	2.0	0.0	0.0		0.1737		
106	HNRNPD	ENSG00000138668	head and neck cancer	3.0	0.0	1.0	0.0				0.1773
107	HNRNPD	ENSG00000138668	liver cancer	8.0	2.0	0.0	1.0				0.001028
108	HNRNPD	ENSG00000138668	lung cancer	9.0	2.0	0.0	1.0				0.0175
109	HNRNPD	ENSG00000138668	lymphoma	10.0	0.0	0.0	0.0				
110	HNRNPD	ENSG00000138668	melanoma	8.0	1.0	0.0	2.0				0.06229
111	HNRNPD	ENSG00000138668	ovarian cancer	8.0	2.0	1.0	1.0		0.02058		
112	HNRNPD	ENSG00000138668	pancreatic cancer	9.0	2.0	0.0	0.0				0.01081
113	HNRNPD	ENSG00000138668	prostate cancer	1.0	3.0	5.0	3.0				0.01035
114	HNRNPD	ENSG00000138668	renal cancer	4.0	2.0	4.0	1.0				0.01404
115	HNRNPD	ENSG00000138668	skin cancer	9.0	1.0	1.0	0.0				
116	HNRNPD	ENSG00000138668	stomach cancer	7.0	4.0	1.0	0.0		0.05932		
117	HNRNPD	ENSG00000138668	testis cancer	12.0	0.0	0.0	0.0		0.1083		
118	HNRNPD	ENSG00000138668	thyroid cancer	3.0	1.0	0.0	0.0				0.2813
119	HNRNPD	ENSG00000138668	urothelial cancer	12.0	0.0	0.0	0.0		0.01306		
120	COL4A1	ENSG00000187498	breast cancer	0.0	0.0	4.0	4.0				0.03822
121	COL4A1	ENSG00000187498	carcinoid	0.0	0.0	2.0	2.0				
122	COL4A1	ENSG00000187498	cervical cancer	0.0	0.0	1.0	11.0			0.0004675	
123	COL4A1	ENSG00000187498	colorectal cancer	0.0	0.0	9.0	2.0				0.2271
124	COL4A1	ENSG00000187498	endometrial cancer	0.0	0.0	10.0	2.0				0.1022
125	COL4A1	ENSG00000187498	glioma	0.0	0.0	2.0	9.0				0.3285
126	COL4A1	ENSG00000187498	head and neck cancer	0.0	0.0	3.0	1.0		0.2397		
127	COL4A1	ENSG00000187498	liver cancer	0.0	2.0	5.0	5.0				0.1096
128	COL4A1	ENSG00000187498	lung cancer	0.0	1.0	6.0	4.0				0.006507
129	COL4A1	ENSG00000187498	lymphoma	0.0	0.0	0.0	12.0				
130	COL4A1	ENSG00000187498	melanoma	0.0	3.0	3.0	2.0				0.0106
131	COL4A1	ENSG00000187498	ovarian cancer	0.0	1.0	4.0	6.0		0.09794		
132	COL4A1	ENSG00000187498	pancreatic cancer	0.0	1.0	2.0	8.0				0.01726
133	COL4A1	ENSG00000187498	prostate cancer	0.0	0.0	3.0	9.0		0.1214		
134	COL4A1	ENSG00000187498	renal cancer	0.0	1.0	4.0	7.0			1.3e-07	
135	COL4A1	ENSG00000187498	skin cancer	0.0	0.0	3.0	8.0				
136	COL4A1	ENSG00000187498	stomach cancer	0.0	1.0	1.0	10.0				0.001465
137	COL4A1	ENSG00000187498	testis cancer	0.0	1.0	8.0	3.0				0.01721
138	COL4A1	ENSG00000187498	thyroid cancer	0.0	1.0	2.0	1.0				0.1577
139	COL4A1	ENSG00000187498	urothelial cancer	0.0	2.0	5.0	5.0				0.01158
140	CLU	ENSG00000120885	breast cancer	0.0	2.0	1.0	8.0				0.01097
141	CLU	ENSG00000120885	carcinoid	0.0	1.0	0.0	3.0				
142	CLU	ENSG00000120885	cervical cancer	0.0	0.0	0.0	12.0		0.01815		
143	CLU	ENSG00000120885	colorectal cancer	0.0	0.0	1.0	11.0				0.00114
144	CLU	ENSG00000120885	endometrial cancer	2.0	4.0	5.0	1.0				0.02739
145	CLU	ENSG00000120885	glioma	0.0	5.0	2.0	5.0				0.05589
146	CLU	ENSG00000120885	head and neck cancer	0.0	0.0	0.0	4.0		0.04132		
147	CLU	ENSG00000120885	liver cancer	0.0	1.0	2.0	8.0		0.01762		
148	CLU	ENSG00000120885	lung cancer	0.0	0.0	0.0	10.0		0.2373		
149	CLU	ENSG00000120885	lymphoma	1.0	0.0	1.0	9.0				
150	CLU	ENSG00000120885	melanoma	0.0	0.0	0.0	9.0		0.1458		
151	CLU	ENSG00000120885	ovarian cancer	0.0	2.0	2.0	8.0		0.1053		
152	CLU	ENSG00000120885	pancreatic cancer	0.0	0.0	0.0	11.0		0.02872		
153	CLU	ENSG00000120885	prostate cancer	0.0	0.0	4.0	7.0		0.1413		
154	CLU	ENSG00000120885	renal cancer	0.0	0.0	2.0	9.0		0.01804		
155	CLU	ENSG00000120885	skin cancer	0.0	0.0	0.0	11.0				
156	CLU	ENSG00000120885	stomach cancer	0.0	0.0	1.0	10.0				0.02328
157	CLU	ENSG00000120885	testis cancer	0.0	0.0	0.0	11.0		0.1724		
158	CLU	ENSG00000120885	thyroid cancer	0.0	0.0	2.0	2.0	7.655e-05			
159	CLU	ENSG00000120885	urothelial cancer	0.0	0.0	1.0	11.0				0.0529
160	RPS3	ENSG00000149273	breast cancer	0.0	7.0	4.0	0.0		0.03615		
161	RPS3	ENSG00000149273	carcinoid	0.0	0.0	1.0	3.0				
162	RPS3	ENSG00000149273	cervical cancer	1.0	3.0	8.0	0.0				0.006937
163	RPS3	ENSG00000149273	colorectal cancer	0.0	9.0	2.0	0.0				0.2637
164	RPS3	ENSG00000149273	endometrial cancer	0.0	11.0	1.0	0.0		0.01442		
165	RPS3	ENSG00000149273	glioma	0.0	1.0	6.0	4.0		0.0555		
166	RPS3	ENSG00000149273	head and neck cancer	0.0	2.0	2.0	0.0				0.01084
167	RPS3	ENSG00000149273	liver cancer	0.0	5.0	5.0	0.0				0.01218
168	RPS3	ENSG00000149273	lung cancer	0.0	5.0	4.0	1.0				0.1347
169	RPS3	ENSG00000149273	lymphoma	0.0	0.0	3.0	7.0				
170	RPS3	ENSG00000149273	melanoma	0.0	3.0	8.0	0.0				0.2689
171	RPS3	ENSG00000149273	ovarian cancer	0.0	5.0	7.0	0.0				0.05752
172	RPS3	ENSG00000149273	pancreatic cancer	0.0	8.0	1.0	0.0				0.003272
173	RPS3	ENSG00000149273	prostate cancer	0.0	4.0	6.0	1.0				0.196
174	RPS3	ENSG00000149273	renal cancer	0.0	3.0	6.0	1.0			6.923e-06	
175	RPS3	ENSG00000149273	skin cancer	0.0	6.0	1.0	3.0				
176	RPS3	ENSG00000149273	stomach cancer	0.0	7.0	3.0	0.0		0.3216		
177	RPS3	ENSG00000149273	testis cancer	0.0	9.0	1.0	0.0		0.2941		
178	RPS3	ENSG00000149273	thyroid cancer	0.0	1.0	1.0	0.0		0.01886		
179	RPS3	ENSG00000149273	urothelial cancer	0.0	6.0	4.0	0.0		0.2191		
180	CCT3	ENSG00000163468	breast cancer	5.0	5.0	0.0	0.0				0.02143
181	CCT3	ENSG00000163468	carcinoid	1.0	1.0	2.0	0.0				
182	CCT3	ENSG00000163468	cervical cancer	3.0	7.0	2.0	0.0				0.0032
183	CCT3	ENSG00000163468	colorectal cancer	4.0	8.0	0.0	0.0				0.1664
184	CCT3	ENSG00000163468	endometrial cancer	5.0	6.0	0.0	0.0				0.006002
185	CCT3	ENSG00000163468	glioma	3.0	6.0	1.0	0.0		0.008394		
186	CCT3	ENSG00000163468	head and neck cancer	1.0	0.0	3.0	0.0				0.003143
187	CCT3	ENSG00000163468	liver cancer	5.0	6.0	1.0	0.0			3.87e-07	
188	CCT3	ENSG00000163468	lung cancer	1.0	7.0	3.0	1.0				0.004433
189	CCT3	ENSG00000163468	lymphoma	6.0	5.0	1.0	0.0				
190	CCT3	ENSG00000163468	melanoma	1.0	6.0	5.0	0.0		0.2777		
191	CCT3	ENSG00000163468	ovarian cancer	1.0	5.0	4.0	0.0		0.1159		
192	CCT3	ENSG00000163468	pancreatic cancer	3.0	6.0	3.0	0.0				0.05441
193	CCT3	ENSG00000163468	prostate cancer	9.0	3.0	0.0	0.0				0.1742
194	CCT3	ENSG00000163468	renal cancer	0.0	1.0	2.0	8.0			0.0006337	
195	CCT3	ENSG00000163468	skin cancer	0.0	9.0	3.0	0.0				
196	CCT3	ENSG00000163468	stomach cancer	1.0	7.0	3.0	0.0		0.07162		
197	CCT3	ENSG00000163468	testis cancer	3.0	6.0	3.0	0.0		0.05761		
198	CCT3	ENSG00000163468	thyroid cancer	0.0	3.0	1.0	0.0		0.05668		
199	CCT3	ENSG00000163468	urothelial cancer	1.0	7.0	4.0	0.0				0.1096
200	HIF3A	ENSG00000124440	breast cancer	0.0	11.0	0.0	0.0		0.09197		
201	HIF3A	ENSG00000124440	carcinoid	2.0	2.0	0.0	0.0				
202	HIF3A	ENSG00000124440	cervical cancer	2.0	9.0	1.0	0.0				0.2992
203	HIF3A	ENSG00000124440	colorectal cancer	2.0	9.0	0.0	0.0				0.05483
204	HIF3A	ENSG00000124440	endometrial cancer	3.0	5.0	3.0	1.0			6.905e-09	
205	HIF3A	ENSG00000124440	glioma	2.0	9.0	0.0	0.0				0.04122
206	HIF3A	ENSG00000124440	head and neck cancer	1.0	3.0	0.0	0.0		0.02348		
207	HIF3A	ENSG00000124440	liver cancer	3.0	6.0	3.0	0.0		0.003571		
208	HIF3A	ENSG00000124440	lung cancer	0.0	7.0	4.0	1.0				0.1296
209	HIF3A	ENSG00000124440	lymphoma	0.0	12.0	0.0	0.0				
210	HIF3A	ENSG00000124440	melanoma	3.0	8.0	1.0	0.0				0.03318
211	HIF3A	ENSG00000124440	ovarian cancer	3.0	9.0	0.0	0.0				0.01381
212	HIF3A	ENSG00000124440	pancreatic cancer	1.0	10.0	0.0	1.0				0.03765
213	HIF3A	ENSG00000124440	prostate cancer	0.0	12.0	0.0	0.0		0.07072		
214	HIF3A	ENSG00000124440	renal cancer	0.0	9.0	3.0	0.0				0.0003409
215	HIF3A	ENSG00000124440	skin cancer	2.0	8.0	0.0	0.0				
216	HIF3A	ENSG00000124440	stomach cancer	0.0	5.0	3.0	1.0				0.01546
217	HIF3A	ENSG00000124440	testis cancer	9.0	2.0	0.0	0.0				0.1607
218	HIF3A	ENSG00000124440	thyroid cancer	0.0	4.0	0.0	0.0				0.0004451
219	HIF3A	ENSG00000124440	urothelial cancer	1.0	9.0	1.0	0.0				0.05978
220	KAT2B	ENSG00000114166	breast cancer	0.0	0.0	10.0	2.0				0.02908
221	KAT2B	ENSG00000114166	carcinoid	1.0	0.0	2.0	1.0				
222	KAT2B	ENSG00000114166	cervical cancer	0.0	1.0	1.0	10.0		0.006847		
223	KAT2B	ENSG00000114166	colorectal cancer	0.0	1.0	7.0	4.0		0.09053		
224	KAT2B	ENSG00000114166	endometrial cancer	0.0	0.0	2.0	9.0		0.2246		
225	KAT2B	ENSG00000114166	glioma	3.0	7.0	2.0	0.0		0.02659		
226	KAT2B	ENSG00000114166	head and neck cancer	0.0	0.0	0.0	4.0		0.003011		
227	KAT2B	ENSG00000114166	liver cancer	0.0	1.0	3.0	8.0		0.2437		
228	KAT2B	ENSG00000114166	lung cancer	0.0	1.0	3.0	8.0		0.003827		
229	KAT2B	ENSG00000114166	lymphoma	1.0	5.0	4.0	2.0				
230	KAT2B	ENSG00000114166	melanoma	4.0	5.0	1.0	2.0		0.02442		
231	KAT2B	ENSG00000114166	ovarian cancer	0.0	0.0	9.0	3.0		0.1027		
232	KAT2B	ENSG00000114166	pancreatic cancer	0.0	1.0	1.0	10.0		0.005232		
233	KAT2B	ENSG00000114166	prostate cancer	0.0	5.0	6.0	1.0				0.07134
234	KAT2B	ENSG00000114166	renal cancer	0.0	1.0	4.0	7.0		0.07031		
235	KAT2B	ENSG00000114166	skin cancer	0.0	2.0	4.0	6.0				
236	KAT2B	ENSG00000114166	stomach cancer	0.0	0.0	1.0	11.0				0.02262
237	KAT2B	ENSG00000114166	testis cancer	0.0	0.0	0.0	12.0				0.1586
238	KAT2B	ENSG00000114166	thyroid cancer	3.0	0.0	0.0	1.0				0.05163
239	KAT2B	ENSG00000114166	urothelial cancer	0.0	2.0	2.0	8.0		0.04632		
240	SKP2	ENSG00000145604	breast cancer	0.0	0.0	4.0	7.0				0.0232
241	SKP2	ENSG00000145604	carcinoid	0.0	0.0	0.0	4.0				
242	SKP2	ENSG00000145604	cervical cancer	1.0	4.0	3.0	2.0				0.2868
243	SKP2	ENSG00000145604	colorectal cancer	1.0	2.0	3.0	1.0		0.1263		
244	SKP2	ENSG00000145604	endometrial cancer	0.0	0.0	4.0	7.0				0.05736
245	SKP2	ENSG00000145604	glioma	0.0	0.0	3.0	9.0		0.09559		
246	SKP2	ENSG00000145604	head and neck cancer	2.0	1.0	0.0	1.0		0.01519		
247	SKP2	ENSG00000145604	liver cancer	0.0	0.0	0.0	11.0				0.001208
248	SKP2	ENSG00000145604	lung cancer	1.0	4.0	3.0	4.0				0.2219
249	SKP2	ENSG00000145604	lymphoma	0.0	1.0	1.0	10.0				
250	SKP2	ENSG00000145604	melanoma	0.0	3.0	3.0	6.0			3.723e-07	
251	SKP2	ENSG00000145604	ovarian cancer	0.0	2.0	7.0	3.0	0.0008575			
252	SKP2	ENSG00000145604	pancreatic cancer	0.0	1.0	5.0	4.0				0.05057
253	SKP2	ENSG00000145604	prostate cancer	0.0	0.0	1.0	9.0				0.271
254	SKP2	ENSG00000145604	renal cancer	0.0	0.0	3.0	9.0			4.774e-15	
255	SKP2	ENSG00000145604	skin cancer	0.0	5.0	7.0	0.0				
256	SKP2	ENSG00000145604	stomach cancer	2.0	3.0	4.0	2.0		0.02497		
257	SKP2	ENSG00000145604	testis cancer	0.0	4.0	4.0	4.0		0.3728		
258	SKP2	ENSG00000145604	thyroid cancer	0.0	0.0	0.0	4.0				0.1628
259	SKP2	ENSG00000145604	urothelial cancer	0.0	2.0	7.0	3.0		0.2189		
260	PIAS4	ENSG00000105229	breast cancer	0.0	0.0	8.0	4.0				0.1226
261	PIAS4	ENSG00000105229	carcinoid	0.0	0.0	2.0	2.0				
262	PIAS4	ENSG00000105229	cervical cancer	0.0	0.0	1.0	11.0		0.008945		
263	PIAS4	ENSG00000105229	colorectal cancer	0.0	0.0	5.0	6.0				0.03501
264	PIAS4	ENSG00000105229	endometrial cancer	0.0	0.0	3.0	7.0	1.178e-05			
265	PIAS4	ENSG00000105229	glioma	0.0	0.0	5.0	7.0				0.2454
266	PIAS4	ENSG00000105229	head and neck cancer	0.0	0.0	3.0	1.0		0.004773		
267	PIAS4	ENSG00000105229	liver cancer	0.0	0.0	5.0	6.0				0.004006
268	PIAS4	ENSG00000105229	lung cancer	0.0	0.0	2.0	8.0		0.09791		
269	PIAS4	ENSG00000105229	lymphoma	0.0	0.0	1.0	11.0				
270	PIAS4	ENSG00000105229	melanoma	0.0	1.0	2.0	9.0				0.06886
271	PIAS4	ENSG00000105229	ovarian cancer	0.0	0.0	8.0	4.0		0.06221		
272	PIAS4	ENSG00000105229	pancreatic cancer	0.0	0.0	9.0	3.0	0.000704			
273	PIAS4	ENSG00000105229	prostate cancer	0.0	0.0	4.0	8.0				0.01328
274	PIAS4	ENSG00000105229	renal cancer	0.0	0.0	2.0	10.0		0.0598		
275	PIAS4	ENSG00000105229	skin cancer	0.0	0.0	2.0	8.0				
276	PIAS4	ENSG00000105229	stomach cancer	0.0	0.0	4.0	7.0		0.00452		
277	PIAS4	ENSG00000105229	testis cancer	0.0	0.0	4.0	6.0		0.05761		
278	PIAS4	ENSG00000105229	thyroid cancer	0.0	0.0	4.0	0.0		0.1255		
279	PIAS4	ENSG00000105229	urothelial cancer	0.0	0.0	6.0	6.0		0.004665		
280	RPS3A	ENSG00000145425	breast cancer	1.0	9.0	0.0	1.0		0.006241		
281	RPS3A	ENSG00000145425	carcinoid	0.0	1.0	3.0	0.0				
282	RPS3A	ENSG00000145425	cervical cancer	0.0	7.0	4.0	0.0		0.03453		
283	RPS3A	ENSG00000145425	colorectal cancer	1.0	11.0	0.0	0.0		0.1787		
284	RPS3A	ENSG00000145425	endometrial cancer	3.0	7.0	0.0	1.0		0.1159		
285	RPS3A	ENSG00000145425	glioma	0.0	4.0	1.0	3.0		0.01794		
286	RPS3A	ENSG00000145425	head and neck cancer	0.0	3.0	0.0	0.0				0.05461
287	RPS3A	ENSG00000145425	liver cancer	7.0	4.0	0.0	0.0			0.0006564	
288	RPS3A	ENSG00000145425	lung cancer	0.0	10.0	1.0	0.0		0.1172		
289	RPS3A	ENSG00000145425	lymphoma	1.0	5.0	3.0	2.0				
290	RPS3A	ENSG00000145425	melanoma	0.0	11.0	0.0	0.0				0.01158
291	RPS3A	ENSG00000145425	ovarian cancer	2.0	9.0	1.0	0.0				0.1009
292	RPS3A	ENSG00000145425	pancreatic cancer	1.0	10.0	0.0	0.0		0.06414		
293	RPS3A	ENSG00000145425	prostate cancer	0.0	7.0	5.0	0.0				0.1265
294	RPS3A	ENSG00000145425	renal cancer	1.0	5.0	5.0	1.0				0.006811
295	RPS3A	ENSG00000145425	skin cancer	0.0	8.0	1.0	0.0				
296	RPS3A	ENSG00000145425	stomach cancer	2.0	8.0	1.0	0.0				0.2364
297	RPS3A	ENSG00000145425	testis cancer	4.0	8.0	0.0	0.0		0.1961		
298	RPS3A	ENSG00000145425	thyroid cancer	0.0	3.0	1.0	0.0				0.1997
299	RPS3A	ENSG00000145425	urothelial cancer	2.0	10.0	0.0	0.0		0.3392		
300	DGKZ	ENSG00000149091	breast cancer	0.0	0.0	1.0	11.0		0.0285		
301	DGKZ	ENSG00000149091	carcinoid	0.0	0.0	1.0	3.0				
302	DGKZ	ENSG00000149091	cervical cancer	0.0	1.0	0.0	9.0		0.03896		
303	DGKZ	ENSG00000149091	colorectal cancer	0.0	0.0	0.0	10.0				0.2389
304	DGKZ	ENSG00000149091	endometrial cancer	0.0	0.0	0.0	12.0				0.1648
305	DGKZ	ENSG00000149091	glioma	0.0	2.0	0.0	9.0				0.1403
306	DGKZ	ENSG00000149091	head and neck cancer	1.0	0.0	2.0	1.0		0.04124		
307	DGKZ	ENSG00000149091	liver cancer	0.0	0.0	0.0	11.0				0.003082
308	DGKZ	ENSG00000149091	lung cancer	0.0	0.0	1.0	8.0				0.1306
309	DGKZ	ENSG00000149091	lymphoma	0.0	0.0	2.0	10.0				
310	DGKZ	ENSG00000149091	melanoma	0.0	1.0	0.0	11.0		0.01033		
311	DGKZ	ENSG00000149091	ovarian cancer	0.0	0.0	1.0	11.0				0.02487
312	DGKZ	ENSG00000149091	pancreatic cancer	0.0	0.0	2.0	10.0		0.003658		
313	DGKZ	ENSG00000149091	prostate cancer	0.0	0.0	0.0	12.0				0.08177
314	DGKZ	ENSG00000149091	renal cancer	0.0	0.0	0.0	12.0			4.736e-05	
315	DGKZ	ENSG00000149091	skin cancer	0.0	1.0	1.0	10.0				
316	DGKZ	ENSG00000149091	stomach cancer	0.0	0.0	1.0	11.0		0.001476		
317	DGKZ	ENSG00000149091	testis cancer	0.0	3.0	5.0	4.0				0.07746
318	DGKZ	ENSG00000149091	thyroid cancer	0.0	0.0	0.0	3.0		0.03614		
319	DGKZ	ENSG00000149091	urothelial cancer	0.0	1.0	0.0	11.0		0.007839		
320	KIF3B	ENSG00000101350	breast cancer	1.0	6.0	5.0	0.0				0.01737
321	KIF3B	ENSG00000101350	carcinoid	0.0	1.0	0.0	3.0				
322	KIF3B	ENSG00000101350	cervical cancer	0.0	2.0	8.0	2.0				0.2253
323	KIF3B	ENSG00000101350	colorectal cancer	0.0	3.0	5.0	4.0		0.05144		
324	KIF3B	ENSG00000101350	endometrial cancer	0.0	3.0	3.0	5.0		0.1845		
325	KIF3B	ENSG00000101350	glioma	0.0	2.0	5.0	4.0		0.273		
326	KIF3B	ENSG00000101350	head and neck cancer	0.0	2.0	1.0	1.0		0.2886		
327	KIF3B	ENSG00000101350	liver cancer	3.0	3.0	1.0	5.0				0.01492
328	KIF3B	ENSG00000101350	lung cancer	0.0	2.0	3.0	6.0				0.2141
329	KIF3B	ENSG00000101350	lymphoma	0.0	0.0	3.0	8.0				
330	KIF3B	ENSG00000101350	melanoma	0.0	6.0	2.0	3.0		0.009014		
331	KIF3B	ENSG00000101350	ovarian cancer	0.0	3.0	3.0	5.0				0.093
332	KIF3B	ENSG00000101350	pancreatic cancer	5.0	5.0	0.0	2.0		0.1408		
333	KIF3B	ENSG00000101350	prostate cancer	0.0	3.0	1.0	8.0		0.1181		
334	KIF3B	ENSG00000101350	renal cancer	0.0	0.0	0.0	11.0	1.437e-12			
335	KIF3B	ENSG00000101350	skin cancer	0.0	4.0	5.0	3.0				
336	KIF3B	ENSG00000101350	stomach cancer	0.0	4.0	5.0	3.0		0.02406		
337	KIF3B	ENSG00000101350	testis cancer	0.0	1.0	1.0	10.0				0.2678
338	KIF3B	ENSG00000101350	thyroid cancer	0.0	1.0	0.0	3.0				0.05114
339	KIF3B	ENSG00000101350	urothelial cancer	1.0	4.0	3.0	4.0				0.04416
340	PARD6A	ENSG00000102981	breast cancer	0.0	3.0	3.0	4.0	0.0005403			
341	PARD6A	ENSG00000102981	carcinoid	0.0	1.0	0.0	3.0				
342	PARD6A	ENSG00000102981	cervical cancer	1.0	7.0	2.0	2.0		0.0618		
343	PARD6A	ENSG00000102981	colorectal cancer	0.0	0.0	5.0	6.0		0.177		
344	PARD6A	ENSG00000102981	endometrial cancer	4.0	4.0	0.0	2.0		0.01333		
345	PARD6A	ENSG00000102981	glioma	0.0	3.0	1.0	6.0		0.07631		
346	PARD6A	ENSG00000102981	head and neck cancer	3.0	0.0	0.0	1.0		0.004075		
347	PARD6A	ENSG00000102981	liver cancer	0.0	1.0	3.0	6.0				0.01229
348	PARD6A	ENSG00000102981	lung cancer	0.0	10.0	1.0	1.0				0.1272
349	PARD6A	ENSG00000102981	lymphoma	0.0	0.0	0.0	12.0				
350	PARD6A	ENSG00000102981	melanoma	6.0	2.0	4.0	0.0		0.06591		
351	PARD6A	ENSG00000102981	ovarian cancer	1.0	6.0	3.0	2.0		0.2091		
352	PARD6A	ENSG00000102981	pancreatic cancer	2.0	3.0	3.0	2.0		0.001977		
353	PARD6A	ENSG00000102981	prostate cancer	0.0	7.0	1.0	2.0				0.09133
354	PARD6A	ENSG00000102981	renal cancer	4.0	1.0	5.0	2.0	3.08e-07			
355	PARD6A	ENSG00000102981	skin cancer	2.0	7.0	2.0	1.0				
356	PARD6A	ENSG00000102981	stomach cancer	0.0	0.0	1.0	8.0		0.009216		
357	PARD6A	ENSG00000102981	testis cancer	4.0	4.0	0.0	1.0		0.06685		
358	PARD6A	ENSG00000102981	thyroid cancer	2.0	0.0	2.0	0.0				0.1246
359	PARD6A	ENSG00000102981	urothelial cancer	3.0	2.0	3.0	1.0		0.01394		
360	MYC	ENSG00000136997	breast cancer	0.0	8.0	3.0	1.0		0.01445		
361	MYC	ENSG00000136997	carcinoid	0.0	1.0	1.0	2.0				
362	MYC	ENSG00000136997	cervical cancer	1.0	7.0	2.0	1.0				0.003998
363	MYC	ENSG00000136997	colorectal cancer	1.0	7.0	2.0	2.0		0.00394		
364	MYC	ENSG00000136997	endometrial cancer	0.0	1.0	9.0	1.0				0.002406
365	MYC	ENSG00000136997	glioma	0.0	2.0	2.0	7.0		0.08145		
366	MYC	ENSG00000136997	head and neck cancer	0.0	1.0	1.0	2.0				0.003357
367	MYC	ENSG00000136997	liver cancer	0.0	8.0	0.0	2.0				0.05805
368	MYC	ENSG00000136997	lung cancer	1.0	6.0	3.0	0.0				0.004942
369	MYC	ENSG00000136997	lymphoma	0.0	2.0	4.0	6.0				
370	MYC	ENSG00000136997	melanoma	1.0	4.0	4.0	3.0				0.1594
371	MYC	ENSG00000136997	ovarian cancer	1.0	5.0	4.0	1.0			0.000752	
372	MYC	ENSG00000136997	pancreatic cancer	0.0	9.0	1.0	2.0				0.005191
373	MYC	ENSG00000136997	prostate cancer	4.0	3.0	2.0	2.0				0.009857
374	MYC	ENSG00000136997	renal cancer	0.0	7.0	3.0	2.0			5.495e-08	
375	MYC	ENSG00000136997	skin cancer	0.0	5.0	3.0	3.0				
376	MYC	ENSG00000136997	stomach cancer	1.0	9.0	2.0	0.0		0.07853		
377	MYC	ENSG00000136997	testis cancer	0.0	4.0	2.0	5.0				0.04661
378	MYC	ENSG00000136997	thyroid cancer	0.0	1.0	1.0	2.0				0.2477
379	MYC	ENSG00000136997	urothelial cancer	0.0	10.0	1.0	0.0			4.963e-05	
380	CBX5	ENSG00000094916	breast cancer	6.0	5.0	1.0	0.0				0.01579
381	CBX5	ENSG00000094916	carcinoid	2.0	2.0	0.0	0.0				
382	CBX5	ENSG00000094916	cervical cancer	4.0	7.0	0.0	0.0		0.07985		
383	CBX5	ENSG00000094916	colorectal cancer	4.0	6.0	2.0	0.0		0.01154		
384	CBX5	ENSG00000094916	endometrial cancer	1.0	5.0	2.0	3.0				0.005052
385	CBX5	ENSG00000094916	glioma	8.0	3.0	1.0	0.0		0.3798		
386	CBX5	ENSG00000094916	head and neck cancer	2.0	0.0	0.0	1.0		0.004591		
387	CBX5	ENSG00000094916	liver cancer	0.0	5.0	3.0	4.0				0.002971
388	CBX5	ENSG00000094916	lung cancer	0.0	1.0	5.0	3.0				0.006386
389	CBX5	ENSG00000094916	lymphoma	0.0	4.0	8.0	0.0				
390	CBX5	ENSG00000094916	melanoma	1.0	4.0	5.0	1.0				0.02568
391	CBX5	ENSG00000094916	ovarian cancer	0.0	5.0	6.0	1.0		0.1411		
392	CBX5	ENSG00000094916	pancreatic cancer	0.0	3.0	5.0	2.0		0.04466		
393	CBX5	ENSG00000094916	prostate cancer	2.0	7.0	0.0	0.0				0.1959
394	CBX5	ENSG00000094916	renal cancer	1.0	2.0	6.0	3.0		0.2339		
395	CBX5	ENSG00000094916	skin cancer	0.0	7.0	3.0	2.0				
396	CBX5	ENSG00000094916	stomach cancer	0.0	2.0	3.0	5.0				0.1697
397	CBX5	ENSG00000094916	testis cancer	1.0	5.0	4.0	2.0				0.1081
398	CBX5	ENSG00000094916	thyroid cancer	1.0	3.0	0.0	0.0				0.0626
399	CBX5	ENSG00000094916	urothelial cancer	1.0	4.0	3.0	2.0				0.08642
400	RBX1	ENSG00000100387	breast cancer						0.2341		
401	RBX1	ENSG00000100387	carcinoid								
402	RBX1	ENSG00000100387	cervical cancer						0.01543		
403	RBX1	ENSG00000100387	colorectal cancer						0.1309		
404	RBX1	ENSG00000100387	endometrial cancer						0.001599		
405	RBX1	ENSG00000100387	glioma						0.2296		
406	RBX1	ENSG00000100387	head and neck cancer								0.02923
407	RBX1	ENSG00000100387	liver cancer								0.001819
408	RBX1	ENSG00000100387	lung cancer						0.1738		
409	RBX1	ENSG00000100387	lymphoma								
410	RBX1	ENSG00000100387	melanoma								0.0661
411	RBX1	ENSG00000100387	ovarian cancer					0.0006627			
412	RBX1	ENSG00000100387	pancreatic cancer								0.005014
413	RBX1	ENSG00000100387	prostate cancer								0.2187
414	RBX1	ENSG00000100387	renal cancer								0.004992
415	RBX1	ENSG00000100387	skin cancer								
416	RBX1	ENSG00000100387	stomach cancer								0.02223
417	RBX1	ENSG00000100387	testis cancer								0.1341
418	RBX1	ENSG00000100387	thyroid cancer						0.04572		
419	RBX1	ENSG00000100387	urothelial cancer						0.03049		
420	TCP1	ENSG00000120438	breast cancer	0.0	0.0	4.0	7.0			8.877e-05	
421	TCP1	ENSG00000120438	carcinoid	0.0	0.0	1.0	3.0				
422	TCP1	ENSG00000120438	cervical cancer	0.0	0.0	1.0	11.0				0.01336
423	TCP1	ENSG00000120438	colorectal cancer	0.0	0.0	2.0	10.0		0.00164		
424	TCP1	ENSG00000120438	endometrial cancer	0.0	0.0	0.0	11.0				0.02666
425	TCP1	ENSG00000120438	glioma	0.0	0.0	1.0	9.0		0.05495		
426	TCP1	ENSG00000120438	head and neck cancer	0.0	0.0	2.0	1.0				0.001389
427	TCP1	ENSG00000120438	liver cancer	0.0	6.0	5.0	0.0			1.491e-05	
428	TCP1	ENSG00000120438	lung cancer	0.0	2.0	3.0	7.0				0.01542
429	TCP1	ENSG00000120438	lymphoma	0.0	0.0	3.0	9.0				
430	TCP1	ENSG00000120438	melanoma	0.0	0.0	3.0	9.0		0.2435		
431	TCP1	ENSG00000120438	ovarian cancer	0.0	1.0	1.0	10.0				0.02643
432	TCP1	ENSG00000120438	pancreatic cancer	0.0	8.0	2.0	2.0		0.09341		
433	TCP1	ENSG00000120438	prostate cancer	0.0	0.0	0.0	12.0				0.05171
434	TCP1	ENSG00000120438	renal cancer	0.0	2.0	1.0	8.0				0.002098
435	TCP1	ENSG00000120438	skin cancer	0.0	0.0	2.0	9.0				
436	TCP1	ENSG00000120438	stomach cancer	0.0	6.0	5.0	1.0		0.1805		
437	TCP1	ENSG00000120438	testis cancer	0.0	4.0	3.0	5.0		0.215		
438	TCP1	ENSG00000120438	thyroid cancer	0.0	1.0	1.0	1.0		0.1761		
439	TCP1	ENSG00000120438	urothelial cancer	0.0	2.0	6.0	3.0				0.1538
440	HNRNPL	ENSG00000104824	breast cancer	12.0	0.0	0.0	0.0		0.05333		
441	HNRNPL	ENSG00000104824	carcinoid	4.0	0.0	0.0	0.0				
442	HNRNPL	ENSG00000104824	cervical cancer	12.0	0.0	0.0	0.0		0.04581		
443	HNRNPL	ENSG00000104824	colorectal cancer	11.0	0.0	0.0	0.0		0.2275		
444	HNRNPL	ENSG00000104824	endometrial cancer	12.0	0.0	0.0	0.0				0.009673
445	HNRNPL	ENSG00000104824	glioma	12.0	0.0	0.0	0.0		0.008987		
446	HNRNPL	ENSG00000104824	head and neck cancer	3.0	0.0	0.0	0.0				0.004903
447	HNRNPL	ENSG00000104824	liver cancer	8.0	2.0	0.0	0.0			3.253e-06	
448	HNRNPL	ENSG00000104824	lung cancer	12.0	0.0	0.0	0.0				0.1445
449	HNRNPL	ENSG00000104824	lymphoma	11.0	1.0	0.0	0.0				
450	HNRNPL	ENSG00000104824	melanoma	10.0	2.0	0.0	0.0				0.08848
451	HNRNPL	ENSG00000104824	ovarian cancer	12.0	0.0	0.0	0.0		0.2411		
452	HNRNPL	ENSG00000104824	pancreatic cancer	10.0	1.0	0.0	0.0			0.0009691	
453	HNRNPL	ENSG00000104824	prostate cancer	11.0	1.0	0.0	0.0				0.01573
454	HNRNPL	ENSG00000104824	renal cancer	9.0	3.0	0.0	0.0			1.964e-11	
455	HNRNPL	ENSG00000104824	skin cancer	12.0	0.0	0.0	0.0				
456	HNRNPL	ENSG00000104824	stomach cancer	9.0	0.0	0.0	0.0		0.02173		
457	HNRNPL	ENSG00000104824	testis cancer	11.0	0.0	0.0	0.0		0.04226		
458	HNRNPL	ENSG00000104824	thyroid cancer	4.0	0.0	0.0	0.0		0.0158		
459	HNRNPL	ENSG00000104824	urothelial cancer	10.0	1.0	0.0	0.0		0.0439		
460	CDKN2A	ENSG00000147889	breast cancer	1.0	2.0	5.0	4.0		0.03407		
461	CDKN2A	ENSG00000147889	carcinoid	1.0	1.0	1.0	1.0				
462	CDKN2A	ENSG00000147889	cervical cancer	9.0	2.0	1.0	0.0				0.04507
463	CDKN2A	ENSG00000147889	colorectal cancer	2.0	8.0	1.0	1.0				0.002996
464	CDKN2A	ENSG00000147889	endometrial cancer	6.0	2.0	4.0	0.0			1.823e-07	
465	CDKN2A	ENSG00000147889	glioma	2.0	5.0	3.0	2.0		0.05224		
466	CDKN2A	ENSG00000147889	head and neck cancer	1.0	1.0	0.0	2.0	0.0005189			
467	CDKN2A	ENSG00000147889	liver cancer	1.0	1.0	1.0	8.0			0.0002167	
468	CDKN2A	ENSG00000147889	lung cancer	2.0	2.0	3.0	4.0				0.01249
469	CDKN2A	ENSG00000147889	lymphoma	0.0	2.0	5.0	5.0				
470	CDKN2A	ENSG00000147889	melanoma	4.0	2.0	0.0	3.0		0.1049		
471	CDKN2A	ENSG00000147889	ovarian cancer	6.0	1.0	0.0	5.0		0.104		
472	CDKN2A	ENSG00000147889	pancreatic cancer	1.0	0.0	1.0	6.0		0.1705		
473	CDKN2A	ENSG00000147889	prostate cancer	0.0	5.0	3.0	3.0				0.01564
474	CDKN2A	ENSG00000147889	renal cancer	0.0	1.0	3.0	8.0			5.759e-07	
475	CDKN2A	ENSG00000147889	skin cancer	1.0	3.0	3.0	4.0				
476	CDKN2A	ENSG00000147889	stomach cancer	6.0	0.0	0.0	3.0		0.09414		
477	CDKN2A	ENSG00000147889	testis cancer	1.0	1.0	1.0	8.0				0.01224
478	CDKN2A	ENSG00000147889	thyroid cancer	3.0	0.0	0.0	1.0				0.03051
479	CDKN2A	ENSG00000147889	urothelial cancer	3.0	0.0	2.0	7.0		0.3549		
480	AR	ENSG00000169083	breast cancer	3.0	6.0	2.0	1.0				0.1338
481	AR	ENSG00000169083	carcinoid	0.0	0.0	0.0	4.0				
482	AR	ENSG00000169083	cervical cancer	0.0	0.0	2.0	9.0		0.008098		
483	AR	ENSG00000169083	colorectal cancer	0.0	0.0	1.0	10.0				0.0249
484	AR	ENSG00000169083	endometrial cancer	0.0	2.0	1.0	8.0		0.05953		
485	AR	ENSG00000169083	glioma	0.0	0.0	0.0	11.0		0.01038		
486	AR	ENSG00000169083	head and neck cancer	0.0	1.0	0.0	3.0		0.03348		
487	AR	ENSG00000169083	liver cancer	0.0	0.0	0.0	12.0	0.000877			
488	AR	ENSG00000169083	lung cancer	0.0	1.0	0.0	11.0		0.04986		
489	AR	ENSG00000169083	lymphoma	0.0	0.0	0.0	12.0				
490	AR	ENSG00000169083	melanoma	0.0	0.0	0.0	12.0		0.1721		
491	AR	ENSG00000169083	ovarian cancer	2.0	3.0	0.0	6.0		0.07793		
492	AR	ENSG00000169083	pancreatic cancer	0.0	0.0	0.0	12.0		0.2296		
493	AR	ENSG00000169083	prostate cancer	7.0	0.0	0.0	1.0				0.2294
494	AR	ENSG00000169083	renal cancer	0.0	0.0	0.0	12.0	1.032e-08			
495	AR	ENSG00000169083	skin cancer	1.0	2.0	2.0	7.0				
496	AR	ENSG00000169083	stomach cancer	0.0	0.0	0.0	12.0				0.008233
497	AR	ENSG00000169083	testis cancer	1.0	1.0	0.0	10.0		0.08899		
498	AR	ENSG00000169083	thyroid cancer	0.0	0.0	0.0	4.0				0.04233
499	AR	ENSG00000169083	urothelial cancer	0.0	0.0	2.0	9.0		0.07967		
500	EP300	ENSG00000100393	breast cancer	3.0	8.0	0.0	0.0				0.07666
501	EP300	ENSG00000100393	carcinoid	1.0	2.0	0.0	0.0				
502	EP300	ENSG00000100393	cervical cancer	2.0	10.0	0.0	0.0		0.0556		
503	EP300	ENSG00000100393	colorectal cancer	3.0	7.0	0.0	1.0		0.229		
504	EP300	ENSG00000100393	endometrial cancer	3.0	8.0	1.0	0.0		0.2515		
505	EP300	ENSG00000100393	glioma	2.0	8.0	2.0	0.0		0.006096		
506	EP300	ENSG00000100393	head and neck cancer	2.0	2.0	0.0	0.0		0.1665		
507	EP300	ENSG00000100393	liver cancer	1.0	6.0	1.0	3.0				0.02209
508	EP300	ENSG00000100393	lung cancer	4.0	7.0	1.0	0.0		0.2134		
509	EP300	ENSG00000100393	lymphoma	0.0	11.0	1.0	0.0				
510	EP300	ENSG00000100393	melanoma	4.0	8.0	0.0	0.0				0.1545
511	EP300	ENSG00000100393	ovarian cancer	1.0	10.0	0.0	0.0				0.08972
512	EP300	ENSG00000100393	pancreatic cancer	3.0	7.0	1.0	0.0				0.01737
513	EP300	ENSG00000100393	prostate cancer	4.0	8.0	0.0	0.0		0.08536		
514	EP300	ENSG00000100393	renal cancer	4.0	7.0	0.0	0.0	7.447e-05			
515	EP300	ENSG00000100393	skin cancer	0.0	12.0	0.0	0.0				
516	EP300	ENSG00000100393	stomach cancer	1.0	10.0	0.0	0.0		0.07972		
517	EP300	ENSG00000100393	testis cancer	4.0	8.0	0.0	0.0				0.1406
518	EP300	ENSG00000100393	thyroid cancer	1.0	3.0	0.0	0.0				0.1015
519	EP300	ENSG00000100393	urothelial cancer	6.0	5.0	1.0	0.0				0.08656
520	DNAJA3	ENSG00000103423	breast cancer	9.0	2.0	1.0	0.0				0.0565
521	DNAJA3	ENSG00000103423	carcinoid	0.0	3.0	1.0	0.0				
522	DNAJA3	ENSG00000103423	cervical cancer	3.0	5.0	2.0	0.0		0.1342		
523	DNAJA3	ENSG00000103423	colorectal cancer	11.0	1.0	0.0	0.0		0.002862		
524	DNAJA3	ENSG00000103423	endometrial cancer	4.0	7.0	0.0	0.0				0.02912
525	DNAJA3	ENSG00000103423	glioma	4.0	6.0	1.0	1.0				0.4167
526	DNAJA3	ENSG00000103423	head and neck cancer	2.0	2.0	0.0	0.0				0.05181
527	DNAJA3	ENSG00000103423	liver cancer	8.0	4.0	0.0	0.0				0.1597
528	DNAJA3	ENSG00000103423	lung cancer	2.0	8.0	1.0	0.0		0.1379		
529	DNAJA3	ENSG00000103423	lymphoma	7.0	5.0	0.0	0.0				
530	DNAJA3	ENSG00000103423	melanoma	8.0	3.0	0.0	0.0				0.2062
531	DNAJA3	ENSG00000103423	ovarian cancer	4.0	7.0	0.0	0.0				0.003159
532	DNAJA3	ENSG00000103423	pancreatic cancer	5.0	6.0	0.0	0.0				0.1552
533	DNAJA3	ENSG00000103423	prostate cancer	4.0	6.0	0.0	0.0				0.03271
534	DNAJA3	ENSG00000103423	renal cancer	1.0	10.0	0.0	1.0	0.0001789			
535	DNAJA3	ENSG00000103423	skin cancer	0.0	6.0	3.0	0.0				
536	DNAJA3	ENSG00000103423	stomach cancer	5.0	6.0	0.0	0.0		0.04172		
537	DNAJA3	ENSG00000103423	testis cancer	3.0	7.0	1.0	0.0				0.1572
538	DNAJA3	ENSG00000103423	thyroid cancer	2.0	1.0	0.0	0.0				0.1343
539	DNAJA3	ENSG00000103423	urothelial cancer	3.0	7.0	0.0	0.0				0.192
540	MKNK2	ENSG00000099875	breast cancer	4.0	8.0	0.0	0.0		0.08757		
541	MKNK2	ENSG00000099875	carcinoid	0.0	4.0	0.0	0.0				
542	MKNK2	ENSG00000099875	cervical cancer	5.0	7.0	0.0	0.0		0.1706		
543	MKNK2	ENSG00000099875	colorectal cancer	5.0	4.0	1.0	1.0				0.1638
544	MKNK2	ENSG00000099875	endometrial cancer	7.0	5.0	0.0	0.0	4.861e-05			
545	MKNK2	ENSG00000099875	glioma	3.0	8.0	0.0	0.0		0.3075		
546	MKNK2	ENSG00000099875	head and neck cancer	2.0	2.0	0.0	0.0		0.01591		
547	MKNK2	ENSG00000099875	liver cancer	4.0	3.0	4.0	0.0				0.006418
548	MKNK2	ENSG00000099875	lung cancer	5.0	6.0	0.0	0.0		0.1346		
549	MKNK2	ENSG00000099875	lymphoma	5.0	4.0	3.0	0.0				
550	MKNK2	ENSG00000099875	melanoma	7.0	5.0	0.0	0.0		0.04318		
551	MKNK2	ENSG00000099875	ovarian cancer	8.0	4.0	0.0	0.0				0.07524
552	MKNK2	ENSG00000099875	pancreatic cancer	3.0	6.0	0.0	1.0				0.1078
553	MKNK2	ENSG00000099875	prostate cancer	1.0	8.0	1.0	0.0				0.06559
554	MKNK2	ENSG00000099875	renal cancer	1.0	7.0	2.0	0.0		0.04066		
555	MKNK2	ENSG00000099875	skin cancer	3.0	9.0	0.0	0.0				
556	MKNK2	ENSG00000099875	stomach cancer	1.0	5.0	6.0	0.0	0.0004008			
557	MKNK2	ENSG00000099875	testis cancer	5.0	6.0	0.0	0.0				0.1634
558	MKNK2	ENSG00000099875	thyroid cancer	2.0	2.0	0.0	0.0		0.1598		
559	MKNK2	ENSG00000099875	urothelial cancer	3.0	8.0	0.0	0.0		0.1595		
560	MCM7	ENSG00000166508	breast cancer	8.0	2.0	2.0	0.0		0.1871		
561	MCM7	ENSG00000166508	carcinoid	1.0	1.0	1.0	0.0				
562	MCM7	ENSG00000166508	cervical cancer	10.0	2.0	0.0	0.0	0.0001278			
563	MCM7	ENSG00000166508	colorectal cancer	8.0	3.0	0.0	1.0		0.1363		
564	MCM7	ENSG00000166508	endometrial cancer	5.0	2.0	2.0	2.0				0.05204
565	MCM7	ENSG00000166508	glioma	2.0	5.0	2.0	2.0				0.1943
566	MCM7	ENSG00000166508	head and neck cancer	2.0	1.0	1.0	0.0		0.07034		
567	MCM7	ENSG00000166508	liver cancer	3.0	2.0	1.0	5.0			0.0002177	
568	MCM7	ENSG00000166508	lung cancer	5.0	2.0	3.0	1.0				0.02084
569	MCM7	ENSG00000166508	lymphoma	7.0	1.0	0.0	4.0				
570	MCM7	ENSG00000166508	melanoma	7.0	3.0	1.0	1.0				0.005786
571	MCM7	ENSG00000166508	ovarian cancer	7.0	3.0	1.0	0.0		0.02162		
572	MCM7	ENSG00000166508	pancreatic cancer	7.0	2.0	1.0	2.0				0.2417
573	MCM7	ENSG00000166508	prostate cancer	0.0	5.0	5.0	2.0				0.009337
574	MCM7	ENSG00000166508	renal cancer	2.0	3.0	2.0	5.0				0.03829
575	MCM7	ENSG00000166508	skin cancer	8.0	3.0	0.0	0.0				
576	MCM7	ENSG00000166508	stomach cancer	4.0	6.0	0.0	0.0		0.05409		
577	MCM7	ENSG00000166508	testis cancer	10.0	1.0	1.0	0.0		0.1762		
578	MCM7	ENSG00000166508	thyroid cancer	2.0	1.0	1.0	0.0		0.01321		
579	MCM7	ENSG00000166508	urothelial cancer	4.0	4.0	2.0	1.0		0.2382		
580	KLF4	ENSG00000136826	breast cancer	0.0	1.0	1.0	10.0		0.2058		
581	KLF4	ENSG00000136826	carcinoid	0.0	0.0	0.0	4.0				
582	KLF4	ENSG00000136826	cervical cancer	0.0	4.0	4.0	3.0		0.01415		
583	KLF4	ENSG00000136826	colorectal cancer	1.0	0.0	4.0	6.0		0.01136		
584	KLF4	ENSG00000136826	endometrial cancer	0.0	0.0	1.0	10.0		0.2453		
585	KLF4	ENSG00000136826	glioma	0.0	0.0	0.0	12.0				0.1548
586	KLF4	ENSG00000136826	head and neck cancer	2.0	1.0	1.0	0.0		0.006582		
587	KLF4	ENSG00000136826	liver cancer	0.0	0.0	2.0	10.0				0.03436
588	KLF4	ENSG00000136826	lung cancer	0.0	3.0	1.0	8.0				0.0649
589	KLF4	ENSG00000136826	lymphoma	0.0	0.0	0.0	12.0				
590	KLF4	ENSG00000136826	melanoma	0.0	1.0	0.0	10.0				0.3452
591	KLF4	ENSG00000136826	ovarian cancer	0.0	1.0	1.0	10.0				0.01287
592	KLF4	ENSG00000136826	pancreatic cancer	0.0	4.0	0.0	7.0				0.01178
593	KLF4	ENSG00000136826	prostate cancer	0.0	0.0	0.0	9.0				0.1084
594	KLF4	ENSG00000136826	renal cancer	0.0	0.0	0.0	12.0	3.93e-05			
595	KLF4	ENSG00000136826	skin cancer	3.0	3.0	0.0	5.0				
596	KLF4	ENSG00000136826	stomach cancer	0.0	2.0	5.0	3.0				0.2549
597	KLF4	ENSG00000136826	testis cancer	1.0	4.0	2.0	5.0				0.1667
598	KLF4	ENSG00000136826	thyroid cancer	0.0	0.0	0.0	4.0				0.08133
599	KLF4	ENSG00000136826	urothelial cancer	2.0	2.0	0.0	7.0				0.08317
600	MYBBP1A	ENSG00000132382	breast cancer	2.0	4.0	4.0	1.0		0.0806		
601	MYBBP1A	ENSG00000132382	carcinoid	2.0	1.0	1.0	0.0				
602	MYBBP1A	ENSG00000132382	cervical cancer	4.0	4.0	0.0	4.0				0.2332
603	MYBBP1A	ENSG00000132382	colorectal cancer	7.0	5.0	0.0	0.0				0.1709
604	MYBBP1A	ENSG00000132382	endometrial cancer	2.0	3.0	5.0	1.0		0.0901		
605	MYBBP1A	ENSG00000132382	glioma	4.0	4.0	2.0	1.0				0.07815
606	MYBBP1A	ENSG00000132382	head and neck cancer	1.0	1.0	0.0	0.0				0.1287
607	MYBBP1A	ENSG00000132382	liver cancer	4.0	3.0	1.0	1.0				0.001566
608	MYBBP1A	ENSG00000132382	lung cancer	4.0	1.0	3.0	2.0				0.2223
609	MYBBP1A	ENSG00000132382	lymphoma	1.0	7.0	1.0	3.0				
610	MYBBP1A	ENSG00000132382	melanoma	9.0	1.0	0.0	1.0			0.0008474	
611	MYBBP1A	ENSG00000132382	ovarian cancer	5.0	5.0	0.0	2.0				0.1843
612	MYBBP1A	ENSG00000132382	pancreatic cancer	4.0	3.0	3.0	1.0	0.000161			
613	MYBBP1A	ENSG00000132382	prostate cancer	7.0	1.0	3.0	1.0				0.003879
614	MYBBP1A	ENSG00000132382	renal cancer	3.0	2.0	1.0	6.0			0.0005955	
615	MYBBP1A	ENSG00000132382	skin cancer	6.0	4.0	1.0	0.0				
616	MYBBP1A	ENSG00000132382	stomach cancer	11.0	0.0	0.0	0.0		0.1785		
617	MYBBP1A	ENSG00000132382	testis cancer	10.0	0.0	1.0	0.0				0.132
618	MYBBP1A	ENSG00000132382	thyroid cancer	0.0	2.0	1.0	1.0			0.0008121	
619	MYBBP1A	ENSG00000132382	urothelial cancer	9.0	2.0	1.0	0.0				0.09703
620	HDAC2	ENSG00000196591	breast cancer	9.0	3.0	0.0	0.0			0.0007074	
621	HDAC2	ENSG00000196591	carcinoid	3.0	0.0	1.0	0.0				
622	HDAC2	ENSG00000196591	cervical cancer	9.0	2.0	1.0	0.0				0.1444
623	HDAC2	ENSG00000196591	colorectal cancer	12.0	0.0	0.0	0.0		0.2666		
624	HDAC2	ENSG00000196591	endometrial cancer	9.0	1.0	0.0	1.0				0.02561
625	HDAC2	ENSG00000196591	glioma	11.0	0.0	0.0	0.0		0.02607		
626	HDAC2	ENSG00000196591	head and neck cancer	4.0	0.0	0.0	0.0				0.0189
627	HDAC2	ENSG00000196591	liver cancer	8.0	1.0	1.0	2.0			5.391e-10	
628	HDAC2	ENSG00000196591	lung cancer	5.0	2.0	1.0	1.0				0.203
629	HDAC2	ENSG00000196591	lymphoma	9.0	2.0	0.0	0.0				
630	HDAC2	ENSG00000196591	melanoma	10.0	0.0	0.0	0.0				0.02634
631	HDAC2	ENSG00000196591	ovarian cancer	10.0	1.0	1.0	0.0				0.08998
632	HDAC2	ENSG00000196591	pancreatic cancer	7.0	2.0	2.0	0.0		0.2012		
633	HDAC2	ENSG00000196591	prostate cancer	6.0	5.0	0.0	0.0		0.3919		
634	HDAC2	ENSG00000196591	renal cancer	7.0	4.0	0.0	0.0				0.01839
635	HDAC2	ENSG00000196591	skin cancer	12.0	0.0	0.0	0.0				
636	HDAC2	ENSG00000196591	stomach cancer	9.0	1.0	0.0	1.0		0.1962		
637	HDAC2	ENSG00000196591	testis cancer	11.0	0.0	0.0	0.0		0.2421		
638	HDAC2	ENSG00000196591	thyroid cancer	2.0	0.0	2.0	0.0		0.09803		
639	HDAC2	ENSG00000196591	urothelial cancer	12.0	0.0	0.0	0.0		0.3511		
640	HDAC1	ENSG00000116478	breast cancer	2.0	9.0	0.0	0.0		0.02514		
641	HDAC1	ENSG00000116478	carcinoid	1.0	3.0	0.0	0.0				
642	HDAC1	ENSG00000116478	cervical cancer	5.0	4.0	0.0	0.0		0.09103		
643	HDAC1	ENSG00000116478	colorectal cancer	9.0	3.0	0.0	0.0				0.2918
644	HDAC1	ENSG00000116478	endometrial cancer	3.0	8.0	0.0	1.0		0.2983		
645	HDAC1	ENSG00000116478	glioma	1.0	4.0	3.0	2.0		0.09147		
646	HDAC1	ENSG00000116478	head and neck cancer	2.0	1.0	1.0	0.0		0.003575		
647	HDAC1	ENSG00000116478	liver cancer	3.0	7.0	0.0	1.0			5.756e-07	
648	HDAC1	ENSG00000116478	lung cancer	4.0	7.0	0.0	0.0				0.09567
649	HDAC1	ENSG00000116478	lymphoma	9.0	2.0	0.0	0.0				
650	HDAC1	ENSG00000116478	melanoma	3.0	8.0	0.0	0.0				0.05015
651	HDAC1	ENSG00000116478	ovarian cancer	2.0	8.0	1.0	0.0				0.03468
652	HDAC1	ENSG00000116478	pancreatic cancer	8.0	4.0	0.0	0.0				0.07062
653	HDAC1	ENSG00000116478	prostate cancer	2.0	10.0	0.0	0.0				0.04444
654	HDAC1	ENSG00000116478	renal cancer	0.0	3.0	4.0	4.0			1.04e-05	
655	HDAC1	ENSG00000116478	skin cancer	2.0	6.0	2.0	0.0				
656	HDAC1	ENSG00000116478	stomach cancer	4.0	7.0	1.0	0.0		0.0686		
657	HDAC1	ENSG00000116478	testis cancer	2.0	8.0	2.0	0.0		0.3776		
658	HDAC1	ENSG00000116478	thyroid cancer	4.0	0.0	0.0	0.0		0.07156		
659	HDAC1	ENSG00000116478	urothelial cancer	4.0	8.0	0.0	0.0		0.1722		
660	PARD3	ENSG00000148498	breast cancer	0.0	2.0	6.0	4.0				0.09494
661	PARD3	ENSG00000148498	carcinoid	0.0	0.0	3.0	1.0				
662	PARD3	ENSG00000148498	cervical cancer	0.0	0.0	1.0	10.0		0.118		
663	PARD3	ENSG00000148498	colorectal cancer	0.0	5.0	6.0	1.0				0.1624
664	PARD3	ENSG00000148498	endometrial cancer	0.0	6.0	3.0	3.0				0.0283
665	PARD3	ENSG00000148498	glioma	0.0	1.0	2.0	7.0		0.01813		
666	PARD3	ENSG00000148498	head and neck cancer	0.0	0.0	0.0	4.0		0.03518		
667	PARD3	ENSG00000148498	liver cancer	0.0	1.0	1.0	10.0			1.728e-05	
668	PARD3	ENSG00000148498	lung cancer	0.0	2.0	1.0	9.0		0.3482		
669	PARD3	ENSG00000148498	lymphoma	0.0	0.0	0.0	11.0				
670	PARD3	ENSG00000148498	melanoma	0.0	2.0	0.0	10.0		0.3495		
671	PARD3	ENSG00000148498	ovarian cancer	0.0	2.0	3.0	7.0				0.08071
672	PARD3	ENSG00000148498	pancreatic cancer	0.0	4.0	4.0	3.0				0.005821
673	PARD3	ENSG00000148498	prostate cancer	0.0	0.0	2.0	10.0				0.1285
674	PARD3	ENSG00000148498	renal cancer	0.0	0.0	1.0	11.0		0.1047		
675	PARD3	ENSG00000148498	skin cancer	0.0	0.0	1.0	11.0				
676	PARD3	ENSG00000148498	stomach cancer	0.0	0.0	2.0	9.0				0.01198
677	PARD3	ENSG00000148498	testis cancer	0.0	2.0	3.0	7.0				0.3544
678	PARD3	ENSG00000148498	thyroid cancer	0.0	2.0	0.0	2.0				0.09197
679	PARD3	ENSG00000148498	urothelial cancer	0.0	1.0	0.0	10.0			0.0004407	
680	HIF1AN	ENSG00000166135	breast cancer	0.0	12.0	0.0	0.0				0.04069
681	HIF1AN	ENSG00000166135	carcinoid	0.0	1.0	3.0	0.0				
682	HIF1AN	ENSG00000166135	cervical cancer	1.0	9.0	2.0	0.0		0.07746		
683	HIF1AN	ENSG00000166135	colorectal cancer	0.0	9.0	2.0	0.0				0.02354
684	HIF1AN	ENSG00000166135	endometrial cancer	1.0	7.0	3.0	0.0				0.03827
685	HIF1AN	ENSG00000166135	glioma	0.0	3.0	3.0	5.0				0.01667
686	HIF1AN	ENSG00000166135	head and neck cancer	0.0	4.0	0.0	0.0		0.1213		
687	HIF1AN	ENSG00000166135	liver cancer	0.0	4.0	5.0	2.0				0.00807
688	HIF1AN	ENSG00000166135	lung cancer	0.0	7.0	3.0	1.0				0.08822
689	HIF1AN	ENSG00000166135	lymphoma	0.0	7.0	3.0	2.0				
690	HIF1AN	ENSG00000166135	melanoma	0.0	4.0	4.0	1.0		0.2545		
691	HIF1AN	ENSG00000166135	ovarian cancer	1.0	9.0	1.0	1.0				0.001413
692	HIF1AN	ENSG00000166135	pancreatic cancer	0.0	5.0	3.0	0.0		0.01536		
693	HIF1AN	ENSG00000166135	prostate cancer	0.0	4.0	5.0	3.0				0.03054
694	HIF1AN	ENSG00000166135	renal cancer	0.0	0.0	7.0	4.0		0.03008		
695	HIF1AN	ENSG00000166135	skin cancer	0.0	9.0	1.0	0.0				
696	HIF1AN	ENSG00000166135	stomach cancer	0.0	8.0	4.0	0.0		0.03086		
697	HIF1AN	ENSG00000166135	testis cancer	2.0	7.0	0.0	0.0		0.09924		
698	HIF1AN	ENSG00000166135	thyroid cancer	0.0	0.0	0.0	4.0		0.141		
699	HIF1AN	ENSG00000166135	urothelial cancer	1.0	9.0	0.0	0.0				0.03236
700	POLR2G	ENSG00000168002	breast cancer	0.0	7.0	3.0	0.0		0.007577		
701	POLR2G	ENSG00000168002	carcinoid	0.0	2.0	2.0	0.0				
702	POLR2G	ENSG00000168002	cervical cancer	0.0	4.0	5.0	3.0		0.275		
703	POLR2G	ENSG00000168002	colorectal cancer	0.0	4.0	3.0	5.0		0.02367		
704	POLR2G	ENSG00000168002	endometrial cancer	0.0	2.0	4.0	5.0	0.0008232			
705	POLR2G	ENSG00000168002	glioma	0.0	2.0	1.0	6.0				0.1389
706	POLR2G	ENSG00000168002	head and neck cancer	0.0	3.0	0.0	1.0				0.02161
707	POLR2G	ENSG00000168002	liver cancer	0.0	6.0	4.0	2.0			6.021e-05	
708	POLR2G	ENSG00000168002	lung cancer	0.0	8.0	2.0	2.0				0.08499
709	POLR2G	ENSG00000168002	lymphoma	0.0	3.0	0.0	9.0				
710	POLR2G	ENSG00000168002	melanoma	0.0	9.0	2.0	1.0				0.06008
711	POLR2G	ENSG00000168002	ovarian cancer	0.0	4.0	5.0	3.0		0.006264		
712	POLR2G	ENSG00000168002	pancreatic cancer	0.0	3.0	4.0	4.0				0.0941
713	POLR2G	ENSG00000168002	prostate cancer	0.0	1.0	4.0	4.0		0.1853		
714	POLR2G	ENSG00000168002	renal cancer	0.0	0.0	0.0	11.0			0.0001115	
715	POLR2G	ENSG00000168002	skin cancer	0.0	7.0	2.0	3.0				
716	POLR2G	ENSG00000168002	stomach cancer	0.0	2.0	4.0	6.0		0.1527		
717	POLR2G	ENSG00000168002	testis cancer	0.0	7.0	2.0	1.0				0.1641
718	POLR2G	ENSG00000168002	thyroid cancer	0.0	3.0	1.0	0.0		0.2462		
719	POLR2G	ENSG00000168002	urothelial cancer	1.0	3.0	3.0	3.0				0.221
720	SP1	ENSG00000185591	breast cancer	5.0	6.0	0.0	0.0				0.112
721	SP1	ENSG00000185591	carcinoid	1.0	3.0	0.0	0.0				
722	SP1	ENSG00000185591	cervical cancer	6.0	5.0	0.0	0.0		0.008523		
723	SP1	ENSG00000185591	colorectal cancer	7.0	5.0	0.0	0.0		0.06109		
724	SP1	ENSG00000185591	endometrial cancer	2.0	8.0	1.0	0.0				0.1242
725	SP1	ENSG00000185591	glioma	1.0	7.0	4.0	0.0		0.2029		
726	SP1	ENSG00000185591	head and neck cancer	2.0	2.0	0.0	0.0		0.004638		
727	SP1	ENSG00000185591	liver cancer	0.0	7.0	3.0	0.0				0.01085
728	SP1	ENSG00000185591	lung cancer	0.0	6.0	5.0	0.0		0.2532		
729	SP1	ENSG00000185591	lymphoma	9.0	3.0	0.0	0.0				
730	SP1	ENSG00000185591	melanoma	1.0	7.0	3.0	0.0				0.1012
731	SP1	ENSG00000185591	ovarian cancer	3.0	6.0	3.0	0.0				0.02659
732	SP1	ENSG00000185591	pancreatic cancer	1.0	5.0	4.0	0.0			0.0001433	
733	SP1	ENSG00000185591	prostate cancer	3.0	8.0	0.0	0.0				0.06377
734	SP1	ENSG00000185591	renal cancer	0.0	8.0	2.0	0.0		0.05137		
735	SP1	ENSG00000185591	skin cancer	3.0	5.0	0.0	0.0				
736	SP1	ENSG00000185591	stomach cancer	0.0	7.0	5.0	0.0		0.04053		
737	SP1	ENSG00000185591	testis cancer	3.0	7.0	2.0	0.0				0.1368
738	SP1	ENSG00000185591	thyroid cancer	1.0	2.0	1.0	0.0				0.04766
739	SP1	ENSG00000185591	urothelial cancer	6.0	5.0	0.0	0.0		0.02117		
740	FN1	ENSG00000115414	breast cancer	0.0	2.0	2.0	8.0				0.08081
741	FN1	ENSG00000115414	carcinoid	0.0	0.0	1.0	3.0				
742	FN1	ENSG00000115414	cervical cancer	0.0	0.0	5.0	7.0				0.001094
743	FN1	ENSG00000115414	colorectal cancer	1.0	2.0	4.0	4.0				0.02201
744	FN1	ENSG00000115414	endometrial cancer	1.0	1.0	1.0	8.0				0.003448
745	FN1	ENSG00000115414	glioma	0.0	0.0	2.0	9.0				0.0182
746	FN1	ENSG00000115414	head and neck cancer	0.0	0.0	2.0	2.0				0.00347
747	FN1	ENSG00000115414	liver cancer	3.0	4.0	2.0	3.0				0.03361
748	FN1	ENSG00000115414	lung cancer	0.0	2.0	5.0	5.0				0.005909
749	FN1	ENSG00000115414	lymphoma	0.0	0.0	1.0	11.0				
750	FN1	ENSG00000115414	melanoma	0.0	3.0	2.0	7.0				0.02964
751	FN1	ENSG00000115414	ovarian cancer	0.0	0.0	2.0	7.0				0.002909
752	FN1	ENSG00000115414	pancreatic cancer	3.0	3.0	3.0	2.0				0.01407
753	FN1	ENSG00000115414	prostate cancer	0.0	0.0	2.0	9.0		0.2843		
754	FN1	ENSG00000115414	renal cancer	0.0	0.0	2.0	10.0			3.441e-08	
755	FN1	ENSG00000115414	skin cancer	0.0	1.0	1.0	9.0				
756	FN1	ENSG00000115414	stomach cancer	0.0	1.0	3.0	4.0			8.82e-05	
757	FN1	ENSG00000115414	testis cancer	0.0	1.0	7.0	4.0				0.07879
758	FN1	ENSG00000115414	thyroid cancer	1.0	2.0	0.0	1.0		0.07742		
759	FN1	ENSG00000115414	urothelial cancer	1.0	4.0	3.0	4.0			0.0003329	
760	CSNK1A1	ENSG00000113712	breast cancer	0.0	4.0	4.0	0.0				0.004268
761	CSNK1A1	ENSG00000113712	carcinoid	0.0	1.0	1.0	2.0				
762	CSNK1A1	ENSG00000113712	cervical cancer	0.0	2.0	7.0	3.0				0.005845
763	CSNK1A1	ENSG00000113712	colorectal cancer	0.0	6.0	4.0	1.0	0.000115			
764	CSNK1A1	ENSG00000113712	endometrial cancer	0.0	3.0	8.0	0.0				0.07385
765	CSNK1A1	ENSG00000113712	glioma	0.0	1.0	4.0	6.0		0.2658		
766	CSNK1A1	ENSG00000113712	head and neck cancer	0.0	2.0	1.0	0.0				0.3136
767	CSNK1A1	ENSG00000113712	liver cancer	0.0	4.0	5.0	3.0				0.01271
768	CSNK1A1	ENSG00000113712	lung cancer	0.0	4.0	6.0	1.0				0.05558
769	CSNK1A1	ENSG00000113712	lymphoma	0.0	3.0	0.0	8.0				
770	CSNK1A1	ENSG00000113712	melanoma	0.0	5.0	4.0	1.0		0.4384		
771	CSNK1A1	ENSG00000113712	ovarian cancer	1.0	7.0	3.0	0.0				0.08308
772	CSNK1A1	ENSG00000113712	pancreatic cancer	0.0	5.0	6.0	1.0			0.0005788	
773	CSNK1A1	ENSG00000113712	prostate cancer	0.0	0.0	8.0	3.0				0.0547
774	CSNK1A1	ENSG00000113712	renal cancer	0.0	0.0	4.0	8.0				0.1562
775	CSNK1A1	ENSG00000113712	skin cancer	0.0	1.0	10.0	1.0				
776	CSNK1A1	ENSG00000113712	stomach cancer	0.0	7.0	3.0	0.0		0.0792		
777	CSNK1A1	ENSG00000113712	testis cancer	2.0	7.0	2.0	0.0				0.04406
778	CSNK1A1	ENSG00000113712	thyroid cancer	0.0	0.0	2.0	1.0				0.006277
779	CSNK1A1	ENSG00000113712	urothelial cancer	0.0	7.0	4.0	1.0				0.06923
780	PRKCI	ENSG00000163558	breast cancer	0.0	5.0	5.0	2.0				0.2256
781	PRKCI	ENSG00000163558	carcinoid	0.0	1.0	1.0	2.0				
782	PRKCI	ENSG00000163558	cervical cancer	0.0	7.0	1.0	4.0		0.06751		
783	PRKCI	ENSG00000163558	colorectal cancer	2.0	6.0	3.0	1.0		0.04567		
784	PRKCI	ENSG00000163558	endometrial cancer	0.0	2.0	5.0	5.0			3.928e-06	
785	PRKCI	ENSG00000163558	glioma	0.0	0.0	0.0	12.0				0.1591
786	PRKCI	ENSG00000163558	head and neck cancer	1.0	0.0	2.0	1.0				0.01838
787	PRKCI	ENSG00000163558	liver cancer	1.0	0.0	2.0	9.0			0.0003023	
788	PRKCI	ENSG00000163558	lung cancer	0.0	3.0	4.0	5.0		0.2524		
789	PRKCI	ENSG00000163558	lymphoma	0.0	0.0	1.0	10.0				
790	PRKCI	ENSG00000163558	melanoma	0.0	0.0	1.0	8.0				0.07097
791	PRKCI	ENSG00000163558	ovarian cancer	4.0	4.0	2.0	2.0				0.01727
792	PRKCI	ENSG00000163558	pancreatic cancer	0.0	5.0	4.0	3.0			0.0001215	
793	PRKCI	ENSG00000163558	prostate cancer	0.0	1.0	5.0	6.0				0.005319
794	PRKCI	ENSG00000163558	renal cancer	0.0	1.0	3.0	8.0	0.0003097			
795	PRKCI	ENSG00000163558	skin cancer	0.0	4.0	2.0	5.0				
796	PRKCI	ENSG00000163558	stomach cancer	1.0	5.0	2.0	2.0		0.1165		
797	PRKCI	ENSG00000163558	testis cancer	0.0	5.0	3.0	1.0		0.2654		
798	PRKCI	ENSG00000163558	thyroid cancer	1.0	2.0	1.0	0.0				0.1062
799	PRKCI	ENSG00000163558	urothelial cancer	2.0	4.0	1.0	5.0				0.0973
800	CARD9	ENSG00000187796	breast cancer	0.0	0.0	0.0	10.0		0.07035		
801	CARD9	ENSG00000187796	carcinoid	0.0	0.0	0.0	4.0				
802	CARD9	ENSG00000187796	cervical cancer	0.0	1.0	0.0	11.0		0.05607		
803	CARD9	ENSG00000187796	colorectal cancer	0.0	0.0	1.0	10.0				0.008624
804	CARD9	ENSG00000187796	endometrial cancer	0.0	0.0	1.0	6.0				0.02063
805	CARD9	ENSG00000187796	glioma	0.0	1.0	1.0	8.0		0.2752		
806	CARD9	ENSG00000187796	head and neck cancer	0.0	0.0	0.0	4.0		0.02108		
807	CARD9	ENSG00000187796	liver cancer	0.0	0.0	0.0	11.0				0.003886
808	CARD9	ENSG00000187796	lung cancer	0.0	0.0	0.0	11.0		0.06358		
809	CARD9	ENSG00000187796	lymphoma	0.0	0.0	0.0	10.0				
810	CARD9	ENSG00000187796	melanoma	0.0	0.0	0.0	12.0				0.2645
811	CARD9	ENSG00000187796	ovarian cancer	0.0	0.0	0.0	11.0				0.01549
812	CARD9	ENSG00000187796	pancreatic cancer	0.0	0.0	1.0	8.0		0.007684		
813	CARD9	ENSG00000187796	prostate cancer	0.0	0.0	0.0	12.0				0.06971
814	CARD9	ENSG00000187796	renal cancer	0.0	0.0	0.0	11.0				2.023e-06
815	CARD9	ENSG00000187796	skin cancer	0.0	0.0	0.0	12.0				
816	CARD9	ENSG00000187796	stomach cancer	0.0	0.0	0.0	9.0		0.252		
817	CARD9	ENSG00000187796	testis cancer	0.0	0.0	0.0	11.0				0.004867
818	CARD9	ENSG00000187796	thyroid cancer	0.0	0.0	0.0	4.0		0.306		
819	CARD9	ENSG00000187796	urothelial cancer	0.0	0.0	1.0	10.0				0.1058
820	GSK3B	ENSG00000082701	breast cancer	0.0	6.0	5.0	0.0				0.01089
821	GSK3B	ENSG00000082701	carcinoid	1.0	1.0	0.0	2.0				
822	GSK3B	ENSG00000082701	cervical cancer	0.0	4.0	5.0	2.0				0.2623
823	GSK3B	ENSG00000082701	colorectal cancer	0.0	5.0	4.0	2.0				0.1398
824	GSK3B	ENSG00000082701	endometrial cancer	0.0	4.0	3.0	5.0				0.002173
825	GSK3B	ENSG00000082701	glioma	1.0	6.0	2.0	2.0		0.1152		
826	GSK3B	ENSG00000082701	head and neck cancer	0.0	3.0	0.0	0.0		0.04863		
827	GSK3B	ENSG00000082701	liver cancer	0.0	3.0	1.0	7.0			8.2e-05	
828	GSK3B	ENSG00000082701	lung cancer	0.0	1.0	4.0	6.0				0.0339
829	GSK3B	ENSG00000082701	lymphoma	2.0	5.0	2.0	3.0				
830	GSK3B	ENSG00000082701	melanoma	0.0	9.0	3.0	0.0				0.1115
831	GSK3B	ENSG00000082701	ovarian cancer	0.0	2.0	2.0	6.0				0.01673
832	GSK3B	ENSG00000082701	pancreatic cancer	0.0	3.0	6.0	1.0				0.001048
833	GSK3B	ENSG00000082701	prostate cancer	0.0	8.0	2.0	2.0				0.06792
834	GSK3B	ENSG00000082701	renal cancer	0.0	2.0	1.0	9.0	0.0001518			
835	GSK3B	ENSG00000082701	skin cancer	0.0	8.0	2.0	0.0				
836	GSK3B	ENSG00000082701	stomach cancer	0.0	1.0	5.0	4.0				0.2386
837	GSK3B	ENSG00000082701	testis cancer	2.0	3.0	4.0	3.0		0.2576		
838	GSK3B	ENSG00000082701	thyroid cancer	0.0	2.0	2.0	0.0		0.01281		
839	GSK3B	ENSG00000082701	urothelial cancer	1.0	8.0	3.0	0.0				0.1159
840	USP33	ENSG00000077254	breast cancer	0.0	2.0	6.0	4.0		0.002313		
841	USP33	ENSG00000077254	carcinoid	0.0	0.0	1.0	3.0				
842	USP33	ENSG00000077254	cervical cancer	0.0	2.0	2.0	8.0				0.02726
843	USP33	ENSG00000077254	colorectal cancer	0.0	6.0	3.0	3.0		0.01036		
844	USP33	ENSG00000077254	endometrial cancer	0.0	3.0	7.0	2.0				0.236
845	USP33	ENSG00000077254	glioma	0.0	1.0	8.0	3.0		0.00919		
846	USP33	ENSG00000077254	head and neck cancer	0.0	0.0	1.0	3.0		0.001881		
847	USP33	ENSG00000077254	liver cancer	1.0	7.0	2.0	1.0				0.01223
848	USP33	ENSG00000077254	lung cancer	0.0	2.0	4.0	5.0		0.06064		
849	USP33	ENSG00000077254	lymphoma	0.0	0.0	2.0	9.0				
850	USP33	ENSG00000077254	melanoma	0.0	7.0	1.0	4.0				0.2479
851	USP33	ENSG00000077254	ovarian cancer	0.0	7.0	2.0	3.0				0.2247
852	USP33	ENSG00000077254	pancreatic cancer	0.0	3.0	7.0	2.0		0.2666		
853	USP33	ENSG00000077254	prostate cancer	0.0	1.0	4.0	5.0		0.3589		
854	USP33	ENSG00000077254	renal cancer	0.0	0.0	8.0	3.0		0.005364		
855	USP33	ENSG00000077254	skin cancer	0.0	2.0	4.0	6.0				
856	USP33	ENSG00000077254	stomach cancer	1.0	3.0	3.0	4.0		0.04894		
857	USP33	ENSG00000077254	testis cancer	0.0	4.0	1.0	5.0		0.05761		
858	USP33	ENSG00000077254	thyroid cancer	0.0	2.0	1.0	1.0		0.219		
859	USP33	ENSG00000077254	urothelial cancer	0.0	0.0	2.0	9.0		0.02021		
860	HIF1A	ENSG00000100644	breast cancer	0.0	2.0	9.0	1.0				0.01071
861	HIF1A	ENSG00000100644	carcinoid	0.0	2.0	1.0	1.0				
862	HIF1A	ENSG00000100644	cervical cancer	0.0	1.0	6.0	4.0				0.001125
863	HIF1A	ENSG00000100644	colorectal cancer	3.0	4.0	2.0	1.0		0.09408		
864	HIF1A	ENSG00000100644	endometrial cancer	0.0	2.0	3.0	7.0		0.1069		
865	HIF1A	ENSG00000100644	glioma	1.0	2.0	5.0	4.0		0.02513		
866	HIF1A	ENSG00000100644	head and neck cancer	1.0	0.0	1.0	1.0				0.1898
867	HIF1A	ENSG00000100644	liver cancer	0.0	1.0	2.0	8.0				0.00294
868	HIF1A	ENSG00000100644	lung cancer	0.0	1.0	4.0	6.0				0.3399
869	HIF1A	ENSG00000100644	lymphoma	1.0	5.0	4.0	1.0				
870	HIF1A	ENSG00000100644	melanoma	0.0	4.0	4.0	4.0				0.4051
871	HIF1A	ENSG00000100644	ovarian cancer	0.0	5.0	4.0	2.0		0.139		
872	HIF1A	ENSG00000100644	pancreatic cancer	0.0	5.0	2.0	4.0				0.01773
873	HIF1A	ENSG00000100644	prostate cancer	0.0	0.0	5.0	5.0				0.08394
874	HIF1A	ENSG00000100644	renal cancer	0.0	1.0	3.0	7.0		0.1235		
875	HIF1A	ENSG00000100644	skin cancer	0.0	2.0	6.0	4.0				
876	HIF1A	ENSG00000100644	stomach cancer	1.0	0.0	3.0	8.0				0.03232
877	HIF1A	ENSG00000100644	testis cancer	0.0	7.0	5.0	0.0		0.3581		
878	HIF1A	ENSG00000100644	thyroid cancer	0.0	0.0	2.0	1.0				0.07348
879	HIF1A	ENSG00000100644	urothelial cancer	4.0	2.0	6.0	0.0				0.03885
880	TUBB	ENSG00000196230	breast cancer	0.0	10.0	1.0	0.0				0.1014
881	TUBB	ENSG00000196230	carcinoid	1.0	2.0	0.0	1.0				
882	TUBB	ENSG00000196230	cervical cancer	0.0	7.0	3.0	1.0				0.233
883	TUBB	ENSG00000196230	colorectal cancer	0.0	10.0	2.0	0.0		0.002172		
884	TUBB	ENSG00000196230	endometrial cancer	0.0	9.0	2.0	0.0				0.01919
885	TUBB	ENSG00000196230	glioma	0.0	9.0	3.0	0.0				0.1556
886	TUBB	ENSG00000196230	head and neck cancer	0.0	3.0	1.0	0.0				0.02156
887	TUBB	ENSG00000196230	liver cancer	0.0	2.0	3.0	7.0			0.0005966	
888	TUBB	ENSG00000196230	lung cancer	0.0	2.0	7.0	2.0				0.02573
889	TUBB	ENSG00000196230	lymphoma	0.0	6.0	1.0	4.0				
890	TUBB	ENSG00000196230	melanoma	0.0	8.0	4.0	0.0				0.2515
891	TUBB	ENSG00000196230	ovarian cancer	0.0	8.0	3.0	0.0		0.002181		
892	TUBB	ENSG00000196230	pancreatic cancer	0.0	9.0	1.0	0.0				0.01268
893	TUBB	ENSG00000196230	prostate cancer	0.0	8.0	2.0	1.0				0.2471
894	TUBB	ENSG00000196230	renal cancer	0.0	7.0	3.0	2.0			2.616e-08	
895	TUBB	ENSG00000196230	skin cancer	0.0	6.0	4.0	2.0				
896	TUBB	ENSG00000196230	stomach cancer	0.0	4.0	3.0	1.0				0.08628
897	TUBB	ENSG00000196230	testis cancer	3.0	7.0	1.0	0.0		0.1471		
898	TUBB	ENSG00000196230	thyroid cancer	0.0	3.0	0.0	1.0				0.2487
899	TUBB	ENSG00000196230	urothelial cancer	0.0	7.0	3.0	2.0				0.2502
900	USP20	ENSG00000136878	breast cancer	3.0	9.0	0.0	0.0				0.02637
901	USP20	ENSG00000136878	carcinoid	2.0	2.0	0.0	0.0				
902	USP20	ENSG00000136878	cervical cancer	1.0	11.0	0.0	0.0	0.0008009			
903	USP20	ENSG00000136878	colorectal cancer	5.0	7.0	0.0	0.0			0.000248	
904	USP20	ENSG00000136878	endometrial cancer	0.0	11.0	0.0	0.0	0.0004015			
905	USP20	ENSG00000136878	glioma	1.0	8.0	3.0	0.0				0.4691
906	USP20	ENSG00000136878	head and neck cancer	1.0	3.0	0.0	0.0		0.01885		
907	USP20	ENSG00000136878	liver cancer	2.0	9.0	0.0	0.0				0.2253
908	USP20	ENSG00000136878	lung cancer	0.0	6.0	6.0	0.0		0.002546		
909	USP20	ENSG00000136878	lymphoma	1.0	4.0	6.0	1.0				
910	USP20	ENSG00000136878	melanoma	1.0	7.0	4.0	0.0		0.1245		
911	USP20	ENSG00000136878	ovarian cancer	3.0	8.0	0.0	0.0				0.07889
912	USP20	ENSG00000136878	pancreatic cancer	1.0	10.0	1.0	0.0	1.539e-07			
913	USP20	ENSG00000136878	prostate cancer	3.0	9.0	0.0	0.0				0.2091
914	USP20	ENSG00000136878	renal cancer	2.0	10.0	0.0	0.0	5.649e-05			
915	USP20	ENSG00000136878	skin cancer	0.0	6.0	6.0	0.0				
916	USP20	ENSG00000136878	stomach cancer	2.0	10.0	0.0	0.0		0.01763		
917	USP20	ENSG00000136878	testis cancer	0.0	12.0	0.0	0.0		0.1197		
918	USP20	ENSG00000136878	thyroid cancer	0.0	4.0	0.0	0.0				0.01186
919	USP20	ENSG00000136878	urothelial cancer	6.0	6.0	0.0	0.0		0.01238		
920	ELOC	ENSG00000154582	breast cancer							0.0006476	
921	ELOC	ENSG00000154582	carcinoid								
922	ELOC	ENSG00000154582	cervical cancer								0.16
923	ELOC	ENSG00000154582	colorectal cancer								0.3144
924	ELOC	ENSG00000154582	endometrial cancer								0.02835
925	ELOC	ENSG00000154582	glioma								0.02463
926	ELOC	ENSG00000154582	head and neck cancer								0.008021
927	ELOC	ENSG00000154582	liver cancer								0.005837
928	ELOC	ENSG00000154582	lung cancer								0.0219
929	ELOC	ENSG00000154582	lymphoma								
930	ELOC	ENSG00000154582	melanoma								0.1767
931	ELOC	ENSG00000154582	ovarian cancer						0.006993		
932	ELOC	ENSG00000154582	pancreatic cancer								0.004021
933	ELOC	ENSG00000154582	prostate cancer								0.0333
934	ELOC	ENSG00000154582	renal cancer								0.002768
935	ELOC	ENSG00000154582	skin cancer								
936	ELOC	ENSG00000154582	stomach cancer						0.03838		
937	ELOC	ENSG00000154582	testis cancer						0.05332		
938	ELOC	ENSG00000154582	thyroid cancer						0.1667		
939	ELOC	ENSG00000154582	urothelial cancer						0.08954		
940	CCT6B	ENSG00000132141	breast cancer	0.0	10.0	2.0	0.0		0.1559		
941	CCT6B	ENSG00000132141	carcinoid	1.0	0.0	3.0	0.0				
942	CCT6B	ENSG00000132141	cervical cancer	0.0	2.0	5.0	4.0		0.01719		
943	CCT6B	ENSG00000132141	colorectal cancer	6.0	6.0	0.0	0.0		0.002988		
944	CCT6B	ENSG00000132141	endometrial cancer	1.0	8.0	1.0	1.0		0.06114		
945	CCT6B	ENSG00000132141	glioma	0.0	6.0	3.0	2.0				0.3376
946	CCT6B	ENSG00000132141	head and neck cancer	0.0	3.0	1.0	0.0		0.1148		
947	CCT6B	ENSG00000132141	liver cancer	4.0	4.0	3.0	1.0		0.001124		
948	CCT6B	ENSG00000132141	lung cancer	0.0	5.0	2.0	3.0		0.03614		
949	CCT6B	ENSG00000132141	lymphoma	1.0	5.0	5.0	1.0				
950	CCT6B	ENSG00000132141	melanoma	2.0	6.0	3.0	1.0		0.1749		
951	CCT6B	ENSG00000132141	ovarian cancer	1.0	6.0	4.0	0.0		0.001435		
952	CCT6B	ENSG00000132141	pancreatic cancer	0.0	5.0	6.0	1.0		0.009561		
953	CCT6B	ENSG00000132141	prostate cancer	0.0	8.0	1.0	1.0		0.0361		
954	CCT6B	ENSG00000132141	renal cancer	0.0	3.0	4.0	5.0		4.822e-07		
955	CCT6B	ENSG00000132141	skin cancer	0.0	7.0	3.0	1.0				
956	CCT6B	ENSG00000132141	stomach cancer	0.0	5.0	2.0	5.0				0.1238
957	CCT6B	ENSG00000132141	testis cancer	4.0	7.0	0.0	1.0		0.4296		
958	CCT6B	ENSG00000132141	thyroid cancer	0.0	1.0	2.0	1.0				0.0004227
959	CCT6B	ENSG00000132141	urothelial cancer	0.0	7.0	1.0	2.0		0.1492		
960	TP53	ENSG00000141510	breast cancer	1.0	1.0	0.0	10.0				0.02289
961	TP53	ENSG00000141510	carcinoid	0.0	0.0	0.0	4.0				
962	TP53	ENSG00000141510	cervical cancer	1.0	2.0	3.0	4.0		0.00883		
963	TP53	ENSG00000141510	colorectal cancer	5.0	1.0	4.0	2.0		0.01257		
964	TP53	ENSG00000141510	endometrial cancer	1.0	0.0	0.0	10.0	0.0001346			
965	TP53	ENSG00000141510	glioma	3.0	2.0	0.0	7.0		0.09953		
966	TP53	ENSG00000141510	head and neck cancer	1.0	1.0	0.0	2.0		0.04		
967	TP53	ENSG00000141510	liver cancer	0.0	0.0	3.0	7.0		0.00279		
968	TP53	ENSG00000141510	lung cancer	2.0	2.0	3.0	5.0		0.04993		
969	TP53	ENSG00000141510	lymphoma	0.0	0.0	3.0	9.0				
970	TP53	ENSG00000141510	melanoma	0.0	3.0	4.0	4.0				0.0275
971	TP53	ENSG00000141510	ovarian cancer	6.0	0.0	0.0	6.0		0.2554		
972	TP53	ENSG00000141510	pancreatic cancer	4.0	3.0	2.0	1.0				0.1303
973	TP53	ENSG00000141510	prostate cancer	0.0	0.0	0.0	10.0			0.0005014	
974	TP53	ENSG00000141510	renal cancer	0.0	0.0	1.0	10.0				0.001861
975	TP53	ENSG00000141510	skin cancer	1.0	1.0	5.0	4.0				
976	TP53	ENSG00000141510	stomach cancer	5.0	0.0	2.0	5.0		0.00789		
977	TP53	ENSG00000141510	testis cancer	1.0	2.0	7.0	2.0				0.08052
978	TP53	ENSG00000141510	thyroid cancer	0.0	0.0	0.0	4.0				0.2743
979	TP53	ENSG00000141510	urothelial cancer	4.0	3.0	2.0	2.0				0.1078
980	KIFAP3	ENSG00000075945	breast cancer	3.0	8.0	0.0	0.0				0.05721
981	KIFAP3	ENSG00000075945	carcinoid	1.0	2.0	1.0	0.0				
982	KIFAP3	ENSG00000075945	cervical cancer	0.0	6.0	4.0	2.0				0.1656
983	KIFAP3	ENSG00000075945	colorectal cancer	2.0	8.0	0.0	1.0				0.3893
984	KIFAP3	ENSG00000075945	endometrial cancer	0.0	3.0	5.0	4.0				0.06045
985	KIFAP3	ENSG00000075945	glioma	0.0	6.0	3.0	3.0				0.04637
986	KIFAP3	ENSG00000075945	head and neck cancer	0.0	1.0	2.0	0.0		0.1474		
987	KIFAP3	ENSG00000075945	liver cancer	0.0	5.0	7.0	0.0				0.007167
988	KIFAP3	ENSG00000075945	lung cancer	0.0	0.0	4.0	7.0				0.07743
989	KIFAP3	ENSG00000075945	lymphoma	0.0	3.0	7.0	2.0				
990	KIFAP3	ENSG00000075945	melanoma	0.0	3.0	4.0	5.0				0.01017
991	KIFAP3	ENSG00000075945	ovarian cancer	0.0	8.0	2.0	1.0				0.3636
992	KIFAP3	ENSG00000075945	pancreatic cancer	0.0	2.0	6.0	2.0		0.1155		
993	KIFAP3	ENSG00000075945	prostate cancer	3.0	8.0	0.0	0.0				0.03999
994	KIFAP3	ENSG00000075945	renal cancer	0.0	3.0	7.0	1.0				0.003079
995	KIFAP3	ENSG00000075945	skin cancer	0.0	0.0	6.0	6.0				
996	KIFAP3	ENSG00000075945	stomach cancer	0.0	2.0	1.0	9.0				0.004388
997	KIFAP3	ENSG00000075945	testis cancer	0.0	7.0	3.0	1.0		0.1997		
998	KIFAP3	ENSG00000075945	thyroid cancer	0.0	3.0	1.0	0.0				0.1112
999	KIFAP3	ENSG00000075945	urothelial cancer	1.0	3.0	4.0	4.0				0.02218
1000	PRKCD	ENSG00000163932	breast cancer	5.0	7.0	0.0	0.0		0.3587		
1001	PRKCD	ENSG00000163932	carcinoid	2.0	1.0	1.0	0.0				
1002	PRKCD	ENSG00000163932	cervical cancer	1.0	9.0	2.0	0.0		0.04853		
1003	PRKCD	ENSG00000163932	colorectal cancer	3.0	6.0	1.0	0.0				0.0266
1004	PRKCD	ENSG00000163932	endometrial cancer	3.0	9.0	0.0	0.0				0.1896
1005	PRKCD	ENSG00000163932	glioma	2.0	6.0	3.0	1.0				0.1171
1006	PRKCD	ENSG00000163932	head and neck cancer	1.0	0.0	2.0	0.0				0.06967
1007	PRKCD	ENSG00000163932	liver cancer	1.0	6.0	3.0	2.0			0.0002241	
1008	PRKCD	ENSG00000163932	lung cancer	1.0	7.0	2.0	1.0	0.0009008			
1009	PRKCD	ENSG00000163932	lymphoma	10.0	1.0	0.0	0.0				
1010	PRKCD	ENSG00000163932	melanoma	4.0	8.0	0.0	0.0		0.01948		
1011	PRKCD	ENSG00000163932	ovarian cancer	9.0	1.0	1.0	1.0		0.1418		
1012	PRKCD	ENSG00000163932	pancreatic cancer	1.0	8.0	1.0	0.0		0.1791		
1013	PRKCD	ENSG00000163932	prostate cancer	3.0	7.0	1.0	0.0				0.2891
1014	PRKCD	ENSG00000163932	renal cancer	1.0	7.0	2.0	2.0		0.2047		
1015	PRKCD	ENSG00000163932	skin cancer	1.0	8.0	3.0	0.0				
1016	PRKCD	ENSG00000163932	stomach cancer	0.0	12.0	0.0	0.0		0.1729		
1017	PRKCD	ENSG00000163932	testis cancer	0.0	1.0	2.0	9.0				0.02478
1018	PRKCD	ENSG00000163932	thyroid cancer	4.0	0.0	0.0	0.0		0.00206		
1019	PRKCD	ENSG00000163932	urothelial cancer	2.0	9.0	0.0	0.0		0.002946		
1020	TUBA4A	ENSG00000127824	breast cancer	0.0	2.0	2.0	6.0				0.08077
1021	TUBA4A	ENSG00000127824	carcinoid	2.0	1.0	0.0	1.0				
1022	TUBA4A	ENSG00000127824	cervical cancer	0.0	1.0	1.0	10.0		0.2315		
1023	TUBA4A	ENSG00000127824	colorectal cancer	0.0	2.0	1.0	9.0		0.04031		
1024	TUBA4A	ENSG00000127824	endometrial cancer	1.0	1.0	1.0	9.0				0.02565
1025	TUBA4A	ENSG00000127824	glioma	4.0	1.0	3.0	3.0				0.005183
1026	TUBA4A	ENSG00000127824	head and neck cancer	0.0	3.0	0.0	1.0				0.03993
1027	TUBA4A	ENSG00000127824	liver cancer	0.0	0.0	2.0	10.0			4.537e-06	
1028	TUBA4A	ENSG00000127824	lung cancer	0.0	0.0	0.0	12.0				0.001522
1029	TUBA4A	ENSG00000127824	lymphoma	0.0	0.0	1.0	10.0				
1030	TUBA4A	ENSG00000127824	melanoma	0.0	3.0	2.0	7.0				0.4471
1031	TUBA4A	ENSG00000127824	ovarian cancer	0.0	1.0	2.0	9.0				0.08851
1032	TUBA4A	ENSG00000127824	pancreatic cancer	0.0	1.0	0.0	9.0				0.01487
1033	TUBA4A	ENSG00000127824	prostate cancer	1.0	2.0	3.0	6.0				0.05272
1034	TUBA4A	ENSG00000127824	renal cancer	0.0	1.0	1.0	10.0		0.1945		
1035	TUBA4A	ENSG00000127824	skin cancer	0.0	3.0	2.0	7.0				
1036	TUBA4A	ENSG00000127824	stomach cancer	0.0	0.0	1.0	11.0		0.2704		
1037	TUBA4A	ENSG00000127824	testis cancer	4.0	3.0	2.0	2.0				0.2355
1038	TUBA4A	ENSG00000127824	thyroid cancer	0.0	1.0	0.0	3.0		0.007383		
1039	TUBA4A	ENSG00000127824	urothelial cancer	0.0	0.0	0.0	10.0				0.09316
1040	KIF3A	ENSG00000131437	breast cancer	0.0	0.0	8.0	4.0				0.008215
1041	KIF3A	ENSG00000131437	carcinoid	0.0	3.0	1.0	0.0				
1042	KIF3A	ENSG00000131437	cervical cancer	0.0	0.0	2.0	10.0				0.2577
1043	KIF3A	ENSG00000131437	colorectal cancer	0.0	5.0	4.0	3.0		0.002286		
1044	KIF3A	ENSG00000131437	endometrial cancer	0.0	4.0	1.0	6.0				0.03587
1045	KIF3A	ENSG00000131437	glioma	0.0	0.0	4.0	6.0				0.2508
1046	KIF3A	ENSG00000131437	head and neck cancer	0.0	0.0	0.0	4.0				0.3796
1047	KIF3A	ENSG00000131437	liver cancer	0.0	0.0	0.0	12.0				0.0008208
1048	KIF3A	ENSG00000131437	lung cancer	0.0	1.0	1.0	9.0				0.1304
1049	KIF3A	ENSG00000131437	lymphoma	0.0	1.0	0.0	10.0				
1050	KIF3A	ENSG00000131437	melanoma	0.0	2.0	0.0	9.0				0.04712
1051	KIF3A	ENSG00000131437	ovarian cancer	0.0	1.0	3.0	7.0				0.1465
1052	KIF3A	ENSG00000131437	pancreatic cancer	0.0	2.0	0.0	9.0		0.01436		
1053	KIF3A	ENSG00000131437	prostate cancer	0.0	0.0	5.0	7.0		0.07641		
1054	KIF3A	ENSG00000131437	renal cancer	0.0	0.0	2.0	10.0		0.006078		
1055	KIF3A	ENSG00000131437	skin cancer	0.0	0.0	0.0	11.0				
1056	KIF3A	ENSG00000131437	stomach cancer	0.0	0.0	2.0	9.0		0.08622		
1057	KIF3A	ENSG00000131437	testis cancer	0.0	2.0	2.0	8.0		0.1922		
1058	KIF3A	ENSG00000131437	thyroid cancer	0.0	0.0	0.0	4.0				0.1167
1059	KIF3A	ENSG00000131437	urothelial cancer	0.0	0.0	3.0	9.0				0.1226
1060	POLR2A	ENSG00000181222	breast cancer	0.0	3.0	7.0	2.0		0.2029		
1061	POLR2A	ENSG00000181222	carcinoid	2.0	1.0	0.0	1.0				
1062	POLR2A	ENSG00000181222	cervical cancer	1.0	3.0	3.0	5.0		0.1316		
1063	POLR2A	ENSG00000181222	colorectal cancer	1.0	2.0	7.0	2.0		0.1575		
1064	POLR2A	ENSG00000181222	endometrial cancer	0.0	4.0	3.0	4.0		0.2403		
1065	POLR2A	ENSG00000181222	glioma	1.0	3.0	1.0	7.0				0.1715
1066	POLR2A	ENSG00000181222	head and neck cancer	1.0	1.0	1.0	1.0		0.05435		
1067	POLR2A	ENSG00000181222	liver cancer	1.0	2.0	1.0	6.0				0.00877
1068	POLR2A	ENSG00000181222	lung cancer	0.0	0.0	1.0	10.0				0.1481
1069	POLR2A	ENSG00000181222	lymphoma	0.0	3.0	4.0	5.0				
1070	POLR2A	ENSG00000181222	melanoma	0.0	0.0	4.0	7.0				0.005194
1071	POLR2A	ENSG00000181222	ovarian cancer	0.0	2.0	2.0	7.0				0.1815
1072	POLR2A	ENSG00000181222	pancreatic cancer	0.0	1.0	1.0	8.0		0.1518		
1073	POLR2A	ENSG00000181222	prostate cancer	0.0	3.0	4.0	4.0				0.03699
1074	POLR2A	ENSG00000181222	renal cancer	0.0	1.0	6.0	5.0		0.001005		
1075	POLR2A	ENSG00000181222	skin cancer	0.0	4.0	4.0	3.0				
1076	POLR2A	ENSG00000181222	stomach cancer	0.0	0.0	0.0	10.0		0.1247		
1077	POLR2A	ENSG00000181222	testis cancer	3.0	6.0	1.0	1.0				0.02303
1078	POLR2A	ENSG00000181222	thyroid cancer	0.0	2.0	0.0	2.0		0.1493		
1079	POLR2A	ENSG00000181222	urothelial cancer	1.0	3.0	6.0	1.0				0.04697
1080	EPAS1	ENSG00000116016	breast cancer								0.1743
1081	EPAS1	ENSG00000116016	carcinoid								
1082	EPAS1	ENSG00000116016	cervical cancer								0.09469
1083	EPAS1	ENSG00000116016	colorectal cancer						0.01293		
1084	EPAS1	ENSG00000116016	endometrial cancer						0.2741		
1085	EPAS1	ENSG00000116016	glioma						0.05247		
1086	EPAS1	ENSG00000116016	head and neck cancer						0.1753		
1087	EPAS1	ENSG00000116016	liver cancer						0.02217		
1088	EPAS1	ENSG00000116016	lung cancer						0.08674		
1089	EPAS1	ENSG00000116016	lymphoma								
1090	EPAS1	ENSG00000116016	melanoma								0.06003
1091	EPAS1	ENSG00000116016	ovarian cancer								0.09716
1092	EPAS1	ENSG00000116016	pancreatic cancer						0.01547		
1093	EPAS1	ENSG00000116016	prostate cancer						0.09294		
1094	EPAS1	ENSG00000116016	renal cancer					0.0002633			
1095	EPAS1	ENSG00000116016	skin cancer								
1096	EPAS1	ENSG00000116016	stomach cancer								0.006657
1097	EPAS1	ENSG00000116016	testis cancer								0.07752
1098	EPAS1	ENSG00000116016	thyroid cancer								0.07555
1099	EPAS1	ENSG00000116016	urothelial cancer						0.1362		
1100	JADE1	ENSG00000077684	breast cancer	0.0	4.0	2.0	5.0		0.01907		
1101	JADE1	ENSG00000077684	carcinoid	0.0	1.0	1.0	2.0				
1102	JADE1	ENSG00000077684	cervical cancer	0.0	0.0	1.0	7.0		0.1807		
1103	JADE1	ENSG00000077684	colorectal cancer	0.0	2.0	3.0	7.0				0.04791
1104	JADE1	ENSG00000077684	endometrial cancer	0.0	1.0	0.0	11.0				0.0163
1105	JADE1	ENSG00000077684	glioma	1.0	6.0	3.0	1.0		0.3188		
1106	JADE1	ENSG00000077684	head and neck cancer	0.0	1.0	0.0	3.0		0.02089		
1107	JADE1	ENSG00000077684	liver cancer	3.0	4.0	3.0	1.0				0.07592
1108	JADE1	ENSG00000077684	lung cancer	0.0	3.0	3.0	5.0		0.006956		
1109	JADE1	ENSG00000077684	lymphoma	0.0	3.0	2.0	7.0				
1110	JADE1	ENSG00000077684	melanoma	0.0	0.0	4.0	7.0		0.06933		
1111	JADE1	ENSG00000077684	ovarian cancer	0.0	3.0	3.0	4.0		0.0816		
1112	JADE1	ENSG00000077684	pancreatic cancer	0.0	4.0	3.0	1.0		0.09386		
1113	JADE1	ENSG00000077684	prostate cancer	0.0	8.0	3.0	0.0		0.008377		
1114	JADE1	ENSG00000077684	renal cancer	3.0	2.0	1.0	6.0	8.217e-06			
1115	JADE1	ENSG00000077684	skin cancer	2.0	0.0	0.0	9.0				
1116	JADE1	ENSG00000077684	stomach cancer	0.0	3.0	5.0	3.0				0.01446
1117	JADE1	ENSG00000077684	testis cancer	0.0	1.0	3.0	8.0		0.2579		
1118	JADE1	ENSG00000077684	thyroid cancer	1.0	1.0	0.0	1.0		0.09918		
1119	JADE1	ENSG00000077684	urothelial cancer	0.0	1.0	5.0	5.0		0.1681		
1120	PRKCZ	ENSG00000067606	breast cancer	0.0	0.0	1.0	10.0		0.01252		
1121	PRKCZ	ENSG00000067606	carcinoid	0.0	2.0	1.0	1.0				
1122	PRKCZ	ENSG00000067606	cervical cancer	0.0	0.0	1.0	10.0				0.2612
1123	PRKCZ	ENSG00000067606	colorectal cancer	0.0	1.0	0.0	11.0		0.05096		
1124	PRKCZ	ENSG00000067606	endometrial cancer	0.0	0.0	3.0	9.0		0.01136		
1125	PRKCZ	ENSG00000067606	glioma	0.0	0.0	0.0	12.0				0.2082
1126	PRKCZ	ENSG00000067606	head and neck cancer	0.0	0.0	0.0	4.0				0.03605
1127	PRKCZ	ENSG00000067606	liver cancer	0.0	0.0	2.0	8.0		0.01726		
1128	PRKCZ	ENSG00000067606	lung cancer	0.0	2.0	4.0	6.0		0.05127		
1129	PRKCZ	ENSG00000067606	lymphoma	0.0	0.0	0.0	12.0				
1130	PRKCZ	ENSG00000067606	melanoma	1.0	0.0	1.0	10.0				0.1184
1131	PRKCZ	ENSG00000067606	ovarian cancer	0.0	1.0	1.0	10.0		0.3104		
1132	PRKCZ	ENSG00000067606	pancreatic cancer	0.0	2.0	1.0	6.0				0.1123
1133	PRKCZ	ENSG00000067606	prostate cancer	0.0	5.0	3.0	4.0		0.2856		
1134	PRKCZ	ENSG00000067606	renal cancer	0.0	0.0	0.0	10.0	1.638e-09			
1135	PRKCZ	ENSG00000067606	skin cancer	0.0	1.0	0.0	11.0				
1136	PRKCZ	ENSG00000067606	stomach cancer	0.0	0.0	1.0	10.0		0.0357		
1137	PRKCZ	ENSG00000067606	testis cancer	0.0	0.0	0.0	10.0		0.03271		
1138	PRKCZ	ENSG00000067606	thyroid cancer	0.0	0.0	1.0	3.0		0.1394		
1139	PRKCZ	ENSG00000067606	urothelial cancer	0.0	0.0	0.0	10.0		0.0785		
1140	COL4A2	ENSG00000134871	breast cancer	0.0	0.0	0.0	12.0		0.2429		
1141	COL4A2	ENSG00000134871	carcinoid	0.0	0.0	0.0	4.0				
1142	COL4A2	ENSG00000134871	cervical cancer	1.0	0.0	1.0	9.0				0.004128
1143	COL4A2	ENSG00000134871	colorectal cancer	0.0	1.0	0.0	11.0				0.08044
1144	COL4A2	ENSG00000134871	endometrial cancer	1.0	0.0	0.0	9.0				0.006029
1145	COL4A2	ENSG00000134871	glioma	0.0	1.0	0.0	11.0				0.2204
1146	COL4A2	ENSG00000134871	head and neck cancer	0.0	0.0	0.0	4.0		0.02637		
1147	COL4A2	ENSG00000134871	liver cancer	0.0	0.0	0.0	12.0				0.03448
1148	COL4A2	ENSG00000134871	lung cancer	0.0	3.0	0.0	8.0				0.01151
1149	COL4A2	ENSG00000134871	lymphoma	0.0	0.0	0.0	12.0				
1150	COL4A2	ENSG00000134871	melanoma	0.0	1.0	0.0	11.0				0.03501
1151	COL4A2	ENSG00000134871	ovarian cancer	1.0	1.0	0.0	9.0				0.1777
1152	COL4A2	ENSG00000134871	pancreatic cancer	1.0	1.0	0.0	10.0				0.149
1153	COL4A2	ENSG00000134871	prostate cancer	0.0	0.0	0.0	11.0		0.1654		
1154	COL4A2	ENSG00000134871	renal cancer	0.0	1.0	0.0	10.0			3.491e-05	
1155	COL4A2	ENSG00000134871	skin cancer	0.0	0.0	0.0	12.0				
1156	COL4A2	ENSG00000134871	stomach cancer	4.0	0.0	0.0	6.0				0.01327
1157	COL4A2	ENSG00000134871	testis cancer	1.0	0.0	0.0	11.0				0.01567
1158	COL4A2	ENSG00000134871	thyroid cancer	0.0	0.0	0.0	4.0				0.06947
1159	COL4A2	ENSG00000134871	urothelial cancer	0.0	0.0	0.0	11.0			0.0009245	
1160	PSMC3	ENSG00000165916	breast cancer	3.0	7.0	1.0	0.0		0.02005		
1161	PSMC3	ENSG00000165916	carcinoid	0.0	2.0	0.0	1.0				
1162	PSMC3	ENSG00000165916	cervical cancer	0.0	5.0	7.0	0.0		0.005082		
1163	PSMC3	ENSG00000165916	colorectal cancer	2.0	10.0	0.0	0.0				0.09434
1164	PSMC3	ENSG00000165916	endometrial cancer	1.0	3.0	7.0	0.0		0.008124		
1165	PSMC3	ENSG00000165916	glioma	8.0	3.0	1.0	0.0				0.06316
1166	PSMC3	ENSG00000165916	head and neck cancer	0.0	2.0	1.0	0.0				0.05713
1167	PSMC3	ENSG00000165916	liver cancer	0.0	5.0	5.0	2.0				0.00899
1168	PSMC3	ENSG00000165916	lung cancer	1.0	1.0	8.0	1.0				0.1631
1169	PSMC3	ENSG00000165916	lymphoma	9.0	2.0	1.0	0.0				
1170	PSMC3	ENSG00000165916	melanoma	4.0	3.0	3.0	0.0		0.09946		
1171	PSMC3	ENSG00000165916	ovarian cancer	0.0	4.0	8.0	0.0		0.01271		
1172	PSMC3	ENSG00000165916	pancreatic cancer	0.0	2.0	10.0	0.0				0.03881
1173	PSMC3	ENSG00000165916	prostate cancer	4.0	7.0	1.0	0.0				0.1117
1174	PSMC3	ENSG00000165916	renal cancer	0.0	4.0	4.0	3.0			0.0004237	
1175	PSMC3	ENSG00000165916	skin cancer	1.0	6.0	5.0	0.0				
1176	PSMC3	ENSG00000165916	stomach cancer	0.0	6.0	6.0	0.0		0.1491		
1177	PSMC3	ENSG00000165916	testis cancer	1.0	10.0	1.0	0.0				0.2246
1178	PSMC3	ENSG00000165916	thyroid cancer	0.0	1.0	1.0	1.0		0.02554		
1179	PSMC3	ENSG00000165916	urothelial cancer	1.0	6.0	5.0	0.0				0.1838
1180	BCL2L11	ENSG00000153094	breast cancer	0.0	11.0	0.0	0.0				0.1429
1181	BCL2L11	ENSG00000153094	carcinoid	0.0	2.0	1.0	1.0				
1182	BCL2L11	ENSG00000153094	cervical cancer	2.0	7.0	3.0	0.0		0.009465		
1183	BCL2L11	ENSG00000153094	colorectal cancer	0.0	12.0	0.0	0.0				0.1875
1184	BCL2L11	ENSG00000153094	endometrial cancer	2.0	9.0	0.0	0.0				0.015
1185	BCL2L11	ENSG00000153094	glioma	0.0	0.0	3.0	6.0				0.1196
1186	BCL2L11	ENSG00000153094	head and neck cancer	0.0	3.0	0.0	1.0		0.003083		
1187	BCL2L11	ENSG00000153094	liver cancer	0.0	12.0	0.0	0.0		0.1054		
1188	BCL2L11	ENSG00000153094	lung cancer	1.0	4.0	2.0	3.0		0.05628		
1189	BCL2L11	ENSG00000153094	lymphoma	1.0	4.0	3.0	4.0				
1190	BCL2L11	ENSG00000153094	melanoma	0.0	1.0	5.0	5.0				0.2388
1191	BCL2L11	ENSG00000153094	ovarian cancer	0.0	12.0	0.0	0.0				0.03429
1192	BCL2L11	ENSG00000153094	pancreatic cancer	1.0	11.0	0.0	0.0				0.1323
1193	BCL2L11	ENSG00000153094	prostate cancer	1.0	11.0	0.0	0.0		0.1109		
1194	BCL2L11	ENSG00000153094	renal cancer	0.0	12.0	0.0	0.0				0.1005
1195	BCL2L11	ENSG00000153094	skin cancer	0.0	1.0	2.0	8.0				
1196	BCL2L11	ENSG00000153094	stomach cancer	0.0	9.0	0.0	0.0				0.02548
1197	BCL2L11	ENSG00000153094	testis cancer	1.0	11.0	0.0	0.0				0.009715
1198	BCL2L11	ENSG00000153094	thyroid cancer	0.0	2.0	2.0	0.0				0.008154
1199	BCL2L11	ENSG00000153094	urothelial cancer	2.0	8.0	1.0	0.0		0.07857		
1200	VBP1	ENSG00000155959	breast cancer	3.0	9.0	0.0	0.0				0.001546
1201	VBP1	ENSG00000155959	carcinoid	2.0	0.0	2.0	0.0				
1202	VBP1	ENSG00000155959	cervical cancer	5.0	5.0	1.0	0.0		0.001115		
1203	VBP1	ENSG00000155959	colorectal cancer	6.0	3.0	0.0	0.0		0.3347		
1204	VBP1	ENSG00000155959	endometrial cancer	4.0	7.0	0.0	0.0				0.01353
1205	VBP1	ENSG00000155959	glioma	0.0	5.0	5.0	1.0		0.03779		
1206	VBP1	ENSG00000155959	head and neck cancer	0.0	3.0	1.0	0.0				0.001846
1207	VBP1	ENSG00000155959	liver cancer	0.0	1.0	5.0	3.0				0.005307
1208	VBP1	ENSG00000155959	lung cancer	2.0	5.0	4.0	0.0				0.1401
1209	VBP1	ENSG00000155959	lymphoma	1.0	8.0	3.0	0.0				
1210	VBP1	ENSG00000155959	melanoma	2.0	6.0	2.0	1.0				0.02442
1211	VBP1	ENSG00000155959	ovarian cancer	4.0	6.0	0.0	0.0		0.01017		
1212	VBP1	ENSG00000155959	pancreatic cancer	1.0	6.0	1.0	3.0		0.09796		
1213	VBP1	ENSG00000155959	prostate cancer	1.0	7.0	3.0	0.0				0.115
1214	VBP1	ENSG00000155959	renal cancer	0.0	2.0	3.0	7.0		0.05758		
1215	VBP1	ENSG00000155959	skin cancer	0.0	3.0	2.0	5.0				
1216	VBP1	ENSG00000155959	stomach cancer	1.0	10.0	0.0	1.0		0.03761		
1217	VBP1	ENSG00000155959	testis cancer	5.0	4.0	2.0	0.0		0.04542		
1218	VBP1	ENSG00000155959	thyroid cancer	0.0	3.0	1.0	0.0		0.09296		
1219	VBP1	ENSG00000155959	urothelial cancer	0.0	4.0	8.0	0.0				0.3798
1220	SAP130	ENSG00000136715	breast cancer						0.02172		
1221	SAP130	ENSG00000136715	carcinoid								
1222	SAP130	ENSG00000136715	cervical cancer						0.01956		
1223	SAP130	ENSG00000136715	colorectal cancer						0.1848		
1224	SAP130	ENSG00000136715	endometrial cancer								0.1326
1225	SAP130	ENSG00000136715	glioma						0.05454		
1226	SAP130	ENSG00000136715	head and neck cancer						0.1648		
1227	SAP130	ENSG00000136715	liver cancer							0.0007894	
1228	SAP130	ENSG00000136715	lung cancer						0.2747		
1229	SAP130	ENSG00000136715	lymphoma								
1230	SAP130	ENSG00000136715	melanoma								0.01299
1231	SAP130	ENSG00000136715	ovarian cancer						0.1429		
1232	SAP130	ENSG00000136715	pancreatic cancer								0.03922
1233	SAP130	ENSG00000136715	prostate cancer						0.06769		
1234	SAP130	ENSG00000136715	renal cancer								0.03755
1235	SAP130	ENSG00000136715	skin cancer								
1236	SAP130	ENSG00000136715	stomach cancer								0.05258
1237	SAP130	ENSG00000136715	testis cancer						0.4413		
1238	SAP130	ENSG00000136715	thyroid cancer								0.2128
1239	SAP130	ENSG00000136715	urothelial cancer								0.1132
1240	HSPA4	ENSG00000170606	breast cancer	0.0	1.0	10.0	0.0				0.02541
1241	HSPA4	ENSG00000170606	carcinoid	0.0	1.0	3.0	0.0				
1242	HSPA4	ENSG00000170606	cervical cancer	0.0	4.0	3.0	4.0		0.3586		
1243	HSPA4	ENSG00000170606	colorectal cancer	0.0	5.0	5.0	2.0		0.02915		
1244	HSPA4	ENSG00000170606	endometrial cancer	0.0	9.0	1.0	0.0				0.2621
1245	HSPA4	ENSG00000170606	glioma	0.0	3.0	3.0	6.0				0.053
1246	HSPA4	ENSG00000170606	head and neck cancer	0.0	2.0	1.0	1.0				0.002518
1247	HSPA4	ENSG00000170606	liver cancer	0.0	2.0	6.0	4.0			0.0004129	
1248	HSPA4	ENSG00000170606	lung cancer	0.0	2.0	4.0	6.0				0.002313
1249	HSPA4	ENSG00000170606	lymphoma	0.0	4.0	6.0	2.0				
1250	HSPA4	ENSG00000170606	melanoma	3.0	2.0	5.0	2.0				0.2904
1251	HSPA4	ENSG00000170606	ovarian cancer	0.0	5.0	5.0	1.0		0.2395		
1252	HSPA4	ENSG00000170606	pancreatic cancer	0.0	2.0	7.0	3.0				0.1532
1253	HSPA4	ENSG00000170606	prostate cancer	0.0	3.0	4.0	5.0				0.2849
1254	HSPA4	ENSG00000170606	renal cancer	0.0	2.0	5.0	5.0		0.004441		
1255	HSPA4	ENSG00000170606	skin cancer	0.0	2.0	9.0	1.0				
1256	HSPA4	ENSG00000170606	stomach cancer	0.0	1.0	6.0	4.0				0.2545
1257	HSPA4	ENSG00000170606	testis cancer	3.0	7.0	1.0	0.0		0.1094		
1258	HSPA4	ENSG00000170606	thyroid cancer	0.0	3.0	1.0	0.0				0.04047
1259	HSPA4	ENSG00000170606	urothelial cancer	0.0	7.0	3.0	0.0				0.1413
1260	SPRY2	ENSG00000136158	breast cancer	0.0	4.0	4.0	3.0		0.009369		
1261	SPRY2	ENSG00000136158	carcinoid	0.0	3.0	0.0	1.0				
1262	SPRY2	ENSG00000136158	cervical cancer	0.0	5.0	4.0	2.0		0.03711		
1263	SPRY2	ENSG00000136158	colorectal cancer	3.0	6.0	1.0	0.0		0.1103		
1264	SPRY2	ENSG00000136158	endometrial cancer	3.0	6.0	1.0	1.0		0.009125		
1265	SPRY2	ENSG00000136158	glioma	0.0	3.0	0.0	9.0				0.03799
1266	SPRY2	ENSG00000136158	head and neck cancer	0.0	2.0	0.0	2.0				0.08985
1267	SPRY2	ENSG00000136158	liver cancer	5.0	7.0	0.0	0.0				0.003952
1268	SPRY2	ENSG00000136158	lung cancer	0.0	6.0	0.0	5.0		0.02434		
1269	SPRY2	ENSG00000136158	lymphoma	0.0	2.0	7.0	2.0				
1270	SPRY2	ENSG00000136158	melanoma	1.0	5.0	1.0	3.0		0.03433		
1271	SPRY2	ENSG00000136158	ovarian cancer	2.0	7.0	0.0	3.0		0.1463		
1272	SPRY2	ENSG00000136158	pancreatic cancer	3.0	2.0	4.0	2.0				0.1529
1273	SPRY2	ENSG00000136158	prostate cancer	0.0	4.0	4.0	2.0				0.04281
1274	SPRY2	ENSG00000136158	renal cancer	0.0	5.0	1.0	3.0		0.0156		
1275	SPRY2	ENSG00000136158	skin cancer	0.0	0.0	1.0	10.0				
1276	SPRY2	ENSG00000136158	stomach cancer	0.0	9.0	2.0	1.0		0.09887		
1277	SPRY2	ENSG00000136158	testis cancer	0.0	8.0	3.0	0.0				0.3222
1278	SPRY2	ENSG00000136158	thyroid cancer	1.0	1.0	0.0	2.0		0.1041		
1279	SPRY2	ENSG00000136158	urothelial cancer	1.0	7.0	1.0	1.0				0.01857
1280	SIRT1	ENSG00000096717	breast cancer	0.0	4.0	4.0	3.0		0.1553		
1281	SIRT1	ENSG00000096717	carcinoid	1.0	0.0	0.0	3.0				
1282	SIRT1	ENSG00000096717	cervical cancer	7.0	2.0	1.0	1.0		0.2782		
1283	SIRT1	ENSG00000096717	colorectal cancer	0.0	4.0	5.0	3.0		0.09125		
1284	SIRT1	ENSG00000096717	endometrial cancer	2.0	3.0	3.0	1.0				0.1054
1285	SIRT1	ENSG00000096717	glioma	1.0	4.0	4.0	0.0		0.1909		
1286	SIRT1	ENSG00000096717	head and neck cancer	1.0	2.0	1.0	0.0		0.02052		
1287	SIRT1	ENSG00000096717	liver cancer	1.0	0.0	2.0	6.0		0.2476		
1288	SIRT1	ENSG00000096717	lung cancer	2.0	1.0	2.0	5.0		0.04955		
1289	SIRT1	ENSG00000096717	lymphoma	0.0	7.0	3.0	2.0				
1290	SIRT1	ENSG00000096717	melanoma	2.0	3.0	2.0	2.0				0.1412
1291	SIRT1	ENSG00000096717	ovarian cancer	5.0	3.0	4.0	0.0		0.04638		
1292	SIRT1	ENSG00000096717	pancreatic cancer	2.0	1.0	6.0	1.0		0.1719		
1293	SIRT1	ENSG00000096717	prostate cancer	0.0	6.0	3.0	2.0				0.0961
1294	SIRT1	ENSG00000096717	renal cancer	1.0	2.0	4.0	4.0		0.02182		
1295	SIRT1	ENSG00000096717	skin cancer	2.0	2.0	4.0	2.0				
1296	SIRT1	ENSG00000096717	stomach cancer	1.0	3.0	3.0	4.0				0.02832
1297	SIRT1	ENSG00000096717	testis cancer	6.0	1.0	2.0	1.0				0.09669
1298	SIRT1	ENSG00000096717	thyroid cancer	2.0	1.0	1.0	0.0				0.1115
1299	SIRT1	ENSG00000096717	urothelial cancer	2.0	6.0	1.0	3.0		0.1391		
1300	LIMD1	ENSG00000144791	breast cancer	7.0	5.0	0.0	0.0				0.2774
1301	LIMD1	ENSG00000144791	carcinoid	1.0	3.0	0.0	0.0				
1302	LIMD1	ENSG00000144791	cervical cancer	0.0	5.0	3.0	0.0		0.0322		
1303	LIMD1	ENSG00000144791	colorectal cancer	11.0	1.0	0.0	0.0		0.05427		
1304	LIMD1	ENSG00000144791	endometrial cancer	4.0	8.0	0.0	0.0				0.07778
1305	LIMD1	ENSG00000144791	glioma	0.0	2.0	6.0	4.0		0.06529		
1306	LIMD1	ENSG00000144791	head and neck cancer	1.0	2.0	1.0	0.0		0.02073		
1307	LIMD1	ENSG00000144791	liver cancer	5.0	5.0	1.0	0.0				0.09444
1308	LIMD1	ENSG00000144791	lung cancer	0.0	7.0	4.0	0.0		0.01528		
1309	LIMD1	ENSG00000144791	lymphoma	2.0	4.0	6.0	0.0				
1310	LIMD1	ENSG00000144791	melanoma	4.0	6.0	1.0	0.0				0.1109
1311	LIMD1	ENSG00000144791	ovarian cancer	4.0	6.0	0.0	0.0		0.2419		
1312	LIMD1	ENSG00000144791	pancreatic cancer	2.0	7.0	3.0	0.0		0.06881		
1313	LIMD1	ENSG00000144791	prostate cancer	5.0	2.0	3.0	1.0				0.002109
1314	LIMD1	ENSG00000144791	renal cancer	0.0	8.0	3.0	1.0	6.729e-05			
1315	LIMD1	ENSG00000144791	skin cancer	0.0	5.0	6.0	1.0				
1316	LIMD1	ENSG00000144791	stomach cancer	4.0	6.0	2.0	0.0		0.08018		
1317	LIMD1	ENSG00000144791	testis cancer	3.0	9.0	0.0	0.0				0.03057
1318	LIMD1	ENSG00000144791	thyroid cancer	1.0	2.0	1.0	0.0				0.02862
1319	LIMD1	ENSG00000144791	urothelial cancer	0.0	7.0	4.0	0.0		0.006605		
1320	TUBA1A	ENSG00000167552	breast cancer	6.0	3.0	0.0	0.0				0.3106
1321	TUBA1A	ENSG00000167552	carcinoid	3.0	1.0	0.0	0.0				
1322	TUBA1A	ENSG00000167552	cervical cancer	7.0	5.0	0.0	0.0				0.1606
1323	TUBA1A	ENSG00000167552	colorectal cancer	9.0	3.0	0.0	0.0				0.3766
1324	TUBA1A	ENSG00000167552	endometrial cancer	10.0	2.0	0.0	0.0		0.1141		
1325	TUBA1A	ENSG00000167552	glioma	7.0	3.0	0.0	0.0		0.4728		
1326	TUBA1A	ENSG00000167552	head and neck cancer	4.0	0.0	0.0	0.0				0.01148
1327	TUBA1A	ENSG00000167552	liver cancer	2.0	3.0	3.0	4.0				0.02563
1328	TUBA1A	ENSG00000167552	lung cancer	2.0	8.0	2.0	0.0				0.2118
1329	TUBA1A	ENSG00000167552	lymphoma	8.0	0.0	3.0	0.0				
1330	TUBA1A	ENSG00000167552	melanoma	8.0	3.0	1.0	0.0		0.03495		
1331	TUBA1A	ENSG00000167552	ovarian cancer	7.0	5.0	0.0	0.0				0.3799
1332	TUBA1A	ENSG00000167552	pancreatic cancer	0.0	9.0	0.0	1.0		0.00111		
1333	TUBA1A	ENSG00000167552	prostate cancer	10.0	2.0	0.0	0.0				0.09789
1334	TUBA1A	ENSG00000167552	renal cancer	4.0	5.0	3.0	0.0			0.0002901	
1335	TUBA1A	ENSG00000167552	skin cancer	8.0	2.0	1.0	0.0				
1336	TUBA1A	ENSG00000167552	stomach cancer	1.0	8.0	2.0	0.0				0.01067
1337	TUBA1A	ENSG00000167552	testis cancer	8.0	3.0	0.0	0.0		0.04268		
1338	TUBA1A	ENSG00000167552	thyroid cancer	2.0	2.0	0.0	0.0		0.01123		
1339	TUBA1A	ENSG00000167552	urothelial cancer	2.0	5.0	1.0	1.0				0.001273
1340	E2F1	ENSG00000101412	breast cancer	2.0	8.0	0.0	0.0				0.07458
1341	E2F1	ENSG00000101412	carcinoid	0.0	2.0	0.0	2.0				
1342	E2F1	ENSG00000101412	cervical cancer	2.0	8.0	1.0	0.0	9.22e-06			
1343	E2F1	ENSG00000101412	colorectal cancer	5.0	6.0	1.0	0.0		0.02109		
1344	E2F1	ENSG00000101412	endometrial cancer	4.0	6.0	2.0	0.0			4.327e-05	
1345	E2F1	ENSG00000101412	glioma	0.0	8.0	4.0	0.0				0.1514
1346	E2F1	ENSG00000101412	head and neck cancer	2.0	2.0	0.0	0.0		0.01209		
1347	E2F1	ENSG00000101412	liver cancer	4.0	6.0	0.0	2.0			3.834e-05	
1348	E2F1	ENSG00000101412	lung cancer	1.0	8.0	1.0	1.0				0.01246
1349	E2F1	ENSG00000101412	lymphoma	8.0	4.0	0.0	0.0				
1350	E2F1	ENSG00000101412	melanoma	4.0	7.0	0.0	0.0				0.08229
1351	E2F1	ENSG00000101412	ovarian cancer	0.0	11.0	1.0	0.0		0.09661		
1352	E2F1	ENSG00000101412	pancreatic cancer	0.0	8.0	1.0	0.0			0.0004184	
1353	E2F1	ENSG00000101412	prostate cancer	0.0	12.0	0.0	0.0				0.03146
1354	E2F1	ENSG00000101412	renal cancer	0.0	7.0	3.0	1.0			8.988e-05	
1355	E2F1	ENSG00000101412	skin cancer	4.0	7.0	0.0	0.0				
1356	E2F1	ENSG00000101412	stomach cancer	2.0	10.0	0.0	0.0		0.01047		
1357	E2F1	ENSG00000101412	testis cancer	2.0	7.0	0.0	1.0				0.07502
1358	E2F1	ENSG00000101412	thyroid cancer	0.0	3.0	1.0	0.0	0.0001622			
1359	E2F1	ENSG00000101412	urothelial cancer	2.0	9.0	0.0	0.0		0.1909		
1360	SARNP	ENSG00000205323	breast cancer	7.0	5.0	0.0	0.0				0.01828
1361	SARNP	ENSG00000205323	carcinoid	1.0	3.0	0.0	0.0				
1362	SARNP	ENSG00000205323	cervical cancer	2.0	8.0	0.0	0.0		0.01583		
1363	SARNP	ENSG00000205323	colorectal cancer	3.0	6.0	2.0	0.0				0.2224
1364	SARNP	ENSG00000205323	endometrial cancer	3.0	6.0	0.0	2.0				0.25
1365	SARNP	ENSG00000205323	glioma	11.0	0.0	0.0	0.0		0.03008		
1366	SARNP	ENSG00000205323	head and neck cancer	4.0	0.0	0.0	0.0				0.21
1367	SARNP	ENSG00000205323	liver cancer	2.0	5.0	0.0	5.0				0.0002362
1368	SARNP	ENSG00000205323	lung cancer	4.0	6.0	1.0	1.0		0.0202		
1369	SARNP	ENSG00000205323	lymphoma	7.0	2.0	1.0	2.0				
1370	SARNP	ENSG00000205323	melanoma	4.0	4.0	1.0	2.0				0.004286
1371	SARNP	ENSG00000205323	ovarian cancer	2.0	8.0	1.0	0.0		0.01213		
1372	SARNP	ENSG00000205323	pancreatic cancer	2.0	6.0	2.0	0.0		0.05033		
1373	SARNP	ENSG00000205323	prostate cancer	5.0	6.0	1.0	0.0				0.06476
1374	SARNP	ENSG00000205323	renal cancer	8.0	2.0	2.0	0.0				2.306e-06
1375	SARNP	ENSG00000205323	skin cancer	9.0	2.0	1.0	0.0				
1376	SARNP	ENSG00000205323	stomach cancer	2.0	4.0	5.0	1.0				0.08498
1377	SARNP	ENSG00000205323	testis cancer	2.0	10.0	0.0	0.0		0.1307		
1378	SARNP	ENSG00000205323	thyroid cancer	4.0	0.0	0.0	0.0		0.005291		
1379	SARNP	ENSG00000205323	urothelial cancer	6.0	4.0	0.0	1.0		0.1193		
1380	IREB2	ENSG00000136381	breast cancer	0.0	0.0	0.0	11.0				0.01002
1381	IREB2	ENSG00000136381	carcinoid	0.0	0.0	0.0	4.0				
1382	IREB2	ENSG00000136381	cervical cancer	0.0	1.0	2.0	7.0				0.13
1383	IREB2	ENSG00000136381	colorectal cancer	0.0	1.0	1.0	9.0		0.06537		
1384	IREB2	ENSG00000136381	endometrial cancer	0.0	0.0	0.0	11.0		0.03441		
1385	IREB2	ENSG00000136381	glioma	0.0	0.0	1.0	11.0		0.03391		
1386	IREB2	ENSG00000136381	head and neck cancer	0.0	0.0	0.0	3.0		0.2293		
1387	IREB2	ENSG00000136381	liver cancer	0.0	0.0	0.0	11.0				0.2334
1388	IREB2	ENSG00000136381	lung cancer	3.0	1.0	0.0	6.0				0.1057
1389	IREB2	ENSG00000136381	lymphoma	0.0	1.0	0.0	9.0				
1390	IREB2	ENSG00000136381	melanoma	0.0	0.0	0.0	10.0				0.07299
1391	IREB2	ENSG00000136381	ovarian cancer	0.0	0.0	0.0	12.0		0.1009		
1392	IREB2	ENSG00000136381	pancreatic cancer	0.0	0.0	1.0	10.0				0.1382
1393	IREB2	ENSG00000136381	prostate cancer	1.0	0.0	0.0	9.0				0.06513
1394	IREB2	ENSG00000136381	renal cancer	0.0	0.0	0.0	11.0		0.003849		
1395	IREB2	ENSG00000136381	skin cancer	0.0	0.0	0.0	9.0				
1396	IREB2	ENSG00000136381	stomach cancer	0.0	1.0	1.0	9.0		0.4093		
1397	IREB2	ENSG00000136381	testis cancer	0.0	0.0	0.0	11.0				0.1361
1398	IREB2	ENSG00000136381	thyroid cancer	0.0	0.0	0.0	3.0				0.0147
1399	IREB2	ENSG00000136381	urothelial cancer	0.0	0.0	1.0	9.0				0.094
1400	WTIP	ENSG00000142279	breast cancer						0.03848		
1401	WTIP	ENSG00000142279	carcinoid								
1402	WTIP	ENSG00000142279	cervical cancer								0.08013
1403	WTIP	ENSG00000142279	colorectal cancer								0.004543
1404	WTIP	ENSG00000142279	endometrial cancer								0.001029
1405	WTIP	ENSG00000142279	glioma								0.1212
1406	WTIP	ENSG00000142279	head and neck cancer						0.0613		
1407	WTIP	ENSG00000142279	liver cancer						0.07695		
1408	WTIP	ENSG00000142279	lung cancer								0.02479
1409	WTIP	ENSG00000142279	lymphoma								
1410	WTIP	ENSG00000142279	melanoma								0.03158
1411	WTIP	ENSG00000142279	ovarian cancer								0.1344
1412	WTIP	ENSG00000142279	pancreatic cancer								0.1183
1413	WTIP	ENSG00000142279	prostate cancer						0.02705		
1414	WTIP	ENSG00000142279	renal cancer								0.06281
1415	WTIP	ENSG00000142279	skin cancer								
1416	WTIP	ENSG00000142279	stomach cancer								0.05704
1417	WTIP	ENSG00000142279	testis cancer						0.0634		
1418	WTIP	ENSG00000142279	thyroid cancer						0.1391		
1419	WTIP	ENSG00000142279	urothelial cancer						0.09362		
1420	TPT1	ENSG00000133112	breast cancer	0.0	7.0	4.0	1.0	5.903e-05			
1421	TPT1	ENSG00000133112	carcinoid	0.0	3.0	1.0	0.0				
1422	TPT1	ENSG00000133112	cervical cancer	0.0	6.0	5.0	1.0				0.1001
1423	TPT1	ENSG00000133112	colorectal cancer	0.0	10.0	0.0	0.0		0.1161		
1424	TPT1	ENSG00000133112	endometrial cancer	1.0	9.0	1.0	0.0	0.0002345			
1425	TPT1	ENSG00000133112	glioma	0.0	3.0	4.0	4.0		0.3252		
1426	TPT1	ENSG00000133112	head and neck cancer	2.0	2.0	0.0	0.0				0.03568
1427	TPT1	ENSG00000133112	liver cancer	0.0	1.0	6.0	5.0		0.008711		
1428	TPT1	ENSG00000133112	lung cancer	0.0	10.0	1.0	0.0		0.2036		
1429	TPT1	ENSG00000133112	lymphoma	0.0	1.0	2.0	9.0				
1430	TPT1	ENSG00000133112	melanoma	0.0	4.0	7.0	1.0				0.1077
1431	TPT1	ENSG00000133112	ovarian cancer	0.0	7.0	4.0	1.0				0.001291
1432	TPT1	ENSG00000133112	pancreatic cancer	1.0	4.0	1.0	4.0				0.456
1433	TPT1	ENSG00000133112	prostate cancer	0.0	8.0	1.0	1.0				0.302
1434	TPT1	ENSG00000133112	renal cancer	0.0	2.0	2.0	8.0			2.542e-05	
1435	TPT1	ENSG00000133112	skin cancer	1.0	7.0	2.0	1.0				
1436	TPT1	ENSG00000133112	stomach cancer	0.0	2.0	5.0	3.0				0.1472
1437	TPT1	ENSG00000133112	testis cancer	0.0	9.0	3.0	0.0		0.08477		
1438	TPT1	ENSG00000133112	thyroid cancer	0.0	1.0	3.0	0.0	4.306e-05			
1439	TPT1	ENSG00000133112	urothelial cancer	0.0	6.0	3.0	2.0				0.06511
1440	CCT5	ENSG00000150753	breast cancer	0.0	2.0	9.0	1.0				0.007024
1441	CCT5	ENSG00000150753	carcinoid	0.0	0.0	2.0	1.0				
1442	CCT5	ENSG00000150753	cervical cancer	0.0	3.0	6.0	2.0				0.1085
1443	CCT5	ENSG00000150753	colorectal cancer	1.0	2.0	6.0	2.0		0.1981		
1444	CCT5	ENSG00000150753	endometrial cancer	0.0	5.0	6.0	0.0				0.01792
1445	CCT5	ENSG00000150753	glioma	0.0	3.0	7.0	0.0				0.3465
1446	CCT5	ENSG00000150753	head and neck cancer	0.0	1.0	3.0	0.0				0.002104
1447	CCT5	ENSG00000150753	liver cancer	0.0	0.0	9.0	2.0			6.568e-11	
1448	CCT5	ENSG00000150753	lung cancer	0.0	1.0	6.0	2.0				0.006398
1449	CCT5	ENSG00000150753	lymphoma	0.0	2.0	9.0	1.0				
1450	CCT5	ENSG00000150753	melanoma	0.0	4.0	5.0	1.0				0.2044
1451	CCT5	ENSG00000150753	ovarian cancer	0.0	6.0	6.0	0.0		0.001905		
1452	CCT5	ENSG00000150753	pancreatic cancer	0.0	0.0	10.0	1.0				0.0113
1453	CCT5	ENSG00000150753	prostate cancer	0.0	5.0	5.0	1.0				0.01298
1454	CCT5	ENSG00000150753	renal cancer	0.0	1.0	4.0	6.0			8.233e-06	
1455	CCT5	ENSG00000150753	skin cancer	0.0	1.0	6.0	2.0				
1456	CCT5	ENSG00000150753	stomach cancer	0.0	1.0	7.0	2.0		0.1017		
1457	CCT5	ENSG00000150753	testis cancer	1.0	8.0	2.0	0.0		0.194		
1458	CCT5	ENSG00000150753	thyroid cancer	0.0	0.0	3.0	1.0		0.3839		
1459	CCT5	ENSG00000150753	urothelial cancer	0.0	2.0	9.0	1.0				0.01824
1460	GLI1	ENSG00000111087	breast cancer	0.0	1.0	11.0	0.0		0.0004968		
1461	GLI1	ENSG00000111087	carcinoid	0.0	1.0	3.0	0.0				
1462	GLI1	ENSG00000111087	cervical cancer	0.0	1.0	0.0	11.0				0.05526
1463	GLI1	ENSG00000111087	colorectal cancer	0.0	1.0	11.0	0.0		0.1259		
1464	GLI1	ENSG00000111087	endometrial cancer	0.0	0.0	11.0	1.0		0.005578		
1465	GLI1	ENSG00000111087	glioma	0.0	0.0	9.0	3.0				0.1109
1466	GLI1	ENSG00000111087	head and neck cancer	0.0	1.0	3.0	0.0				0.1485
1467	GLI1	ENSG00000111087	liver cancer	0.0	0.0	6.0	6.0				0.01804
1468	GLI1	ENSG00000111087	lung cancer	0.0	1.0	3.0	8.0		0.09		
1469	GLI1	ENSG00000111087	lymphoma	0.0	0.0	0.0	12.0				
1470	GLI1	ENSG00000111087	melanoma	0.0	0.0	4.0	6.0				0.1877
1471	GLI1	ENSG00000111087	ovarian cancer	0.0	1.0	4.0	7.0		0.1429		
1472	GLI1	ENSG00000111087	pancreatic cancer	0.0	0.0	1.0	11.0		0.08516		
1473	GLI1	ENSG00000111087	prostate cancer	0.0	1.0	10.0	1.0		0.1021		
1474	GLI1	ENSG00000111087	renal cancer	0.0	0.0	4.0	8.0				1.529e-08
1475	GLI1	ENSG00000111087	skin cancer	0.0	0.0	2.0	10.0				
1476	GLI1	ENSG00000111087	stomach cancer	0.0	0.0	2.0	10.0				0.004586
1477	GLI1	ENSG00000111087	testis cancer	0.0	0.0	6.0	5.0				0.02976
1478	GLI1	ENSG00000111087	thyroid cancer	0.0	0.0	3.0	0.0				0.02781
1479	GLI1	ENSG00000111087	urothelial cancer	0.0	0.0	4.0	8.0				0.01043
1480	TOP2A	ENSG00000131747	breast cancer	8.0	3.0	0.0	0.0		0.2093		
1481	TOP2A	ENSG00000131747	carcinoid	1.0	3.0	0.0	0.0				
1482	TOP2A	ENSG00000131747	cervical cancer	10.0	1.0	0.0	0.0		0.1243		
1483	TOP2A	ENSG00000131747	colorectal cancer	11.0	1.0	0.0	0.0		0.00228		
1484	TOP2A	ENSG00000131747	endometrial cancer	5.0	5.0	0.0	0.0				0.00942
1485	TOP2A	ENSG00000131747	glioma	2.0	5.0	3.0	0.0		0.1797		
1486	TOP2A	ENSG00000131747	head and neck cancer	4.0	0.0	0.0	0.0				0.1517
1487	TOP2A	ENSG00000131747	liver cancer	4.0	7.0	0.0	0.0			5.92e-06	
1488	TOP2A	ENSG00000131747	lung cancer	10.0	1.0	0.0	0.0			0.0004994	
1489	TOP2A	ENSG00000131747	lymphoma	5.0	7.0	0.0	0.0				
1490	TOP2A	ENSG00000131747	melanoma	4.0	7.0	0.0	0.0				0.006213
1491	TOP2A	ENSG00000131747	ovarian cancer	9.0	3.0	0.0	0.0				0.2087
1492	TOP2A	ENSG00000131747	pancreatic cancer	5.0	6.0	0.0	0.0			3.832e-05	
1493	TOP2A	ENSG00000131747	prostate cancer	0.0	11.0	0.0	0.0				0.05032
1494	TOP2A	ENSG00000131747	renal cancer	1.0	8.0	2.0	1.0			0.0	
1495	TOP2A	ENSG00000131747	skin cancer	6.0	3.0	0.0	0.0				
1496	TOP2A	ENSG00000131747	stomach cancer	4.0	7.0	0.0	0.0		0.07455		
1497	TOP2A	ENSG00000131747	testis cancer	12.0	0.0	0.0	0.0		0.1066		
1498	TOP2A	ENSG00000131747	thyroid cancer	0.0	4.0	0.0	0.0				0.2183
1499	TOP2A	ENSG00000131747	urothelial cancer	7.0	3.0	1.0	0.0		0.2292		
1500	KNG1	ENSG00000113889	breast cancer	0.0	1.0	1.0	10.0		0.3882		
1501	KNG1	ENSG00000113889	carcinoid	0.0	0.0	1.0	3.0				
1502	KNG1	ENSG00000113889	cervical cancer	0.0	0.0	1.0	11.0		0.1633		
1503	KNG1	ENSG00000113889	colorectal cancer	0.0	0.0	1.0	11.0		0.2823		
1504	KNG1	ENSG00000113889	endometrial cancer	0.0	0.0	3.0	8.0				0.327
1505	KNG1	ENSG00000113889	glioma	0.0	0.0	1.0	11.0				0.008302
1506	KNG1	ENSG00000113889	head and neck cancer	0.0	0.0	1.0	3.0				0.2041
1507	KNG1	ENSG00000113889	liver cancer	0.0	2.0	3.0	5.0	1.279e-06			
1508	KNG1	ENSG00000113889	lung cancer	0.0	0.0	0.0	12.0				0.01288
1509	KNG1	ENSG00000113889	lymphoma	0.0	0.0	0.0	12.0				
1510	KNG1	ENSG00000113889	melanoma	0.0	0.0	0.0	12.0				0.1098
1511	KNG1	ENSG00000113889	ovarian cancer	0.0	1.0	0.0	11.0				0.01973
1512	KNG1	ENSG00000113889	pancreatic cancer	0.0	0.0	1.0	11.0		0.0996		
1513	KNG1	ENSG00000113889	prostate cancer	0.0	0.0	0.0	11.0				0.1651
1514	KNG1	ENSG00000113889	renal cancer	0.0	0.0	1.0	9.0				0.00345
1515	KNG1	ENSG00000113889	skin cancer	0.0	0.0	0.0	12.0				
1516	KNG1	ENSG00000113889	stomach cancer	0.0	0.0	0.0	12.0				0.05198
1517	KNG1	ENSG00000113889	testis cancer	0.0	0.0	0.0	12.0				0.2459
1518	KNG1	ENSG00000113889	thyroid cancer	0.0	1.0	2.0	1.0		0.04516		
1519	KNG1	ENSG00000113889	urothelial cancer	0.0	0.0	0.0	12.0				
1520	STUB1	ENSG00000103266	breast cancer	10.0	1.0	0.0	0.0				0.05704
1521	STUB1	ENSG00000103266	carcinoid	0.0	4.0	0.0	0.0				
1522	STUB1	ENSG00000103266	cervical cancer	4.0	3.0	4.0	0.0				0.2534
1523	STUB1	ENSG00000103266	colorectal cancer	11.0	0.0	0.0	0.0				0.1899
1524	STUB1	ENSG00000103266	endometrial cancer	3.0	9.0	0.0	0.0				0.3891
1525	STUB1	ENSG00000103266	glioma	0.0	0.0	0.0	10.0				0.08996
1526	STUB1	ENSG00000103266	head and neck cancer	0.0	2.0	2.0	0.0				0.3058
1527	STUB1	ENSG00000103266	liver cancer	4.0	4.0	1.0	1.0				0.004088
1528	STUB1	ENSG00000103266	lung cancer	1.0	8.0	1.0	1.0				0.2209
1529	STUB1	ENSG00000103266	lymphoma	0.0	0.0	2.0	10.0				
1530	STUB1	ENSG00000103266	melanoma	2.0	5.0	3.0	1.0				0.2235
1531	STUB1	ENSG00000103266	ovarian cancer	4.0	5.0	2.0	0.0		0.08313		
1532	STUB1	ENSG00000103266	pancreatic cancer	9.0	1.0	0.0	0.0		0.05779		
1533	STUB1	ENSG00000103266	prostate cancer	9.0	3.0	0.0	0.0		0.06771		
1534	STUB1	ENSG00000103266	renal cancer	2.0	7.0	1.0	2.0	6.493e-09			
1535	STUB1	ENSG00000103266	skin cancer	0.0	4.0	2.0	5.0				
1536	STUB1	ENSG00000103266	stomach cancer	11.0	0.0	0.0	0.0		0.09666		
1537	STUB1	ENSG00000103266	testis cancer	1.0	4.0	3.0	3.0				0.3567
1538	STUB1	ENSG00000103266	thyroid cancer	0.0	1.0	1.0	1.0				0.1551
1539	STUB1	ENSG00000103266	urothelial cancer	8.0	1.0	1.0	1.0				0.1304
1540	SLC3A2	ENSG00000168003	breast cancer	0.0	3.0	0.0	9.0				0.1786
1541	SLC3A2	ENSG00000168003	carcinoid	2.0	1.0	0.0	1.0				
1542	SLC3A2	ENSG00000168003	cervical cancer	0.0	5.0	1.0	5.0				0.009612
1543	SLC3A2	ENSG00000168003	colorectal cancer	0.0	7.0	4.0	1.0				0.359
1544	SLC3A2	ENSG00000168003	endometrial cancer	0.0	3.0	6.0	2.0				0.00787
1545	SLC3A2	ENSG00000168003	glioma	0.0	4.0	0.0	8.0				0.2057
1546	SLC3A2	ENSG00000168003	head and neck cancer	1.0	0.0	3.0	0.0				0.002415
1547	SLC3A2	ENSG00000168003	liver cancer	0.0	0.0	5.0	6.0			0.0008167	
1548	SLC3A2	ENSG00000168003	lung cancer	0.0	3.0	3.0	4.0				0.00209
1549	SLC3A2	ENSG00000168003	lymphoma	0.0	4.0	3.0	5.0				
1550	SLC3A2	ENSG00000168003	melanoma	8.0	2.0	0.0	2.0		0.2619		
1551	SLC3A2	ENSG00000168003	ovarian cancer	1.0	0.0	3.0	8.0		0.04157		
1552	SLC3A2	ENSG00000168003	pancreatic cancer	0.0	3.0	3.0	6.0		0.02287		
1553	SLC3A2	ENSG00000168003	prostate cancer	0.0	1.0	0.0	10.0				0.3714
1554	SLC3A2	ENSG00000168003	renal cancer	0.0	2.0	0.0	10.0	0.0008216			
1555	SLC3A2	ENSG00000168003	skin cancer	2.0	9.0	1.0	0.0				
1556	SLC3A2	ENSG00000168003	stomach cancer	0.0	3.0	1.0	5.0		0.02916		
1557	SLC3A2	ENSG00000168003	testis cancer	3.0	4.0	0.0	4.0				0.005516
1558	SLC3A2	ENSG00000168003	thyroid cancer	0.0	0.0	0.0	3.0		0.00349		
1559	SLC3A2	ENSG00000168003	urothelial cancer	2.0	1.0	6.0	2.0			0.0001483	
1560	RPS15A	ENSG00000134419	breast cancer	0.0	8.0	2.0	0.0		0.01252		
1561	RPS15A	ENSG00000134419	carcinoid	0.0	4.0	0.0	0.0				
1562	RPS15A	ENSG00000134419	cervical cancer	0.0	5.0	5.0	1.0		0.2243		
1563	RPS15A	ENSG00000134419	colorectal cancer	1.0	11.0	0.0	0.0		0.09007		
1564	RPS15A	ENSG00000134419	endometrial cancer	0.0	9.0	1.0	0.0				0.04316
1565	RPS15A	ENSG00000134419	glioma	1.0	7.0	3.0	0.0		0.08528		
1566	RPS15A	ENSG00000134419	head and neck cancer	0.0	4.0	0.0	0.0				0.06755
1567	RPS15A	ENSG00000134419	liver cancer	2.0	10.0	0.0	0.0				0.05399
1568	RPS15A	ENSG00000134419	lung cancer	0.0	5.0	2.0	5.0		0.2612		
1569	RPS15A	ENSG00000134419	lymphoma	0.0	1.0	3.0	7.0				
1570	RPS15A	ENSG00000134419	melanoma	0.0	9.0	2.0	0.0				0.03959
1571	RPS15A	ENSG00000134419	ovarian cancer	0.0	4.0	5.0	2.0		0.1185		
1572	RPS15A	ENSG00000134419	pancreatic cancer	1.0	8.0	1.0	0.0				0.00418
1573	RPS15A	ENSG00000134419	prostate cancer	5.0	5.0	1.0	0.0				0.1755
1574	RPS15A	ENSG00000134419	renal cancer	0.0	11.0	1.0	0.0			7.29e-07	
1575	RPS15A	ENSG00000134419	skin cancer	0.0	4.0	2.0	4.0				
1576	RPS15A	ENSG00000134419	stomach cancer	0.0	7.0	3.0	1.0				0.1069
1577	RPS15A	ENSG00000134419	testis cancer	1.0	9.0	0.0	0.0		0.2022		
1578	RPS15A	ENSG00000134419	thyroid cancer	2.0	2.0	0.0	0.0		0.1074		
1579	RPS15A	ENSG00000134419	urothelial cancer	1.0	10.0	0.0	0.0				0.06324
1580	TRAFD1	ENSG00000135148	breast cancer	0.0	3.0	2.0	6.0		0.07796		
1581	TRAFD1	ENSG00000135148	carcinoid	0.0	0.0	0.0	4.0				
1582	TRAFD1	ENSG00000135148	cervical cancer	0.0	1.0	0.0	9.0	0.0005727			
1583	TRAFD1	ENSG00000135148	colorectal cancer	0.0	0.0	3.0	9.0				0.06123
1584	TRAFD1	ENSG00000135148	endometrial cancer	0.0	0.0	0.0	11.0				0.1438
1585	TRAFD1	ENSG00000135148	glioma	0.0	0.0	2.0	8.0		0.09464		
1586	TRAFD1	ENSG00000135148	head and neck cancer	0.0	1.0	0.0	3.0		0.02514		
1587	TRAFD1	ENSG00000135148	liver cancer	0.0	0.0	0.0	12.0			0.0004871	
1588	TRAFD1	ENSG00000135148	lung cancer	0.0	1.0	3.0	8.0		0.00121		
1589	TRAFD1	ENSG00000135148	lymphoma	1.0	1.0	6.0	4.0				
1590	TRAFD1	ENSG00000135148	melanoma	0.0	1.0	1.0	10.0				0.1687
1591	TRAFD1	ENSG00000135148	ovarian cancer	0.0	1.0	3.0	8.0				0.1778
1592	TRAFD1	ENSG00000135148	pancreatic cancer	0.0	0.0	2.0	9.0				0.3087
1593	TRAFD1	ENSG00000135148	prostate cancer	0.0	5.0	4.0	3.0		0.2204		
1594	TRAFD1	ENSG00000135148	renal cancer	0.0	1.0	4.0	7.0			9.259e-06	
1595	TRAFD1	ENSG00000135148	skin cancer	0.0	0.0	2.0	9.0				
1596	TRAFD1	ENSG00000135148	stomach cancer	0.0	0.0	2.0	8.0				0.1074
1597	TRAFD1	ENSG00000135148	testis cancer	0.0	2.0	3.0	7.0				0.06146
1598	TRAFD1	ENSG00000135148	thyroid cancer	0.0	0.0	1.0	3.0		0.00333		
1599	TRAFD1	ENSG00000135148	urothelial cancer	0.0	3.0	2.0	3.0	3.92e-05			
1600	HDAC3	ENSG00000171720	breast cancer	0.0	4.0	4.0	4.0				0.06652
1601	HDAC3	ENSG00000171720	carcinoid	0.0	1.0	1.0	1.0				
1602	HDAC3	ENSG00000171720	cervical cancer	1.0	1.0	5.0	5.0				0.1958
1603	HDAC3	ENSG00000171720	colorectal cancer	1.0	5.0	5.0	1.0	0.0003389			
1604	HDAC3	ENSG00000171720	endometrial cancer	0.0	1.0	4.0	6.0				0.1173
1605	HDAC3	ENSG00000171720	glioma	2.0	2.0	3.0	3.0				0.1241
1606	HDAC3	ENSG00000171720	head and neck cancer	1.0	0.0	2.0	1.0				0.1072
1607	HDAC3	ENSG00000171720	liver cancer	1.0	3.0	1.0	3.0				0.01188
1608	HDAC3	ENSG00000171720	lung cancer	0.0	1.0	4.0	4.0				0.3159
1609	HDAC3	ENSG00000171720	lymphoma	0.0	3.0	3.0	6.0				
1610	HDAC3	ENSG00000171720	melanoma	0.0	0.0	0.0	10.0				0.05557
1611	HDAC3	ENSG00000171720	ovarian cancer	0.0	2.0	4.0	4.0				0.02454
1612	HDAC3	ENSG00000171720	pancreatic cancer	0.0	3.0	6.0	1.0	0.0003953			
1613	HDAC3	ENSG00000171720	prostate cancer	0.0	2.0	5.0	5.0				0.1123
1614	HDAC3	ENSG00000171720	renal cancer	1.0	4.0	1.0	5.0			2.654e-06	
1615	HDAC3	ENSG00000171720	skin cancer	0.0	0.0	2.0	7.0				
1616	HDAC3	ENSG00000171720	stomach cancer	0.0	2.0	6.0	2.0		0.1847		
1617	HDAC3	ENSG00000171720	testis cancer	0.0	3.0	2.0	7.0				0.01629
1618	HDAC3	ENSG00000171720	thyroid cancer	0.0	2.0	1.0	1.0				0.002279
1619	HDAC3	ENSG00000171720	urothelial cancer	2.0	3.0	4.0	3.0		0.2167		
1620	FZR1	ENSG00000105325	breast cancer	0.0	0.0	4.0	8.0				0.2783
1621	FZR1	ENSG00000105325	carcinoid	0.0	1.0	2.0	1.0				
1622	FZR1	ENSG00000105325	cervical cancer	0.0	0.0	1.0	10.0	0.0001755			
1623	FZR1	ENSG00000105325	colorectal cancer	0.0	2.0	8.0	2.0				0.1151
1624	FZR1	ENSG00000105325	endometrial cancer	0.0	1.0	4.0	7.0	0.0002575			
1625	FZR1	ENSG00000105325	glioma	0.0	0.0	2.0	8.0				0.1596
1626	FZR1	ENSG00000105325	head and neck cancer	0.0	1.0	0.0	3.0		0.01361		
1627	FZR1	ENSG00000105325	liver cancer	0.0	0.0	0.0	12.0				0.09196
1628	FZR1	ENSG00000105325	lung cancer	0.0	0.0	0.0	12.0		0.1613		
1629	FZR1	ENSG00000105325	lymphoma	0.0	0.0	0.0	11.0				
1630	FZR1	ENSG00000105325	melanoma	0.0	2.0	5.0	5.0		0.09701		
1631	FZR1	ENSG00000105325	ovarian cancer	0.0	3.0	2.0	6.0				0.1178
1632	FZR1	ENSG00000105325	pancreatic cancer	0.0	0.0	0.0	12.0		0.004152		
1633	FZR1	ENSG00000105325	prostate cancer	0.0	0.0	1.0	9.0				0.01414
1634	FZR1	ENSG00000105325	renal cancer	0.0	0.0	3.0	9.0		0.3749		
1635	FZR1	ENSG00000105325	skin cancer	0.0	2.0	0.0	9.0				
1636	FZR1	ENSG00000105325	stomach cancer	0.0	0.0	0.0	12.0		0.005414		
1637	FZR1	ENSG00000105325	testis cancer	0.0	0.0	2.0	10.0		0.1755		
1638	FZR1	ENSG00000105325	thyroid cancer	0.0	4.0	0.0	0.0				0.09043
1639	FZR1	ENSG00000105325	urothelial cancer	0.0	0.0	1.0	10.0		0.1044		
1640	AJUBA	ENSG00000129474	breast cancer	7.0	2.0	2.0	1.0		0.1149		
1641	AJUBA	ENSG00000129474	carcinoid	2.0	0.0	0.0	2.0				
1642	AJUBA	ENSG00000129474	cervical cancer	5.0	3.0	2.0	2.0		0.02988		
1643	AJUBA	ENSG00000129474	colorectal cancer	3.0	7.0	2.0	0.0				0.2389
1644	AJUBA	ENSG00000129474	endometrial cancer	5.0	4.0	1.0	1.0				0.001239
1645	AJUBA	ENSG00000129474	glioma	3.0	3.0	1.0	3.0		0.09811		
1646	AJUBA	ENSG00000129474	head and neck cancer	0.0	2.0	1.0	1.0				0.149
1647	AJUBA	ENSG00000129474	liver cancer	5.0	4.0	0.0	3.0				0.001797
1648	AJUBA	ENSG00000129474	lung cancer	4.0	2.0	1.0	2.0				0.2726
1649	AJUBA	ENSG00000129474	lymphoma	0.0	3.0	3.0	6.0				
1650	AJUBA	ENSG00000129474	melanoma	1.0	5.0	4.0	0.0				0.1393
1651	AJUBA	ENSG00000129474	ovarian cancer	6.0	4.0	1.0	0.0				0.1856
1652	AJUBA	ENSG00000129474	pancreatic cancer	3.0	5.0	2.0	1.0			0.0005668	
1653	AJUBA	ENSG00000129474	prostate cancer	0.0	2.0	4.0	6.0				0.1474
1654	AJUBA	ENSG00000129474	renal cancer	5.0	1.0	2.0	3.0		0.003191		
1655	AJUBA	ENSG00000129474	skin cancer	1.0	5.0	3.0	0.0				
1656	AJUBA	ENSG00000129474	stomach cancer	2.0	4.0	0.0	5.0		0.2941		
1657	AJUBA	ENSG00000129474	testis cancer	0.0	0.0	1.0	10.0		0.2676		
1658	AJUBA	ENSG00000129474	thyroid cancer	2.0	2.0	0.0	0.0		0.009353		
1659	AJUBA	ENSG00000129474	urothelial cancer	4.0	5.0	2.0	1.0		0.2068		
1660	DVL2	ENSG00000004975	breast cancer	0.0	9.0	1.0	0.0		0.00763		
1661	DVL2	ENSG00000004975	carcinoid	1.0	1.0	1.0	0.0				
1662	DVL2	ENSG00000004975	cervical cancer	0.0	10.0	2.0	0.0		0.0684		
1663	DVL2	ENSG00000004975	colorectal cancer	0.0	12.0	0.0	0.0				0.1202
1664	DVL2	ENSG00000004975	endometrial cancer	0.0	6.0	6.0	0.0				0.1596
1665	DVL2	ENSG00000004975	glioma	0.0	11.0	1.0	0.0				0.1442
1666	DVL2	ENSG00000004975	head and neck cancer	0.0	4.0	0.0	0.0		0.2394		
1667	DVL2	ENSG00000004975	liver cancer	7.0	4.0	1.0	0.0			4.343e-06	
1668	DVL2	ENSG00000004975	lung cancer	0.0	5.0	4.0	2.0				0.05657
1669	DVL2	ENSG00000004975	lymphoma	0.0	6.0	3.0	2.0				
1670	DVL2	ENSG00000004975	melanoma	0.0	9.0	3.0	0.0				0.0801
1671	DVL2	ENSG00000004975	ovarian cancer	0.0	5.0	3.0	2.0		0.08973		
1672	DVL2	ENSG00000004975	pancreatic cancer	0.0	7.0	4.0	0.0	0.0003853			
1673	DVL2	ENSG00000004975	prostate cancer	1.0	11.0	0.0	0.0				0.08901
1674	DVL2	ENSG00000004975	renal cancer	0.0	4.0	4.0	4.0				0.1285
1675	DVL2	ENSG00000004975	skin cancer	0.0	10.0	1.0	0.0				
1676	DVL2	ENSG00000004975	stomach cancer	0.0	3.0	5.0	2.0				0.3234
1677	DVL2	ENSG00000004975	testis cancer	0.0	12.0	0.0	0.0				0.2296
1678	DVL2	ENSG00000004975	thyroid cancer	1.0	3.0	0.0	0.0				0.2796
1679	DVL2	ENSG00000004975	urothelial cancer	1.0	10.0	1.0	0.0				0.05447
1680	KIF2C	ENSG00000142945	breast cancer	0.0	0.0	0.0	12.0				0.03285
1681	KIF2C	ENSG00000142945	carcinoid	0.0	0.0	0.0	4.0				
1682	KIF2C	ENSG00000142945	cervical cancer	0.0	1.0	1.0	10.0		0.01353		
1683	KIF2C	ENSG00000142945	colorectal cancer	0.0	0.0	2.0	10.0		0.01027		
1684	KIF2C	ENSG00000142945	endometrial cancer	0.0	0.0	0.0	11.0				0.001713
1685	KIF2C	ENSG00000142945	glioma	0.0	0.0	0.0	11.0		0.2765		
1686	KIF2C	ENSG00000142945	head and neck cancer	0.0	0.0	0.0	3.0		0.05167		
1687	KIF2C	ENSG00000142945	liver cancer	0.0	0.0	0.0	12.0			3.066e-07	
1688	KIF2C	ENSG00000142945	lung cancer	0.0	0.0	1.0	11.0				0.007489
1689	KIF2C	ENSG00000142945	lymphoma	0.0	0.0	0.0	12.0				
1690	KIF2C	ENSG00000142945	melanoma	0.0	0.0	0.0	11.0				0.003329
1691	KIF2C	ENSG00000142945	ovarian cancer	0.0	0.0	1.0	10.0				0.3665
1692	KIF2C	ENSG00000142945	pancreatic cancer	0.0	0.0	0.0	12.0			0.000686	
1693	KIF2C	ENSG00000142945	prostate cancer	0.0	0.0	0.0	12.0				0.04273
1694	KIF2C	ENSG00000142945	renal cancer	0.0	0.0	0.0	11.0			0.0	
1695	KIF2C	ENSG00000142945	skin cancer	0.0	0.0	0.0	9.0				
1696	KIF2C	ENSG00000142945	stomach cancer	0.0	0.0	1.0	10.0		0.002334		
1697	KIF2C	ENSG00000142945	testis cancer	0.0	0.0	0.0	11.0				0.1485
1698	KIF2C	ENSG00000142945	thyroid cancer	0.0	0.0	0.0	4.0				0.01856
1699	KIF2C	ENSG00000142945	urothelial cancer	0.0	0.0	0.0	12.0				0.2411
1700	MSH4	ENSG00000057468	breast cancer								0.06641
1701	MSH4	ENSG00000057468	carcinoid								
1702	MSH4	ENSG00000057468	cervical cancer								0.2111
1703	MSH4	ENSG00000057468	colorectal cancer								0.03456
1704	MSH4	ENSG00000057468	endometrial cancer								0.1243
1705	MSH4	ENSG00000057468	glioma						0.1034		
1706	MSH4	ENSG00000057468	head and neck cancer						0.01993		
1707	MSH4	ENSG00000057468	liver cancer								0.006883
1708	MSH4	ENSG00000057468	lung cancer						0.01743		
1709	MSH4	ENSG00000057468	lymphoma								
1710	MSH4	ENSG00000057468	melanoma								0.04365
1711	MSH4	ENSG00000057468	ovarian cancer								0.3003
1712	MSH4	ENSG00000057468	pancreatic cancer						0.003577		
1713	MSH4	ENSG00000057468	prostate cancer								0.0972
1714	MSH4	ENSG00000057468	renal cancer								6.883e-08
1715	MSH4	ENSG00000057468	skin cancer								
1716	MSH4	ENSG00000057468	stomach cancer						0.05333		
1717	MSH4	ENSG00000057468	testis cancer						0.04902		
1718	MSH4	ENSG00000057468	thyroid cancer						0.05083		
1719	MSH4	ENSG00000057468	urothelial cancer						0.04633		
1720	PKD1L3	ENSG00000277481	breast cancer								0.1748
1721	PKD1L3	ENSG00000277481	carcinoid								
1722	PKD1L3	ENSG00000277481	cervical cancer						0.1552		
1723	PKD1L3	ENSG00000277481	colorectal cancer								0.1119
1724	PKD1L3	ENSG00000277481	endometrial cancer								0.1547
1725	PKD1L3	ENSG00000277481	glioma								0.01804
1726	PKD1L3	ENSG00000277481	head and neck cancer								0.1355
1727	PKD1L3	ENSG00000277481	liver cancer						0.02461		
1728	PKD1L3	ENSG00000277481	lung cancer						0.0724		
1729	PKD1L3	ENSG00000277481	lymphoma								
1730	PKD1L3	ENSG00000277481	melanoma						0.1676		
1731	PKD1L3	ENSG00000277481	ovarian cancer						0.1738		
1732	PKD1L3	ENSG00000277481	pancreatic cancer						0.0009901		
1733	PKD1L3	ENSG00000277481	prostate cancer						0.2224		
1734	PKD1L3	ENSG00000277481	renal cancer								1.346e-06
1735	PKD1L3	ENSG00000277481	skin cancer								
1736	PKD1L3	ENSG00000277481	stomach cancer								0.06706
1737	PKD1L3	ENSG00000277481	testis cancer								0.1731
1738	PKD1L3	ENSG00000277481	thyroid cancer								0.1247
1739	PKD1L3	ENSG00000277481	urothelial cancer						0.001925		
1740	DCUN1D1	ENSG00000043093	breast cancer	0.0	2.0	2.0	8.0				0.2131
1741	DCUN1D1	ENSG00000043093	carcinoid	0.0	0.0	2.0	1.0				
1742	DCUN1D1	ENSG00000043093	cervical cancer	0.0	0.0	1.0	10.0		0.2365		
1743	DCUN1D1	ENSG00000043093	colorectal cancer	1.0	2.0	1.0	7.0		0.004826		
1744	DCUN1D1	ENSG00000043093	endometrial cancer	0.0	0.0	0.0	12.0				0.001942
1745	DCUN1D1	ENSG00000043093	glioma	0.0	0.0	2.0	9.0		0.001437		
1746	DCUN1D1	ENSG00000043093	head and neck cancer	0.0	0.0	0.0	3.0				0.06058
1747	DCUN1D1	ENSG00000043093	liver cancer	1.0	2.0	3.0	2.0				0.05927
1748	DCUN1D1	ENSG00000043093	lung cancer	0.0	0.0	0.0	11.0				0.01723
1749	DCUN1D1	ENSG00000043093	lymphoma	0.0	0.0	0.0	12.0				
1750	DCUN1D1	ENSG00000043093	melanoma	1.0	1.0	0.0	10.0				0.09345
1751	DCUN1D1	ENSG00000043093	ovarian cancer	0.0	0.0	0.0	12.0		0.009247		
1752	DCUN1D1	ENSG00000043093	pancreatic cancer	0.0	4.0	5.0	2.0				0.004978
1753	DCUN1D1	ENSG00000043093	prostate cancer	4.0	6.0	2.0	0.0				0.07259
1754	DCUN1D1	ENSG00000043093	renal cancer	0.0	2.0	1.0	9.0				0.001007
1755	DCUN1D1	ENSG00000043093	skin cancer	0.0	0.0	0.0	11.0				
1756	DCUN1D1	ENSG00000043093	stomach cancer	0.0	0.0	3.0	3.0		0.1518		
1757	DCUN1D1	ENSG00000043093	testis cancer	0.0	0.0	1.0	11.0		0.2119		
1758	DCUN1D1	ENSG00000043093	thyroid cancer	1.0	1.0	0.0	1.0				0.05008
1759	DCUN1D1	ENSG00000043093	urothelial cancer	0.0	1.0	2.0	6.0		0.3518		
1760	KNTC1	ENSG00000184445	breast cancer	0.0	6.0	4.0	1.0				0.1169
1761	KNTC1	ENSG00000184445	carcinoid	0.0	0.0	2.0	1.0				
1762	KNTC1	ENSG00000184445	cervical cancer	6.0	2.0	2.0	2.0		0.002117		
1763	KNTC1	ENSG00000184445	colorectal cancer	0.0	5.0	7.0	0.0		0.2511		
1764	KNTC1	ENSG00000184445	endometrial cancer	0.0	1.0	5.0	6.0				0.01532
1765	KNTC1	ENSG00000184445	glioma	0.0	1.0	4.0	7.0				0.09343
1766	KNTC1	ENSG00000184445	head and neck cancer	0.0	1.0	2.0	1.0	0.000869			
1767	KNTC1	ENSG00000184445	liver cancer	0.0	1.0	2.0	9.0			4.787e-06	
1768	KNTC1	ENSG00000184445	lung cancer	1.0	2.0	0.0	7.0				0.04043
1769	KNTC1	ENSG00000184445	lymphoma	0.0	3.0	3.0	6.0				
1770	KNTC1	ENSG00000184445	melanoma	0.0	1.0	2.0	9.0				0.007203
1771	KNTC1	ENSG00000184445	ovarian cancer	0.0	4.0	6.0	1.0		0.0159		
1772	KNTC1	ENSG00000184445	pancreatic cancer	0.0	2.0	5.0	4.0				0.04777
1773	KNTC1	ENSG00000184445	prostate cancer	0.0	6.0	4.0	2.0				0.0192
1774	KNTC1	ENSG00000184445	renal cancer	0.0	0.0	3.0	9.0			7.886e-08	
1775	KNTC1	ENSG00000184445	skin cancer	4.0	1.0	4.0	3.0				
1776	KNTC1	ENSG00000184445	stomach cancer	0.0	0.0	9.0	3.0		0.02172		
1777	KNTC1	ENSG00000184445	testis cancer	0.0	1.0	8.0	3.0		0.3078		
1778	KNTC1	ENSG00000184445	thyroid cancer	0.0	1.0	3.0	0.0		0.08036		
1779	KNTC1	ENSG00000184445	urothelial cancer	3.0	1.0	6.0	2.0		0.1741		
1780	KAT5	ENSG00000172977	breast cancer	0.0	6.0	6.0	0.0		0.22		
1781	KAT5	ENSG00000172977	carcinoid	0.0	0.0	2.0	1.0				
1782	KAT5	ENSG00000172977	cervical cancer	0.0	4.0	8.0	0.0				0.3578
1783	KAT5	ENSG00000172977	colorectal cancer	0.0	0.0	12.0	0.0		0.03588		
1784	KAT5	ENSG00000172977	endometrial cancer	0.0	5.0	7.0	0.0				0.274
1785	KAT5	ENSG00000172977	glioma	0.0	4.0	6.0	1.0		0.09607		
1786	KAT5	ENSG00000172977	head and neck cancer	0.0	2.0	1.0	0.0				0.07163
1787	KAT5	ENSG00000172977	liver cancer	0.0	6.0	6.0	0.0				0.001294
1788	KAT5	ENSG00000172977	lung cancer	0.0	3.0	5.0	1.0				0.12
1789	KAT5	ENSG00000172977	lymphoma	0.0	9.0	3.0	0.0				
1790	KAT5	ENSG00000172977	melanoma	1.0	8.0	1.0	0.0		0.2006		
1791	KAT5	ENSG00000172977	ovarian cancer	1.0	7.0	3.0	1.0				0.2736
1792	KAT5	ENSG00000172977	pancreatic cancer	0.0	1.0	9.0	0.0		0.2134		
1793	KAT5	ENSG00000172977	prostate cancer	0.0	0.0	7.0	5.0		0.2542		
1794	KAT5	ENSG00000172977	renal cancer	1.0	5.0	5.0	1.0	1.099e-13			
1795	KAT5	ENSG00000172977	skin cancer	0.0	4.0	5.0	0.0				
1796	KAT5	ENSG00000172977	stomach cancer	0.0	1.0	10.0	0.0		0.1366		
1797	KAT5	ENSG00000172977	testis cancer	0.0	9.0	2.0	0.0				0.2548
1798	KAT5	ENSG00000172977	thyroid cancer	0.0	1.0	2.0	0.0		0.1846		
1799	KAT5	ENSG00000172977	urothelial cancer	0.0	6.0	5.0	0.0				0.08538
1800	MOB4	ENSG00000115540	breast cancer	4.0	7.0	0.0	0.0				0.04604
1801	MOB4	ENSG00000115540	carcinoid	2.0	1.0	0.0	1.0				
1802	MOB4	ENSG00000115540	cervical cancer	0.0	3.0	4.0	2.0		0.323		
1803	MOB4	ENSG00000115540	colorectal cancer	10.0	1.0	0.0	0.0		0.02163		
1804	MOB4	ENSG00000115540	endometrial cancer	4.0	3.0	2.0	3.0				0.02811
1805	MOB4	ENSG00000115540	glioma	1.0	6.0	1.0	3.0		0.2531		
1806	MOB4	ENSG00000115540	head and neck cancer	2.0	1.0	0.0	0.0				0.1157
1807	MOB4	ENSG00000115540	liver cancer	3.0	7.0	2.0	0.0			0.0008289	
1808	MOB4	ENSG00000115540	lung cancer	2.0	5.0	0.0	3.0		0.1232		
1809	MOB4	ENSG00000115540	lymphoma	5.0	4.0	0.0	2.0				
1810	MOB4	ENSG00000115540	melanoma	4.0	5.0	0.0	1.0				0.04885
1811	MOB4	ENSG00000115540	ovarian cancer	5.0	4.0	0.0	0.0		0.1717		
1812	MOB4	ENSG00000115540	pancreatic cancer	4.0	4.0	0.0	2.0				0.08032
1813	MOB4	ENSG00000115540	prostate cancer	8.0	2.0	1.0	0.0				0.08442
1814	MOB4	ENSG00000115540	renal cancer	0.0	3.0	6.0	3.0			0.0004684	
1815	MOB4	ENSG00000115540	skin cancer	1.0	4.0	3.0	2.0				
1816	MOB4	ENSG00000115540	stomach cancer	7.0	3.0	0.0	0.0				0.3348
1817	MOB4	ENSG00000115540	testis cancer	3.0	6.0	1.0	1.0		0.0836		
1818	MOB4	ENSG00000115540	thyroid cancer	3.0	1.0	0.0	0.0		0.03302		
1819	MOB4	ENSG00000115540	urothelial cancer	4.0	6.0	0.0	0.0		0.03072		
1820	CYBA	ENSG00000051523	breast cancer	0.0	0.0	0.0	10.0	0.0008191			
1821	CYBA	ENSG00000051523	carcinoid	0.0	0.0	0.0	4.0				
1822	CYBA	ENSG00000051523	cervical cancer	0.0	0.0	0.0	12.0				0.1048
1823	CYBA	ENSG00000051523	colorectal cancer	0.0	0.0	3.0	9.0				0.0832
1824	CYBA	ENSG00000051523	endometrial cancer	0.0	0.0	0.0	12.0	4.75e-05			
1825	CYBA	ENSG00000051523	glioma	0.0	0.0	0.0	12.0				0.2419
1826	CYBA	ENSG00000051523	head and neck cancer	0.0	0.0	0.0	4.0				0.04767
1827	CYBA	ENSG00000051523	liver cancer	0.0	0.0	0.0	12.0				0.04881
1828	CYBA	ENSG00000051523	lung cancer	0.0	0.0	0.0	12.0				0.09158
1829	CYBA	ENSG00000051523	lymphoma	2.0	5.0	0.0	4.0				
1830	CYBA	ENSG00000051523	melanoma	0.0	0.0	0.0	11.0		0.1723		
1831	CYBA	ENSG00000051523	ovarian cancer	0.0	0.0	1.0	10.0		0.1113		
1832	CYBA	ENSG00000051523	pancreatic cancer	0.0	0.0	1.0	8.0				0.03083
1833	CYBA	ENSG00000051523	prostate cancer	0.0	0.0	0.0	11.0		0.2675		
1834	CYBA	ENSG00000051523	renal cancer	0.0	0.0	0.0	12.0			0.000183	
1835	CYBA	ENSG00000051523	skin cancer	0.0	0.0	0.0	12.0				
1836	CYBA	ENSG00000051523	stomach cancer	0.0	0.0	3.0	8.0		0.1907		
1837	CYBA	ENSG00000051523	testis cancer	0.0	0.0	0.0	12.0				0.05218
1838	CYBA	ENSG00000051523	thyroid cancer	0.0	0.0	0.0	3.0		0.0257		
1839	CYBA	ENSG00000051523	urothelial cancer	0.0	0.0	0.0	11.0		0.01628		
1840	SON	ENSG00000159140	breast cancer	0.0	10.0	0.0	0.0				0.01577
1841	SON	ENSG00000159140	carcinoid	0.0	2.0	2.0	0.0				
1842	SON	ENSG00000159140	cervical cancer	1.0	9.0	2.0	0.0				0.2079
1843	SON	ENSG00000159140	colorectal cancer	1.0	8.0	3.0	0.0		0.4688		
1844	SON	ENSG00000159140	endometrial cancer	0.0	8.0	4.0	0.0				0.2304
1845	SON	ENSG00000159140	glioma	0.0	9.0	3.0	0.0		0.05629		
1846	SON	ENSG00000159140	head and neck cancer	1.0	3.0	0.0	0.0		0.2752		
1847	SON	ENSG00000159140	liver cancer	3.0	4.0	4.0	1.0				0.04225
1848	SON	ENSG00000159140	lung cancer	0.0	6.0	1.0	3.0		0.2385		
1849	SON	ENSG00000159140	lymphoma	0.0	7.0	5.0	0.0				
1850	SON	ENSG00000159140	melanoma	1.0	9.0	1.0	0.0				0.1046
1851	SON	ENSG00000159140	ovarian cancer	1.0	7.0	4.0	0.0				0.02311
1852	SON	ENSG00000159140	pancreatic cancer	6.0	4.0	0.0	1.0				0.2021
1853	SON	ENSG00000159140	prostate cancer	0.0	10.0	2.0	0.0				0.1243
1854	SON	ENSG00000159140	renal cancer	3.0	7.0	1.0	0.0		0.0975		
1855	SON	ENSG00000159140	skin cancer	1.0	10.0	1.0	0.0				
1856	SON	ENSG00000159140	stomach cancer	1.0	7.0	3.0	0.0		0.4183		
1857	SON	ENSG00000159140	testis cancer	9.0	3.0	0.0	0.0		0.09201		
1858	SON	ENSG00000159140	thyroid cancer	0.0	4.0	0.0	0.0				0.1189
1859	SON	ENSG00000159140	urothelial cancer	11.0	0.0	0.0	0.0				0.2539
1860	CNTF	ENSG00000242689	breast cancer	0.0	2.0	6.0	2.0				0.188
1861	CNTF	ENSG00000242689	carcinoid	0.0	0.0	0.0	4.0				
1862	CNTF	ENSG00000242689	cervical cancer	0.0	0.0	1.0	11.0				0.002636
1863	CNTF	ENSG00000242689	colorectal cancer	0.0	1.0	6.0	5.0		0.01008		
1864	CNTF	ENSG00000242689	endometrial cancer	0.0	0.0	0.0	12.0				0.04368
1865	CNTF	ENSG00000242689	glioma	0.0	0.0	1.0	11.0		0.1524		
1866	CNTF	ENSG00000242689	head and neck cancer	0.0	0.0	1.0	3.0		0.05907		
1867	CNTF	ENSG00000242689	liver cancer	0.0	3.0	2.0	6.0				0.1634
1868	CNTF	ENSG00000242689	lung cancer	0.0	0.0	0.0	11.0		0.09238		
1869	CNTF	ENSG00000242689	lymphoma	0.0	0.0	0.0	12.0				
1870	CNTF	ENSG00000242689	melanoma	0.0	0.0	0.0	12.0				0.05875
1871	CNTF	ENSG00000242689	ovarian cancer	0.0	1.0	2.0	9.0		0.1628		
1872	CNTF	ENSG00000242689	pancreatic cancer	0.0	1.0	2.0	8.0				0.0008251
1873	CNTF	ENSG00000242689	prostate cancer	0.0	2.0	1.0	9.0				0.05419
1874	CNTF	ENSG00000242689	renal cancer	0.0	0.0	1.0	11.0				0.08503
1875	CNTF	ENSG00000242689	skin cancer	0.0	0.0	2.0	10.0				
1876	CNTF	ENSG00000242689	stomach cancer	0.0	0.0	1.0	11.0				0.1024
1877	CNTF	ENSG00000242689	testis cancer	0.0	0.0	4.0	8.0		0.1914		
1878	CNTF	ENSG00000242689	thyroid cancer	0.0	0.0	2.0	1.0		0.09501		
1879	CNTF	ENSG00000242689	urothelial cancer	0.0	0.0	0.0	11.0				0.09667
1880	SLC2A1	ENSG00000117394	breast cancer	0.0	0.0	0.0	11.0				0.03596
1881	SLC2A1	ENSG00000117394	carcinoid	0.0	0.0	0.0	4.0				
1882	SLC2A1	ENSG00000117394	cervical cancer	0.0	3.0	1.0	8.0				0.005853
1883	SLC2A1	ENSG00000117394	colorectal cancer	1.0	1.0	5.0	5.0				0.07585
1884	SLC2A1	ENSG00000117394	endometrial cancer	0.0	0.0	4.0	8.0				0.01315
1885	SLC2A1	ENSG00000117394	glioma	0.0	0.0	0.0	12.0				0.004102
1886	SLC2A1	ENSG00000117394	head and neck cancer	0.0	0.0	3.0	1.0				0.03221
1887	SLC2A1	ENSG00000117394	liver cancer	0.0	0.0	0.0	12.0			3.653e-08	
1888	SLC2A1	ENSG00000117394	lung cancer	0.0	2.0	3.0	7.0			0.0001089	
1889	SLC2A1	ENSG00000117394	lymphoma	0.0	0.0	0.0	11.0				
1890	SLC2A1	ENSG00000117394	melanoma	0.0	0.0	2.0	10.0				0.1098
1891	SLC2A1	ENSG00000117394	ovarian cancer	0.0	0.0	1.0	10.0		0.04836		
1892	SLC2A1	ENSG00000117394	pancreatic cancer	0.0	0.0	1.0	8.0			4.386e-05	
1893	SLC2A1	ENSG00000117394	prostate cancer	0.0	0.0	0.0	11.0				0.1872
1894	SLC2A1	ENSG00000117394	renal cancer	0.0	0.0	2.0	10.0			4.547e-09	
1895	SLC2A1	ENSG00000117394	skin cancer	1.0	1.0	2.0	8.0				
1896	SLC2A1	ENSG00000117394	stomach cancer	0.0	0.0	0.0	12.0				0.1113
1897	SLC2A1	ENSG00000117394	testis cancer	1.0	2.0	2.0	7.0				0.09489
1898	SLC2A1	ENSG00000117394	thyroid cancer	0.0	0.0	0.0	4.0				0.1173
1899	SLC2A1	ENSG00000117394	urothelial cancer	1.0	2.0	3.0	5.0			0.0004054	
1900	PPIB	ENSG00000166794	breast cancer	0.0	6.0	3.0	2.0		0.003		
1901	PPIB	ENSG00000166794	carcinoid	0.0	0.0	2.0	2.0				
1902	PPIB	ENSG00000166794	cervical cancer	2.0	3.0	5.0	2.0				0.005645
1903	PPIB	ENSG00000166794	colorectal cancer	0.0	10.0	1.0	0.0				0.2808
1904	PPIB	ENSG00000166794	endometrial cancer	2.0	8.0	1.0	0.0	1.56e-05			
1905	PPIB	ENSG00000166794	glioma	0.0	8.0	1.0	0.0				0.1653
1906	PPIB	ENSG00000166794	head and neck cancer	0.0	3.0	1.0	0.0				0.001067
1907	PPIB	ENSG00000166794	liver cancer	0.0	9.0	2.0	0.0				0.0369
1908	PPIB	ENSG00000166794	lung cancer	0.0	8.0	3.0	1.0				0.0127
1909	PPIB	ENSG00000166794	lymphoma	0.0	2.0	6.0	4.0				
1910	PPIB	ENSG00000166794	melanoma	0.0	6.0	3.0	2.0				0.07188
1911	PPIB	ENSG00000166794	ovarian cancer	1.0	8.0	1.0	1.0		0.0088		
1912	PPIB	ENSG00000166794	pancreatic cancer	1.0	7.0	3.0	0.0				0.2868
1913	PPIB	ENSG00000166794	prostate cancer	0.0	11.0	0.0	0.0		0.0279		
1914	PPIB	ENSG00000166794	renal cancer	0.0	9.0	0.0	1.0			2.025e-11	
1915	PPIB	ENSG00000166794	skin cancer	0.0	2.0	6.0	4.0				
1916	PPIB	ENSG00000166794	stomach cancer	0.0	7.0	4.0	0.0				0.07045
1917	PPIB	ENSG00000166794	testis cancer	0.0	0.0	3.0	9.0				0.03768
1918	PPIB	ENSG00000166794	thyroid cancer	0.0	3.0	0.0	0.0				0.1823
1919	PPIB	ENSG00000166794	urothelial cancer	0.0	6.0	5.0	1.0				0.03903
1920	IVNS1ABP	ENSG00000116679	breast cancer	0.0	6.0	5.0	0.0				0.004111
1921	IVNS1ABP	ENSG00000116679	carcinoid	1.0	0.0	2.0	0.0				
1922	IVNS1ABP	ENSG00000116679	cervical cancer	0.0	6.0	6.0	0.0				0.09693
1923	IVNS1ABP	ENSG00000116679	colorectal cancer	2.0	7.0	2.0	0.0		0.04292		
1924	IVNS1ABP	ENSG00000116679	endometrial cancer	3.0	6.0	3.0	0.0		0.1775		
1925	IVNS1ABP	ENSG00000116679	glioma	0.0	4.0	7.0	0.0		0.02029		
1926	IVNS1ABP	ENSG00000116679	head and neck cancer	0.0	2.0	2.0	0.0				0.04419
1927	IVNS1ABP	ENSG00000116679	liver cancer	1.0	2.0	5.0	2.0				0.004313
1928	IVNS1ABP	ENSG00000116679	lung cancer	0.0	3.0	9.0	0.0		0.4184		
1929	IVNS1ABP	ENSG00000116679	lymphoma	2.0	5.0	2.0	3.0				
1930	IVNS1ABP	ENSG00000116679	melanoma	3.0	4.0	3.0	0.0				0.07041
1931	IVNS1ABP	ENSG00000116679	ovarian cancer	0.0	4.0	8.0	0.0		0.05125		
1932	IVNS1ABP	ENSG00000116679	pancreatic cancer	1.0	8.0	2.0	0.0				0.4279
1933	IVNS1ABP	ENSG00000116679	prostate cancer	1.0	3.0	7.0	0.0				0.005418
1934	IVNS1ABP	ENSG00000116679	renal cancer	5.0	7.0	0.0	0.0				0.001851
1935	IVNS1ABP	ENSG00000116679	skin cancer	1.0	6.0	4.0	0.0				
1936	IVNS1ABP	ENSG00000116679	stomach cancer	1.0	5.0	6.0	0.0		0.0373		
1937	IVNS1ABP	ENSG00000116679	testis cancer	2.0	5.0	5.0	0.0		0.1282		
1938	IVNS1ABP	ENSG00000116679	thyroid cancer	0.0	3.0	1.0	0.0				0.04071
1939	IVNS1ABP	ENSG00000116679	urothelial cancer	3.0	5.0	4.0	0.0		0.04129		
1940	PIN1	ENSG00000127445	breast cancer	0.0	4.0	7.0	1.0		0.2535		
1941	PIN1	ENSG00000127445	carcinoid	0.0	2.0	2.0	0.0				
1942	PIN1	ENSG00000127445	cervical cancer	0.0	2.0	6.0	4.0		0.006142		
1943	PIN1	ENSG00000127445	colorectal cancer	0.0	1.0	4.0	6.0				0.06502
1944	PIN1	ENSG00000127445	endometrial cancer	0.0	1.0	3.0	7.0		0.04359		
1945	PIN1	ENSG00000127445	glioma	5.0	2.0	3.0	1.0		0.01712		
1946	PIN1	ENSG00000127445	head and neck cancer	0.0	1.0	1.0	2.0		0.0065		
1947	PIN1	ENSG00000127445	liver cancer	0.0	0.0	0.0	10.0				0.1896
1948	PIN1	ENSG00000127445	lung cancer	1.0	0.0	0.0	9.0		0.02861		
1949	PIN1	ENSG00000127445	lymphoma	0.0	2.0	1.0	9.0				
1950	PIN1	ENSG00000127445	melanoma	2.0	1.0	6.0	2.0		0.2674		
1951	PIN1	ENSG00000127445	ovarian cancer	0.0	1.0	6.0	5.0		0.007226		
1952	PIN1	ENSG00000127445	pancreatic cancer	0.0	0.0	1.0	9.0	0.000325			
1953	PIN1	ENSG00000127445	prostate cancer	0.0	5.0	6.0	1.0				0.09431
1954	PIN1	ENSG00000127445	renal cancer	1.0	1.0	2.0	8.0	7.799e-05			
1955	PIN1	ENSG00000127445	skin cancer	0.0	0.0	1.0	8.0				
1956	PIN1	ENSG00000127445	stomach cancer	0.0	0.0	1.0	10.0		0.02199		
1957	PIN1	ENSG00000127445	testis cancer	0.0	5.0	3.0	4.0				0.2555
1958	PIN1	ENSG00000127445	thyroid cancer	0.0	0.0	1.0	3.0		0.03129		
1959	PIN1	ENSG00000127445	urothelial cancer	1.0	0.0	1.0	10.0		0.01205		
1960	ATM	ENSG00000149311	breast cancer	4.0	7.0	0.0	0.0				0.09767
1961	ATM	ENSG00000149311	carcinoid	2.0	2.0	0.0	0.0				
1962	ATM	ENSG00000149311	cervical cancer	2.0	9.0	1.0	0.0		0.1475		
1963	ATM	ENSG00000149311	colorectal cancer	9.0	3.0	0.0	0.0		0.3044		
1964	ATM	ENSG00000149311	endometrial cancer	6.0	5.0	0.0	0.0				0.236
1965	ATM	ENSG00000149311	glioma	10.0	2.0	0.0	0.0		0.05699		
1966	ATM	ENSG00000149311	head and neck cancer	4.0	0.0	0.0	0.0		0.02863		
1967	ATM	ENSG00000149311	liver cancer	0.0	2.0	7.0	3.0				0.006324
1968	ATM	ENSG00000149311	lung cancer	0.0	8.0	3.0	1.0		0.1052		
1969	ATM	ENSG00000149311	lymphoma	12.0	0.0	0.0	0.0				
1970	ATM	ENSG00000149311	melanoma	0.0	11.0	0.0	0.0				0.08185
1971	ATM	ENSG00000149311	ovarian cancer	8.0	4.0	0.0	0.0				0.1631
1972	ATM	ENSG00000149311	pancreatic cancer	0.0	4.0	6.0	1.0		0.07677		
1973	ATM	ENSG00000149311	prostate cancer	10.0	2.0	0.0	0.0				0.06156
1974	ATM	ENSG00000149311	renal cancer	0.0	10.0	2.0	0.0				0.002165
1975	ATM	ENSG00000149311	skin cancer	3.0	8.0	0.0	0.0				
1976	ATM	ENSG00000149311	stomach cancer	0.0	11.0	1.0	0.0		0.3097		
1977	ATM	ENSG00000149311	testis cancer	5.0	7.0	0.0	0.0				0.07868
1978	ATM	ENSG00000149311	thyroid cancer	4.0	0.0	0.0	0.0				0.1215
1979	ATM	ENSG00000149311	urothelial cancer	2.0	10.0	0.0	0.0				0.2811
1980	APRT	ENSG00000198931	breast cancer	0.0	7.0	2.0	3.0				0.05867
1981	APRT	ENSG00000198931	carcinoid	0.0	0.0	1.0	3.0				
1982	APRT	ENSG00000198931	cervical cancer	0.0	1.0	7.0	4.0		0.05099		
1983	APRT	ENSG00000198931	colorectal cancer	0.0	2.0	5.0	5.0				0.1978
1984	APRT	ENSG00000198931	endometrial cancer	0.0	2.0	10.0	0.0		0.03666		
1985	APRT	ENSG00000198931	glioma	0.0	0.0	0.0	12.0		0.1776		
1986	APRT	ENSG00000198931	head and neck cancer	0.0	0.0	1.0	3.0				0.002497
1987	APRT	ENSG00000198931	liver cancer	0.0	5.0	5.0	1.0				0.001723
1988	APRT	ENSG00000198931	lung cancer	0.0	2.0	5.0	5.0				0.06898
1989	APRT	ENSG00000198931	lymphoma	0.0	0.0	3.0	8.0				
1990	APRT	ENSG00000198931	melanoma	0.0	4.0	6.0	2.0		0.1708		
1991	APRT	ENSG00000198931	ovarian cancer	0.0	3.0	7.0	1.0		0.1821		
1992	APRT	ENSG00000198931	pancreatic cancer	0.0	5.0	7.0	0.0				0.06785
1993	APRT	ENSG00000198931	prostate cancer	0.0	7.0	1.0	4.0				0.08742
1994	APRT	ENSG00000198931	renal cancer	0.0	7.0	4.0	1.0		0.009577		
1995	APRT	ENSG00000198931	skin cancer	0.0	1.0	8.0	2.0				
1996	APRT	ENSG00000198931	stomach cancer	0.0	4.0	2.0	3.0				0.1141
1997	APRT	ENSG00000198931	testis cancer	0.0	7.0	2.0	0.0				0.2507
1998	APRT	ENSG00000198931	thyroid cancer	0.0	0.0	2.0	2.0		0.04754		
1999	APRT	ENSG00000198931	urothelial cancer	0.0	4.0	3.0	4.0		0.01483		
2000	DDX3Y	ENSG00000067048	breast cancer	0.0	3.0	8.0	0.0				
2001	DDX3Y	ENSG00000067048	carcinoid	0.0	0.0	1.0	3.0				
2002	DDX3Y	ENSG00000067048	cervical cancer	0.0	0.0	7.0	4.0				
2003	DDX3Y	ENSG00000067048	colorectal cancer	0.0	2.0	9.0	0.0				0.03892
2004	DDX3Y	ENSG00000067048	endometrial cancer	0.0	1.0	6.0	3.0				
2005	DDX3Y	ENSG00000067048	glioma	0.0	1.0	2.0	8.0		0.17		
2006	DDX3Y	ENSG00000067048	head and neck cancer	0.0	1.0	2.0	0.0	4.699e-05			
2007	DDX3Y	ENSG00000067048	liver cancer	0.0	0.0	1.0	11.0				0.06504
2008	DDX3Y	ENSG00000067048	lung cancer	0.0	1.0	5.0	6.0				0.04737
2009	DDX3Y	ENSG00000067048	lymphoma	0.0	2.0	6.0	4.0				
2010	DDX3Y	ENSG00000067048	melanoma	0.0	0.0	5.0	6.0				0.02221
2011	DDX3Y	ENSG00000067048	ovarian cancer	0.0	1.0	3.0	6.0				
2012	DDX3Y	ENSG00000067048	pancreatic cancer	0.0	0.0	4.0	6.0		0.04169		
2013	DDX3Y	ENSG00000067048	prostate cancer	0.0	0.0	4.0	5.0				0.03372
2014	DDX3Y	ENSG00000067048	renal cancer	0.0	0.0	3.0	9.0				0.09606
2015	DDX3Y	ENSG00000067048	skin cancer	0.0	0.0	4.0	7.0				
2016	DDX3Y	ENSG00000067048	stomach cancer	0.0	0.0	7.0	5.0				0.00258
2017	DDX3Y	ENSG00000067048	testis cancer	2.0	7.0	3.0	0.0		0.1741		
2018	DDX3Y	ENSG00000067048	thyroid cancer	0.0	0.0	0.0	4.0				0.02662
2019	DDX3Y	ENSG00000067048	urothelial cancer	0.0	6.0	6.0	0.0		0.07867		
2020	DNAJA2	ENSG00000069345	breast cancer	0.0	5.0	3.0	4.0				0.007679
2021	DNAJA2	ENSG00000069345	carcinoid	0.0	0.0	1.0	2.0				
2022	DNAJA2	ENSG00000069345	cervical cancer	0.0	5.0	6.0	1.0		0.01049		
2023	DNAJA2	ENSG00000069345	colorectal cancer	0.0	6.0	4.0	2.0		0.04774		
2024	DNAJA2	ENSG00000069345	endometrial cancer	0.0	5.0	3.0	3.0		0.03666		
2025	DNAJA2	ENSG00000069345	glioma	0.0	1.0	6.0	1.0		0.0446		
2026	DNAJA2	ENSG00000069345	head and neck cancer	0.0	2.0	1.0	1.0			0.000281	
2027	DNAJA2	ENSG00000069345	liver cancer	0.0	3.0	4.0	3.0				0.1026
2028	DNAJA2	ENSG00000069345	lung cancer	0.0	5.0	5.0	1.0				0.04558
2029	DNAJA2	ENSG00000069345	lymphoma	0.0	7.0	4.0	0.0				
2030	DNAJA2	ENSG00000069345	melanoma	0.0	3.0	7.0	1.0				0.1179
2031	DNAJA2	ENSG00000069345	ovarian cancer	0.0	6.0	6.0	0.0		0.01534		
2032	DNAJA2	ENSG00000069345	pancreatic cancer	0.0	5.0	5.0	1.0				0.05413
2033	DNAJA2	ENSG00000069345	prostate cancer	0.0	12.0	0.0	0.0		0.2124		
2034	DNAJA2	ENSG00000069345	renal cancer	1.0	5.0	3.0	2.0	1.191e-09			
2035	DNAJA2	ENSG00000069345	skin cancer	0.0	3.0	3.0	3.0				
2036	DNAJA2	ENSG00000069345	stomach cancer	0.0	3.0	8.0	0.0				0.09218
2037	DNAJA2	ENSG00000069345	testis cancer	1.0	8.0	2.0	0.0		0.2281		
2038	DNAJA2	ENSG00000069345	thyroid cancer	0.0	2.0	1.0	0.0				0.09216
2039	DNAJA2	ENSG00000069345	urothelial cancer	0.0	4.0	7.0	0.0		0.04685		
2040	PSMB3	ENSG00000277791	breast cancer	1.0	11.0	0.0	0.0		0.1862		
2041	PSMB3	ENSG00000277791	carcinoid	1.0	2.0	1.0	0.0				
2042	PSMB3	ENSG00000277791	cervical cancer	0.0	9.0	2.0	0.0		0.004843		
2043	PSMB3	ENSG00000277791	colorectal cancer	0.0	9.0	1.0	0.0		0.1442		
2044	PSMB3	ENSG00000277791	endometrial cancer	3.0	8.0	1.0	0.0		0.048		
2045	PSMB3	ENSG00000277791	glioma	0.0	5.0	2.0	3.0				0.06677
2046	PSMB3	ENSG00000277791	head and neck cancer	1.0	2.0	0.0	0.0				0.001139
2047	PSMB3	ENSG00000277791	liver cancer	0.0	7.0	2.0	3.0				0.05458
2048	PSMB3	ENSG00000277791	lung cancer	2.0	9.0	0.0	0.0				0.02458
2049	PSMB3	ENSG00000277791	lymphoma	0.0	7.0	1.0	3.0				
2050	PSMB3	ENSG00000277791	melanoma	2.0	7.0	2.0	0.0		0.2023		
2051	PSMB3	ENSG00000277791	ovarian cancer	0.0	10.0	1.0	0.0		0.01751		
2052	PSMB3	ENSG00000277791	pancreatic cancer	0.0	1.0	6.0	4.0				0.3654
2053	PSMB3	ENSG00000277791	prostate cancer	0.0	9.0	2.0	1.0		0.1133		
2054	PSMB3	ENSG00000277791	renal cancer	0.0	2.0	4.0	6.0			1.708e-06	
2055	PSMB3	ENSG00000277791	skin cancer	1.0	6.0	3.0	2.0				
2056	PSMB3	ENSG00000277791	stomach cancer	0.0	0.0	3.0	6.0				0.4444
2057	PSMB3	ENSG00000277791	testis cancer	0.0	0.0	3.0	8.0		0.1277		
2058	PSMB3	ENSG00000277791	thyroid cancer	0.0	4.0	0.0	0.0		0.002415		
2059	PSMB3	ENSG00000277791	urothelial cancer	0.0	1.0	1.0	8.0		0.0603		
2060	VAPB	ENSG00000124164	breast cancer	9.0	3.0	0.0	0.0				0.003276
2061	VAPB	ENSG00000124164	carcinoid	3.0	1.0	0.0	0.0				
2062	VAPB	ENSG00000124164	cervical cancer	3.0	8.0	0.0	0.0				0.0388
2063	VAPB	ENSG00000124164	colorectal cancer	11.0	1.0	0.0	0.0		0.1019		
2064	VAPB	ENSG00000124164	endometrial cancer	0.0	10.0	0.0	1.0				0.02513
2065	VAPB	ENSG00000124164	glioma	9.0	1.0	0.0	0.0		0.09365		
2066	VAPB	ENSG00000124164	head and neck cancer	2.0	2.0	0.0	0.0				0.03147
2067	VAPB	ENSG00000124164	liver cancer	4.0	8.0	0.0	0.0				0.00476
2068	VAPB	ENSG00000124164	lung cancer	1.0	9.0	0.0	0.0		0.2803		
2069	VAPB	ENSG00000124164	lymphoma	0.0	8.0	4.0	0.0				
2070	VAPB	ENSG00000124164	melanoma	8.0	4.0	0.0	0.0		0.04466		
2071	VAPB	ENSG00000124164	ovarian cancer	3.0	7.0	0.0	1.0		0.008062		
2072	VAPB	ENSG00000124164	pancreatic cancer	7.0	3.0	0.0	0.0		0.03107		
2073	VAPB	ENSG00000124164	prostate cancer	10.0	1.0	0.0	0.0				0.2988
2074	VAPB	ENSG00000124164	renal cancer	5.0	6.0	1.0	0.0	1.078e-08			
2075	VAPB	ENSG00000124164	skin cancer	0.0	8.0	3.0	0.0				
2076	VAPB	ENSG00000124164	stomach cancer	10.0	2.0	0.0	0.0		0.105		
2077	VAPB	ENSG00000124164	testis cancer	7.0	3.0	2.0	0.0				0.5314
2078	VAPB	ENSG00000124164	thyroid cancer	3.0	0.0	0.0	0.0				0.006339
2079	VAPB	ENSG00000124164	urothelial cancer	4.0	5.0	2.0	0.0				0.02992
2080	DGKI	ENSG00000157680	breast cancer								0.1764
2081	DGKI	ENSG00000157680	carcinoid								
2082	DGKI	ENSG00000157680	cervical cancer								0.122
2083	DGKI	ENSG00000157680	colorectal cancer								0.006656
2084	DGKI	ENSG00000157680	endometrial cancer								0.1756
2085	DGKI	ENSG00000157680	glioma						0.0608		
2086	DGKI	ENSG00000157680	head and neck cancer						0.1425		
2087	DGKI	ENSG00000157680	liver cancer								0.09618
2088	DGKI	ENSG00000157680	lung cancer						0.2233		
2089	DGKI	ENSG00000157680	lymphoma								
2090	DGKI	ENSG00000157680	melanoma						0.1091		
2091	DGKI	ENSG00000157680	ovarian cancer								0.09008
2092	DGKI	ENSG00000157680	pancreatic cancer								0.08743
2093	DGKI	ENSG00000157680	prostate cancer						0.04464		
2094	DGKI	ENSG00000157680	renal cancer								5.984e-05
2095	DGKI	ENSG00000157680	skin cancer								
2096	DGKI	ENSG00000157680	stomach cancer								0.002851
2097	DGKI	ENSG00000157680	testis cancer						0.1846		
2098	DGKI	ENSG00000157680	thyroid cancer								0.01261
2099	DGKI	ENSG00000157680	urothelial cancer								0.001728
2100	PLD1	ENSG00000075651	breast cancer	0.0	2.0	7.0	1.0		0.3227		
2101	PLD1	ENSG00000075651	carcinoid	0.0	0.0	1.0	3.0				
2102	PLD1	ENSG00000075651	cervical cancer	2.0	7.0	2.0	0.0				0.327
2103	PLD1	ENSG00000075651	colorectal cancer	2.0	4.0	5.0	1.0		0.05818		
2104	PLD1	ENSG00000075651	endometrial cancer	0.0	0.0	5.0	7.0				0.05134
2105	PLD1	ENSG00000075651	glioma	0.0	4.0	4.0	2.0				0.4581
2106	PLD1	ENSG00000075651	head and neck cancer	0.0	4.0	0.0	0.0		0.04762		
2107	PLD1	ENSG00000075651	liver cancer	1.0	2.0	7.0	1.0		0.0903		
2108	PLD1	ENSG00000075651	lung cancer	0.0	4.0	2.0	3.0				0.1457
2109	PLD1	ENSG00000075651	lymphoma	0.0	3.0	4.0	5.0				
2110	PLD1	ENSG00000075651	melanoma	2.0	4.0	3.0	2.0		0.06233		
2111	PLD1	ENSG00000075651	ovarian cancer	1.0	4.0	3.0	3.0		0.08017		
2112	PLD1	ENSG00000075651	pancreatic cancer	3.0	3.0	1.0	1.0				0.02064
2113	PLD1	ENSG00000075651	prostate cancer	0.0	1.0	3.0	4.0		0.02946		
2114	PLD1	ENSG00000075651	renal cancer	0.0	7.0	5.0	0.0				0.1234
2115	PLD1	ENSG00000075651	skin cancer	2.0	6.0	1.0	0.0				
2116	PLD1	ENSG00000075651	stomach cancer	1.0	4.0	3.0	3.0				0.1287
2117	PLD1	ENSG00000075651	testis cancer	0.0	0.0	2.0	8.0		0.1157		
2118	PLD1	ENSG00000075651	thyroid cancer	0.0	1.0	1.0	2.0				0.1188
2119	PLD1	ENSG00000075651	urothelial cancer	1.0	9.0	0.0	0.0			4.763e-06	
2120	ELAVL1	ENSG00000066044	breast cancer	0.0	9.0	2.0	0.0				0.1194
2121	ELAVL1	ENSG00000066044	carcinoid	0.0	3.0	1.0	0.0				
2122	ELAVL1	ENSG00000066044	cervical cancer	0.0	4.0	7.0	1.0		0.009656		
2123	ELAVL1	ENSG00000066044	colorectal cancer	0.0	10.0	1.0	0.0		0.02461		
2124	ELAVL1	ENSG00000066044	endometrial cancer	0.0	4.0	7.0	0.0		0.3983		
2125	ELAVL1	ENSG00000066044	glioma	0.0	12.0	0.0	0.0		0.1044		
2126	ELAVL1	ENSG00000066044	head and neck cancer	0.0	1.0	3.0	0.0		0.006374		
2127	ELAVL1	ENSG00000066044	liver cancer	0.0	1.0	9.0	1.0				0.01808
2128	ELAVL1	ENSG00000066044	lung cancer	0.0	4.0	5.0	3.0				0.08439
2129	ELAVL1	ENSG00000066044	lymphoma	0.0	0.0	12.0	0.0				
2130	ELAVL1	ENSG00000066044	melanoma	0.0	3.0	8.0	0.0				0.03747
2131	ELAVL1	ENSG00000066044	ovarian cancer	0.0	6.0	4.0	1.0	0.0004927			
2132	ELAVL1	ENSG00000066044	pancreatic cancer	0.0	5.0	6.0	1.0		0.2093		
2133	ELAVL1	ENSG00000066044	prostate cancer	0.0	11.0	0.0	0.0				0.01585
2134	ELAVL1	ENSG00000066044	renal cancer	0.0	8.0	2.0	1.0		0.07229		
2135	ELAVL1	ENSG00000066044	skin cancer	0.0	4.0	8.0	0.0				
2136	ELAVL1	ENSG00000066044	stomach cancer	0.0	2.0	10.0	0.0		0.0614		
2137	ELAVL1	ENSG00000066044	testis cancer	0.0	6.0	6.0	0.0		0.15		
2138	ELAVL1	ENSG00000066044	thyroid cancer	0.0	1.0	2.0	1.0		0.01181		
2139	ELAVL1	ENSG00000066044	urothelial cancer	1.0	6.0	4.0	1.0		0.01648		
2140	NR4A1	ENSG00000123358	breast cancer	0.0	6.0	4.0	1.0		0.02405		
2141	NR4A1	ENSG00000123358	carcinoid	0.0	1.0	0.0	3.0				
2142	NR4A1	ENSG00000123358	cervical cancer	0.0	1.0	6.0	4.0		0.2566		
2143	NR4A1	ENSG00000123358	colorectal cancer	0.0	5.0	5.0	1.0				0.1291
2144	NR4A1	ENSG00000123358	endometrial cancer	0.0	0.0	5.0	7.0				0.1736
2145	NR4A1	ENSG00000123358	glioma	0.0	0.0	3.0	9.0				0.1646
2146	NR4A1	ENSG00000123358	head and neck cancer	0.0	4.0	0.0	0.0				0.1157
2147	NR4A1	ENSG00000123358	liver cancer	0.0	2.0	2.0	8.0		0.01262		
2148	NR4A1	ENSG00000123358	lung cancer	0.0	5.0	2.0	4.0				0.1945
2149	NR4A1	ENSG00000123358	lymphoma	0.0	3.0	3.0	6.0				
2150	NR4A1	ENSG00000123358	melanoma	3.0	4.0	3.0	2.0		0.01922		
2151	NR4A1	ENSG00000123358	ovarian cancer	0.0	5.0	3.0	4.0				0.002225
2152	NR4A1	ENSG00000123358	pancreatic cancer	2.0	4.0	2.0	4.0				0.1899
2153	NR4A1	ENSG00000123358	prostate cancer	1.0	5.0	6.0	0.0		0.1158		
2154	NR4A1	ENSG00000123358	renal cancer	0.0	3.0	2.0	7.0	0.000699			
2155	NR4A1	ENSG00000123358	skin cancer	0.0	6.0	5.0	1.0				
2156	NR4A1	ENSG00000123358	stomach cancer	0.0	4.0	7.0	1.0				0.03405
2157	NR4A1	ENSG00000123358	testis cancer	1.0	10.0	0.0	1.0		0.2708		
2158	NR4A1	ENSG00000123358	thyroid cancer	0.0	4.0	0.0	0.0				0.01843
2159	NR4A1	ENSG00000123358	urothelial cancer	3.0	3.0	5.0	1.0				0.008885
2160	ZNF197	ENSG00000186448	breast cancer	0.0	0.0	3.0	9.0		0.1061		
2161	ZNF197	ENSG00000186448	carcinoid	0.0	0.0	0.0	4.0				
2162	ZNF197	ENSG00000186448	cervical cancer	0.0	0.0	1.0	9.0				0.06348
2163	ZNF197	ENSG00000186448	colorectal cancer	0.0	7.0	3.0	0.0		0.06097		
2164	ZNF197	ENSG00000186448	endometrial cancer	0.0	3.0	2.0	6.0				0.1087
2165	ZNF197	ENSG00000186448	glioma	0.0	0.0	1.0	10.0		0.05494		
2166	ZNF197	ENSG00000186448	head and neck cancer	0.0	1.0	0.0	2.0		0.01684		
2167	ZNF197	ENSG00000186448	liver cancer	0.0	1.0	1.0	10.0				0.1135
2168	ZNF197	ENSG00000186448	lung cancer	0.0	0.0	3.0	8.0		0.02229		
2169	ZNF197	ENSG00000186448	lymphoma	0.0	0.0	1.0	10.0				
2170	ZNF197	ENSG00000186448	melanoma	0.0	0.0	0.0	12.0				0.07493
2171	ZNF197	ENSG00000186448	ovarian cancer	0.0	0.0	4.0	8.0		0.2012		
2172	ZNF197	ENSG00000186448	pancreatic cancer	0.0	1.0	1.0	7.0				0.1614
2173	ZNF197	ENSG00000186448	prostate cancer	0.0	0.0	0.0	12.0			0.0006779	
2174	ZNF197	ENSG00000186448	renal cancer	0.0	0.0	0.0	10.0		0.01487		
2175	ZNF197	ENSG00000186448	skin cancer	0.0	1.0	1.0	7.0				
2176	ZNF197	ENSG00000186448	stomach cancer	0.0	1.0	2.0	6.0				0.3143
2177	ZNF197	ENSG00000186448	testis cancer	0.0	0.0	3.0	8.0		0.07832		
2178	ZNF197	ENSG00000186448	thyroid cancer	0.0	0.0	3.0	1.0				0.1227
2179	ZNF197	ENSG00000186448	urothelial cancer	0.0	0.0	4.0	8.0		0.02851		
2180	NDRG3	ENSG00000101079	breast cancer	0.0	10.0	2.0	0.0				0.04593
2181	NDRG3	ENSG00000101079	carcinoid	0.0	2.0	1.0	1.0				
2182	NDRG3	ENSG00000101079	cervical cancer	0.0	4.0	4.0	3.0		0.009378		
2183	NDRG3	ENSG00000101079	colorectal cancer	0.0	10.0	1.0	0.0		0.06731		
2184	NDRG3	ENSG00000101079	endometrial cancer	0.0	11.0	1.0	0.0				0.01339
2185	NDRG3	ENSG00000101079	glioma	0.0	10.0	2.0	0.0		0.2804		
2186	NDRG3	ENSG00000101079	head and neck cancer	0.0	4.0	0.0	0.0				0.09274
2187	NDRG3	ENSG00000101079	liver cancer	0.0	7.0	3.0	2.0			0.0004349	
2188	NDRG3	ENSG00000101079	lung cancer	0.0	3.0	3.0	5.0				0.1556
2189	NDRG3	ENSG00000101079	lymphoma	0.0	9.0	3.0	0.0				
2190	NDRG3	ENSG00000101079	melanoma	0.0	4.0	5.0	1.0		0.01296		
2191	NDRG3	ENSG00000101079	ovarian cancer	0.0	8.0	3.0	1.0				0.00542
2192	NDRG3	ENSG00000101079	pancreatic cancer	0.0	4.0	6.0	2.0		0.002479		
2193	NDRG3	ENSG00000101079	prostate cancer	0.0	9.0	1.0	0.0		0.3522		
2194	NDRG3	ENSG00000101079	renal cancer	0.0	5.0	3.0	3.0				0.09571
2195	NDRG3	ENSG00000101079	skin cancer	0.0	3.0	7.0	1.0				
2196	NDRG3	ENSG00000101079	stomach cancer	0.0	4.0	4.0	1.0		0.02663		
2197	NDRG3	ENSG00000101079	testis cancer	1.0	9.0	0.0	0.0		0.3388		
2198	NDRG3	ENSG00000101079	thyroid cancer	0.0	3.0	1.0	0.0		0.03983		
2199	NDRG3	ENSG00000101079	urothelial cancer	0.0	10.0	1.0	0.0				0.1613
2200	CSNK2A1	ENSG00000101266	breast cancer	0.0	11.0	1.0	0.0				0.1191
2201	CSNK2A1	ENSG00000101266	carcinoid	0.0	2.0	0.0	2.0				
2202	CSNK2A1	ENSG00000101266	cervical cancer	2.0	5.0	4.0	1.0				0.1442
2203	CSNK2A1	ENSG00000101266	colorectal cancer	0.0	11.0	1.0	0.0				0.05443
2204	CSNK2A1	ENSG00000101266	endometrial cancer	0.0	6.0	5.0	1.0				0.008283
2205	CSNK2A1	ENSG00000101266	glioma	1.0	5.0	6.0	0.0		0.03619		
2206	CSNK2A1	ENSG00000101266	head and neck cancer	2.0	1.0	1.0	0.0				0.0204
2207	CSNK2A1	ENSG00000101266	liver cancer	1.0	2.0	3.0	4.0			4.108e-06	
2208	CSNK2A1	ENSG00000101266	lung cancer	1.0	7.0	3.0	1.0				0.04077
2209	CSNK2A1	ENSG00000101266	lymphoma	0.0	3.0	8.0	1.0				
2210	CSNK2A1	ENSG00000101266	melanoma	1.0	6.0	2.0	3.0				0.3886
2211	CSNK2A1	ENSG00000101266	ovarian cancer	1.0	5.0	6.0	0.0		0.06879		
2212	CSNK2A1	ENSG00000101266	pancreatic cancer	1.0	3.0	6.0	1.0				0.01939
2213	CSNK2A1	ENSG00000101266	prostate cancer	2.0	5.0	2.0	1.0		0.1159		
2214	CSNK2A1	ENSG00000101266	renal cancer	0.0	3.0	3.0	6.0		0.08575		
2215	CSNK2A1	ENSG00000101266	skin cancer	0.0	8.0	3.0	1.0				
2216	CSNK2A1	ENSG00000101266	stomach cancer	1.0	6.0	4.0	0.0		0.1503		
2217	CSNK2A1	ENSG00000101266	testis cancer	2.0	8.0	1.0	1.0		0.447		
2218	CSNK2A1	ENSG00000101266	thyroid cancer	0.0	0.0	4.0	0.0				0.09528
2219	CSNK2A1	ENSG00000101266	urothelial cancer	3.0	8.0	1.0	0.0		0.07372		
2220	DACT1	ENSG00000165617	breast cancer	0.0	3.0	6.0	3.0				0.02474
2221	DACT1	ENSG00000165617	carcinoid	0.0	1.0	3.0	0.0				
2222	DACT1	ENSG00000165617	cervical cancer	0.0	1.0	6.0	5.0				0.02724
2223	DACT1	ENSG00000165617	colorectal cancer	1.0	3.0	6.0	1.0				0.01789
2224	DACT1	ENSG00000165617	endometrial cancer	0.0	3.0	8.0	0.0		0.1216		
2225	DACT1	ENSG00000165617	glioma	0.0	0.0	12.0	0.0				0.01031
2226	DACT1	ENSG00000165617	head and neck cancer	0.0	0.0	4.0	0.0				0.0355
2227	DACT1	ENSG00000165617	liver cancer	0.0	2.0	10.0	0.0				0.1368
2228	DACT1	ENSG00000165617	lung cancer	0.0	0.0	7.0	5.0				0.01167
2229	DACT1	ENSG00000165617	lymphoma	0.0	0.0	11.0	1.0				
2230	DACT1	ENSG00000165617	melanoma	0.0	0.0	12.0	0.0				0.04789
2231	DACT1	ENSG00000165617	ovarian cancer	0.0	0.0	10.0	2.0				0.1933
2232	DACT1	ENSG00000165617	pancreatic cancer	0.0	0.0	12.0	0.0				0.05418
2233	DACT1	ENSG00000165617	prostate cancer	0.0	0.0	4.0	7.0				0.06541
2234	DACT1	ENSG00000165617	renal cancer	0.0	0.0	8.0	4.0				0.04163
2235	DACT1	ENSG00000165617	skin cancer	0.0	0.0	6.0	6.0				
2236	DACT1	ENSG00000165617	stomach cancer	0.0	1.0	9.0	1.0				0.01636
2237	DACT1	ENSG00000165617	testis cancer	0.0	12.0	0.0	0.0				0.2538
2238	DACT1	ENSG00000165617	thyroid cancer	0.0	2.0	2.0	0.0				0.001372
2239	DACT1	ENSG00000165617	urothelial cancer	1.0	3.0	8.0	0.0				0.001891
2240	ID1	ENSG00000125968	breast cancer	0.0	1.0	5.0	6.0		0.03887		
2241	ID1	ENSG00000125968	carcinoid	0.0	1.0	2.0	1.0				
2242	ID1	ENSG00000125968	cervical cancer	0.0	3.0	5.0	4.0				0.03454
2243	ID1	ENSG00000125968	colorectal cancer	0.0	2.0	3.0	6.0		0.02618		
2244	ID1	ENSG00000125968	endometrial cancer	0.0	3.0	7.0	2.0		0.03186		
2245	ID1	ENSG00000125968	glioma	0.0	4.0	6.0	1.0		0.01273		
2246	ID1	ENSG00000125968	head and neck cancer	0.0	1.0	2.0	1.0				0.1741
2247	ID1	ENSG00000125968	liver cancer	0.0	7.0	5.0	0.0		0.2354		
2248	ID1	ENSG00000125968	lung cancer	0.0	1.0	6.0	5.0			0.0004852	
2249	ID1	ENSG00000125968	lymphoma	0.0	3.0	7.0	1.0				
2250	ID1	ENSG00000125968	melanoma	0.0	2.0	8.0	2.0				0.2292
2251	ID1	ENSG00000125968	ovarian cancer	0.0	1.0	5.0	6.0				0.1577
2252	ID1	ENSG00000125968	pancreatic cancer	0.0	8.0	3.0	0.0				0.02143
2253	ID1	ENSG00000125968	prostate cancer	0.0	2.0	7.0	3.0		0.07828		
2254	ID1	ENSG00000125968	renal cancer	0.0	0.0	3.0	9.0		0.01672		
2255	ID1	ENSG00000125968	skin cancer	0.0	6.0	6.0	0.0				
2256	ID1	ENSG00000125968	stomach cancer	0.0	3.0	8.0	1.0		0.001709		
2257	ID1	ENSG00000125968	testis cancer	0.0	4.0	7.0	0.0				0.2969
2258	ID1	ENSG00000125968	thyroid cancer	0.0	3.0	1.0	0.0				0.00617
2259	ID1	ENSG00000125968	urothelial cancer	0.0	3.0	6.0	2.0		0.003414		
2260	ID3	ENSG00000117318	breast cancer	2.0	4.0	3.0	2.0				0.06729
2261	ID3	ENSG00000117318	carcinoid	0.0	0.0	2.0	2.0				
2262	ID3	ENSG00000117318	cervical cancer	1.0	3.0	1.0	7.0				0.2479
2263	ID3	ENSG00000117318	colorectal cancer	2.0	2.0	7.0	1.0		0.05187		
2264	ID3	ENSG00000117318	endometrial cancer	2.0	0.0	8.0	2.0	1.269e-05			
2265	ID3	ENSG00000117318	glioma	4.0	0.0	4.0	4.0		0.005576		
2266	ID3	ENSG00000117318	head and neck cancer	1.0	1.0	0.0	2.0				0.1457
2267	ID3	ENSG00000117318	liver cancer	0.0	3.0	4.0	5.0		0.08981		
2268	ID3	ENSG00000117318	lung cancer	0.0	0.0	3.0	7.0				0.07759
2269	ID3	ENSG00000117318	lymphoma	1.0	3.0	2.0	5.0				
2270	ID3	ENSG00000117318	melanoma	3.0	1.0	1.0	7.0				0.03889
2271	ID3	ENSG00000117318	ovarian cancer	3.0	5.0	1.0	2.0				0.006467
2272	ID3	ENSG00000117318	pancreatic cancer	2.0	0.0	4.0	4.0		0.2425		
2273	ID3	ENSG00000117318	prostate cancer	0.0	1.0	2.0	7.0		0.1499		
2274	ID3	ENSG00000117318	renal cancer	2.0	0.0	2.0	7.0				0.02516
2275	ID3	ENSG00000117318	skin cancer	7.0	3.0	0.0	1.0				
2276	ID3	ENSG00000117318	stomach cancer	0.0	1.0	3.0	7.0		0.136		
2277	ID3	ENSG00000117318	testis cancer	5.0	2.0	2.0	3.0		0.201		
2278	ID3	ENSG00000117318	thyroid cancer	0.0	1.0	1.0	2.0				0.004373
2279	ID3	ENSG00000117318	urothelial cancer	3.0	2.0	0.0	7.0		0.0836		
2280	ID2	ENSG00000115738	breast cancer						0.2527		
2281	ID2	ENSG00000115738	carcinoid								
2282	ID2	ENSG00000115738	cervical cancer						0.008164		
2283	ID2	ENSG00000115738	colorectal cancer						0.08507		
2284	ID2	ENSG00000115738	endometrial cancer						0.06656		
2285	ID2	ENSG00000115738	glioma								0.224
2286	ID2	ENSG00000115738	head and neck cancer					0.0009946			
2287	ID2	ENSG00000115738	liver cancer						0.0439		
2288	ID2	ENSG00000115738	lung cancer						0.06314		
2289	ID2	ENSG00000115738	lymphoma								
2290	ID2	ENSG00000115738	melanoma						0.1949		
2291	ID2	ENSG00000115738	ovarian cancer						0.2073		
2292	ID2	ENSG00000115738	pancreatic cancer						0.1109		
2293	ID2	ENSG00000115738	prostate cancer						0.281		
2294	ID2	ENSG00000115738	renal cancer						0.05984		
2295	ID2	ENSG00000115738	skin cancer								
2296	ID2	ENSG00000115738	stomach cancer						0.02415		
2297	ID2	ENSG00000115738	testis cancer								0.1743
2298	ID2	ENSG00000115738	thyroid cancer						0.001382		
2299	ID2	ENSG00000115738	urothelial cancer						0.001917		
2300	RHOBTB3	ENSG00000164292	breast cancer								0.1682
2301	RHOBTB3	ENSG00000164292	carcinoid								
2302	RHOBTB3	ENSG00000164292	cervical cancer								0.096
2303	RHOBTB3	ENSG00000164292	colorectal cancer						0.05622		
2304	RHOBTB3	ENSG00000164292	endometrial cancer								0.001315
2305	RHOBTB3	ENSG00000164292	glioma								0.1839
2306	RHOBTB3	ENSG00000164292	head and neck cancer						0.0339		
2307	RHOBTB3	ENSG00000164292	liver cancer						0.07373		
2308	RHOBTB3	ENSG00000164292	lung cancer						0.4282		
2309	RHOBTB3	ENSG00000164292	lymphoma								
2310	RHOBTB3	ENSG00000164292	melanoma								0.006001
2311	RHOBTB3	ENSG00000164292	ovarian cancer								0.09291
2312	RHOBTB3	ENSG00000164292	pancreatic cancer						0.09151		
2313	RHOBTB3	ENSG00000164292	prostate cancer								0.3636
2314	RHOBTB3	ENSG00000164292	renal cancer								0.001562
2315	RHOBTB3	ENSG00000164292	skin cancer								
2316	RHOBTB3	ENSG00000164292	stomach cancer								0.007009
2317	RHOBTB3	ENSG00000164292	testis cancer						0.1153		
2318	RHOBTB3	ENSG00000164292	thyroid cancer								0.3228
2319	RHOBTB3	ENSG00000164292	urothelial cancer								0.08209
2320	RPL6	ENSG00000089009	breast cancer	0.0	3.0	6.0	3.0		0.05953		
2321	RPL6	ENSG00000089009	carcinoid	0.0	0.0	0.0	4.0				
2322	RPL6	ENSG00000089009	cervical cancer	0.0	2.0	4.0	5.0				0.1308
2323	RPL6	ENSG00000089009	colorectal cancer	0.0	4.0	6.0	1.0				0.1399
2324	RPL6	ENSG00000089009	endometrial cancer	0.0	2.0	5.0	4.0		0.05485		
2325	RPL6	ENSG00000089009	glioma	0.0	0.0	0.0	11.0		0.01097		
2326	RPL6	ENSG00000089009	head and neck cancer	0.0	1.0	1.0	2.0		0.2499		
2327	RPL6	ENSG00000089009	liver cancer	0.0	0.0	3.0	9.0				0.01023
2328	RPL6	ENSG00000089009	lung cancer	0.0	2.0	4.0	5.0				0.3744
2329	RPL6	ENSG00000089009	lymphoma	0.0	1.0	0.0	11.0				
2330	RPL6	ENSG00000089009	melanoma	0.0	1.0	6.0	5.0				0.05629
2331	RPL6	ENSG00000089009	ovarian cancer	0.0	0.0	8.0	4.0				0.01074
2332	RPL6	ENSG00000089009	pancreatic cancer	0.0	3.0	6.0	3.0		0.004188		
2333	RPL6	ENSG00000089009	prostate cancer	0.0	0.0	5.0	7.0				0.02517
2334	RPL6	ENSG00000089009	renal cancer	0.0	0.0	2.0	10.0			0.0006953	
2335	RPL6	ENSG00000089009	skin cancer	0.0	3.0	5.0	2.0				
2336	RPL6	ENSG00000089009	stomach cancer	0.0	0.0	7.0	5.0		0.245		
2337	RPL6	ENSG00000089009	testis cancer	0.0	3.0	6.0	1.0		0.02402		
2338	RPL6	ENSG00000089009	thyroid cancer	0.0	0.0	1.0	3.0		0.03376		
2339	RPL6	ENSG00000089009	urothelial cancer	0.0	6.0	4.0	2.0		0.05901		
2340	TRIP6	ENSG00000087077	breast cancer	2.0	8.0	0.0	0.0		0.007936		
2341	TRIP6	ENSG00000087077	carcinoid	0.0	4.0	0.0	0.0				
2342	TRIP6	ENSG00000087077	cervical cancer	2.0	10.0	0.0	0.0				0.1064
2343	TRIP6	ENSG00000087077	colorectal cancer	1.0	10.0	0.0	0.0				0.003219
2344	TRIP6	ENSG00000087077	endometrial cancer	0.0	11.0	0.0	0.0				0.002845
2345	TRIP6	ENSG00000087077	glioma	4.0	5.0	1.0	0.0				0.0352
2346	TRIP6	ENSG00000087077	head and neck cancer	1.0	3.0	0.0	0.0				0.02917
2347	TRIP6	ENSG00000087077	liver cancer	1.0	8.0	2.0	0.0				0.03182
2348	TRIP6	ENSG00000087077	lung cancer	2.0	8.0	0.0	0.0		0.004608		
2349	TRIP6	ENSG00000087077	lymphoma	0.0	3.0	2.0	7.0				
2350	TRIP6	ENSG00000087077	melanoma	0.0	11.0	0.0	0.0				0.08485
2351	TRIP6	ENSG00000087077	ovarian cancer	1.0	11.0	0.0	0.0				0.0418
2352	TRIP6	ENSG00000087077	pancreatic cancer	0.0	12.0	0.0	0.0				0.05081
2353	TRIP6	ENSG00000087077	prostate cancer	1.0	11.0	0.0	0.0		0.1418		
2354	TRIP6	ENSG00000087077	renal cancer	1.0	11.0	0.0	0.0		0.01252		
2355	TRIP6	ENSG00000087077	skin cancer	0.0	11.0	0.0	0.0				
2356	TRIP6	ENSG00000087077	stomach cancer	0.0	6.0	1.0	0.0		0.0507		
2357	TRIP6	ENSG00000087077	testis cancer	0.0	11.0	1.0	0.0				0.09706
2358	TRIP6	ENSG00000087077	thyroid cancer	0.0	3.0	0.0	0.0				0.1921
2359	TRIP6	ENSG00000087077	urothelial cancer	2.0	10.0	0.0	0.0				0.1247
2360	TARDBP	ENSG00000120948	breast cancer	12.0	0.0	0.0	0.0		0.003723		
2361	TARDBP	ENSG00000120948	carcinoid	3.0	1.0	0.0	0.0				
2362	TARDBP	ENSG00000120948	cervical cancer	8.0	4.0	0.0	0.0	1.149e-05			
2363	TARDBP	ENSG00000120948	colorectal cancer	10.0	0.0	0.0	0.0		0.1064		
2364	TARDBP	ENSG00000120948	endometrial cancer	7.0	5.0	0.0	0.0				0.1222
2365	TARDBP	ENSG00000120948	glioma	11.0	1.0	0.0	0.0		0.08516		
2366	TARDBP	ENSG00000120948	head and neck cancer	3.0	1.0	0.0	0.0				0.04097
2367	TARDBP	ENSG00000120948	liver cancer	7.0	5.0	0.0	0.0			1.195e-07	
2368	TARDBP	ENSG00000120948	lung cancer	7.0	5.0	0.0	0.0		0.1063		
2369	TARDBP	ENSG00000120948	lymphoma	9.0	2.0	0.0	0.0				
2370	TARDBP	ENSG00000120948	melanoma	9.0	3.0	0.0	0.0				0.003413
2371	TARDBP	ENSG00000120948	ovarian cancer	7.0	4.0	0.0	0.0		0.004753		
2372	TARDBP	ENSG00000120948	pancreatic cancer	8.0	4.0	0.0	0.0				0.2239
2373	TARDBP	ENSG00000120948	prostate cancer	11.0	0.0	0.0	0.0				0.0254
2374	TARDBP	ENSG00000120948	renal cancer	9.0	2.0	0.0	0.0				0.002266
2375	TARDBP	ENSG00000120948	skin cancer	10.0	1.0	0.0	0.0				
2376	TARDBP	ENSG00000120948	stomach cancer	11.0	1.0	0.0	0.0		0.2269		
2377	TARDBP	ENSG00000120948	testis cancer	12.0	0.0	0.0	0.0				0.1873
2378	TARDBP	ENSG00000120948	thyroid cancer	3.0	1.0	0.0	0.0				0.2858
2379	TARDBP	ENSG00000120948	urothelial cancer	12.0	0.0	0.0	0.0		0.02711		
2380	SQSTM1	ENSG00000161011	breast cancer	2.0	7.0	1.0	0.0				0.1078
2381	SQSTM1	ENSG00000161011	carcinoid	0.0	1.0	0.0	1.0				
2382	SQSTM1	ENSG00000161011	cervical cancer	5.0	5.0	0.0	0.0		0.1387		
2383	SQSTM1	ENSG00000161011	colorectal cancer	7.0	5.0	0.0	0.0		0.3186		
2384	SQSTM1	ENSG00000161011	endometrial cancer	1.0	4.0	1.0	4.0				0.09453
2385	SQSTM1	ENSG00000161011	glioma	1.0	3.0	6.0	0.0				0.01466
2386	SQSTM1	ENSG00000161011	head and neck cancer	1.0	3.0	0.0	0.0				0.1081
2387	SQSTM1	ENSG00000161011	liver cancer	3.0	3.0	4.0	2.0			2.306e-05	
2388	SQSTM1	ENSG00000161011	lung cancer	2.0	6.0	0.0	0.0				0.134
2389	SQSTM1	ENSG00000161011	lymphoma	2.0	7.0	2.0	0.0				
2390	SQSTM1	ENSG00000161011	melanoma	1.0	6.0	0.0	0.0		0.2337		
2391	SQSTM1	ENSG00000161011	ovarian cancer	3.0	4.0	3.0	2.0				0.05647
2392	SQSTM1	ENSG00000161011	pancreatic cancer	4.0	4.0	2.0	0.0				0.1664
2393	SQSTM1	ENSG00000161011	prostate cancer	0.0	4.0	3.0	2.0		0.1701		
2394	SQSTM1	ENSG00000161011	renal cancer	1.0	8.0	2.0	1.0				0.09515
2395	SQSTM1	ENSG00000161011	skin cancer	4.0	1.0	2.0	2.0				
2396	SQSTM1	ENSG00000161011	stomach cancer	2.0	9.0	0.0	0.0		0.321		
2397	SQSTM1	ENSG00000161011	testis cancer	1.0	1.0	5.0	5.0				0.008681
2398	SQSTM1	ENSG00000161011	thyroid cancer	2.0	1.0	0.0	0.0		0.04411		
2399	SQSTM1	ENSG00000161011	urothelial cancer	2.0	9.0	1.0	0.0		0.2014		
2400	AKT1	ENSG00000142208	breast cancer	4.0	5.0	2.0	0.0				0.03297
2401	AKT1	ENSG00000142208	carcinoid	0.0	3.0	1.0	0.0				
2402	AKT1	ENSG00000142208	cervical cancer	3.0	5.0	3.0	0.0				0.04272
2403	AKT1	ENSG00000142208	colorectal cancer	4.0	8.0	0.0	0.0				0.1981
2404	AKT1	ENSG00000142208	endometrial cancer	6.0	5.0	0.0	0.0		0.1839		
2405	AKT1	ENSG00000142208	glioma	0.0	11.0	1.0	0.0		0.3696		
2406	AKT1	ENSG00000142208	head and neck cancer	0.0	4.0	0.0	0.0				0.009168
2407	AKT1	ENSG00000142208	liver cancer	1.0	3.0	6.0	0.0				0.001548
2408	AKT1	ENSG00000142208	lung cancer	2.0	8.0	2.0	0.0		0.1215		
2409	AKT1	ENSG00000142208	lymphoma	3.0	6.0	3.0	0.0				
2410	AKT1	ENSG00000142208	melanoma	0.0	10.0	1.0	0.0				0.1474
2411	AKT1	ENSG00000142208	ovarian cancer	0.0	3.0	8.0	0.0	0.0004833			
2412	AKT1	ENSG00000142208	pancreatic cancer	1.0	5.0	4.0	0.0		0.03584		
2413	AKT1	ENSG00000142208	prostate cancer	5.0	6.0	0.0	0.0				0.01898
2414	AKT1	ENSG00000142208	renal cancer	0.0	12.0	0.0	0.0	0.0002117			
2415	AKT1	ENSG00000142208	skin cancer	2.0	6.0	0.0	0.0				
2416	AKT1	ENSG00000142208	stomach cancer	0.0	9.0	3.0	0.0		0.07144		
2417	AKT1	ENSG00000142208	testis cancer	4.0	8.0	0.0	0.0				0.1284
2418	AKT1	ENSG00000142208	thyroid cancer	1.0	3.0	0.0	0.0		0.1064		
2419	AKT1	ENSG00000142208	urothelial cancer	5.0	7.0	0.0	0.0				0.2407
2420	ZNF350	ENSG00000256683	breast cancer	0.0	0.0	10.0	2.0				0.00726
2421	ZNF350	ENSG00000256683	carcinoid	0.0	0.0	0.0	4.0				
2422	ZNF350	ENSG00000256683	cervical cancer	0.0	1.0	2.0	9.0				0.04025
2423	ZNF350	ENSG00000256683	colorectal cancer	0.0	0.0	5.0	7.0		0.02514		
2424	ZNF350	ENSG00000256683	endometrial cancer	0.0	0.0	3.0	9.0				0.0584
2425	ZNF350	ENSG00000256683	glioma	0.0	0.0	2.0	9.0		0.01028		
2426	ZNF350	ENSG00000256683	head and neck cancer	0.0	1.0	2.0	1.0		0.04173		
2427	ZNF350	ENSG00000256683	liver cancer	0.0	0.0	3.0	9.0				0.0708
2428	ZNF350	ENSG00000256683	lung cancer	0.0	0.0	0.0	12.0		0.06637		
2429	ZNF350	ENSG00000256683	lymphoma	0.0	0.0	9.0	1.0				
2430	ZNF350	ENSG00000256683	melanoma	0.0	0.0	1.0	11.0				0.0208
2431	ZNF350	ENSG00000256683	ovarian cancer	0.0	0.0	1.0	11.0		0.1301		
2432	ZNF350	ENSG00000256683	pancreatic cancer	0.0	0.0	3.0	8.0		0.1763		
2433	ZNF350	ENSG00000256683	prostate cancer	0.0	3.0	9.0	0.0				0.003249
2434	ZNF350	ENSG00000256683	renal cancer	0.0	0.0	4.0	8.0		0.006639		
2435	ZNF350	ENSG00000256683	skin cancer	0.0	0.0	2.0	10.0				
2436	ZNF350	ENSG00000256683	stomach cancer	0.0	0.0	1.0	11.0				0.01193
2437	ZNF350	ENSG00000256683	testis cancer	0.0	0.0	11.0	1.0				0.3155
2438	ZNF350	ENSG00000256683	thyroid cancer	0.0	0.0	0.0	4.0		0.08297		
2439	ZNF350	ENSG00000256683	urothelial cancer	0.0	0.0	9.0	3.0	0.0002537			
2440	RWDD3	ENSG00000122481	breast cancer						0.004866		
2441	RWDD3	ENSG00000122481	carcinoid								
2442	RWDD3	ENSG00000122481	cervical cancer						0.1621		
2443	RWDD3	ENSG00000122481	colorectal cancer								0.199
2444	RWDD3	ENSG00000122481	endometrial cancer								0.02208
2445	RWDD3	ENSG00000122481	glioma								0.04351
2446	RWDD3	ENSG00000122481	head and neck cancer						0.1085		
2447	RWDD3	ENSG00000122481	liver cancer								0.007537
2448	RWDD3	ENSG00000122481	lung cancer						0.008577		
2449	RWDD3	ENSG00000122481	lymphoma								
2450	RWDD3	ENSG00000122481	melanoma								0.09477
2451	RWDD3	ENSG00000122481	ovarian cancer						0.04783		
2452	RWDD3	ENSG00000122481	pancreatic cancer						0.1774		
2453	RWDD3	ENSG00000122481	prostate cancer								0.259
2454	RWDD3	ENSG00000122481	renal cancer							6.461e-08	
2455	RWDD3	ENSG00000122481	skin cancer								
2456	RWDD3	ENSG00000122481	stomach cancer						0.02583		
2457	RWDD3	ENSG00000122481	testis cancer						0.2144		
2458	RWDD3	ENSG00000122481	thyroid cancer						0.009366		
2459	RWDD3	ENSG00000122481	urothelial cancer					0.0002056			
2460	AKT2	ENSG00000105221	breast cancer	9.0	1.0	1.0	1.0		0.06131		
2461	AKT2	ENSG00000105221	carcinoid	1.0	2.0	0.0	0.0				
2462	AKT2	ENSG00000105221	cervical cancer	1.0	2.0	3.0	6.0				0.2212
2463	AKT2	ENSG00000105221	colorectal cancer	1.0	6.0	2.0	2.0				0.1555
2464	AKT2	ENSG00000105221	endometrial cancer	1.0	1.0	2.0	8.0			1.052e-06	
2465	AKT2	ENSG00000105221	glioma	5.0	6.0	1.0	0.0				0.2847
2466	AKT2	ENSG00000105221	head and neck cancer	0.0	0.0	1.0	3.0		0.0064		
2467	AKT2	ENSG00000105221	liver cancer	1.0	2.0	2.0	5.0		0.0959		
2468	AKT2	ENSG00000105221	lung cancer	1.0	2.0	1.0	7.0				0.01221
2469	AKT2	ENSG00000105221	lymphoma	4.0	3.0	1.0	4.0				
2470	AKT2	ENSG00000105221	melanoma	2.0	3.0	5.0	2.0				0.02975
2471	AKT2	ENSG00000105221	ovarian cancer	6.0	2.0	2.0	2.0				0.02486
2472	AKT2	ENSG00000105221	pancreatic cancer	1.0	3.0	1.0	6.0				0.3024
2473	AKT2	ENSG00000105221	prostate cancer	7.0	3.0	1.0	1.0			0.0004742	
2474	AKT2	ENSG00000105221	renal cancer	2.0	5.0	3.0	2.0		0.01302		
2475	AKT2	ENSG00000105221	skin cancer	0.0	1.0	5.0	5.0				
2476	AKT2	ENSG00000105221	stomach cancer	0.0	3.0	3.0	6.0		0.1889		
2477	AKT2	ENSG00000105221	testis cancer	0.0	9.0	2.0	1.0				0.3279
2478	AKT2	ENSG00000105221	thyroid cancer	1.0	1.0	1.0	1.0				0.06163
2479	AKT2	ENSG00000105221	urothelial cancer	0.0	5.0	4.0	3.0		0.2002		
2480	CEP68	ENSG00000011523	breast cancer	0.0	5.0	6.0	0.0				0.07989
2481	CEP68	ENSG00000011523	carcinoid	0.0	2.0	2.0	0.0				
2482	CEP68	ENSG00000011523	cervical cancer	1.0	8.0	2.0	0.0		0.06151		
2483	CEP68	ENSG00000011523	colorectal cancer	1.0	11.0	0.0	0.0		0.05091		
2484	CEP68	ENSG00000011523	endometrial cancer	1.0	10.0	1.0	0.0				0.004903
2485	CEP68	ENSG00000011523	glioma	1.0	4.0	1.0	4.0		0.01309		
2486	CEP68	ENSG00000011523	head and neck cancer	0.0	2.0	1.0	1.0		0.0175		
2487	CEP68	ENSG00000011523	liver cancer	0.0	4.0	7.0	1.0				0.004839
2488	CEP68	ENSG00000011523	lung cancer	0.0	3.0	4.0	3.0		0.008249		
2489	CEP68	ENSG00000011523	lymphoma	0.0	0.0	6.0	5.0				
2490	CEP68	ENSG00000011523	melanoma	0.0	3.0	6.0	3.0				0.09944
2491	CEP68	ENSG00000011523	ovarian cancer	1.0	11.0	0.0	0.0				0.05092
2492	CEP68	ENSG00000011523	pancreatic cancer	0.0	6.0	2.0	1.0		0.0922		
2493	CEP68	ENSG00000011523	prostate cancer	0.0	10.0	1.0	1.0				0.177
2494	CEP68	ENSG00000011523	renal cancer	1.0	8.0	3.0	0.0	0.0003927			
2495	CEP68	ENSG00000011523	skin cancer	0.0	3.0	7.0	2.0				
2496	CEP68	ENSG00000011523	stomach cancer	0.0	3.0	3.0	2.0		0.2253		
2497	CEP68	ENSG00000011523	testis cancer	0.0	5.0	7.0	0.0		0.2499		
2498	CEP68	ENSG00000011523	thyroid cancer	0.0	2.0	2.0	0.0				0.0845
2499	CEP68	ENSG00000011523	urothelial cancer	0.0	3.0	7.0	1.0		0.1708		
2500	SOCS1	ENSG00000185338	breast cancer	1.0	10.0	1.0	0.0		0.004499		
2501	SOCS1	ENSG00000185338	carcinoid	0.0	2.0	1.0	0.0				
2502	SOCS1	ENSG00000185338	cervical cancer	0.0	9.0	3.0	0.0		0.03299		
2503	SOCS1	ENSG00000185338	colorectal cancer	8.0	3.0	0.0	0.0		0.1238		
2504	SOCS1	ENSG00000185338	endometrial cancer	2.0	8.0	1.0	1.0		0.01664		
2505	SOCS1	ENSG00000185338	glioma	0.0	5.0	5.0	2.0				0.01251
2506	SOCS1	ENSG00000185338	head and neck cancer	0.0	3.0	1.0	0.0	0.0001104			
2507	SOCS1	ENSG00000185338	liver cancer	1.0	6.0	4.0	1.0		0.01714		
2508	SOCS1	ENSG00000185338	lung cancer	0.0	6.0	4.0	2.0		0.004086		
2509	SOCS1	ENSG00000185338	lymphoma	0.0	3.0	7.0	2.0				
2510	SOCS1	ENSG00000185338	melanoma	1.0	9.0	2.0	0.0		0.005309		
2511	SOCS1	ENSG00000185338	ovarian cancer	2.0	6.0	4.0	0.0		0.04818		
2512	SOCS1	ENSG00000185338	pancreatic cancer	0.0	6.0	5.0	0.0		0.1171		
2513	SOCS1	ENSG00000185338	prostate cancer	2.0	10.0	0.0	0.0		0.05389		
2514	SOCS1	ENSG00000185338	renal cancer	0.0	2.0	6.0	4.0			1.077e-06	
2515	SOCS1	ENSG00000185338	skin cancer	0.0	8.0	2.0	1.0				
2516	SOCS1	ENSG00000185338	stomach cancer	0.0	4.0	6.0	0.0				0.1564
2517	SOCS1	ENSG00000185338	testis cancer	3.0	3.0	3.0	0.0				0.05685
2518	SOCS1	ENSG00000185338	thyroid cancer	0.0	4.0	0.0	0.0				0.06081
2519	SOCS1	ENSG00000185338	urothelial cancer	0.0	8.0	4.0	0.0				0.167
2520	EPOR	ENSG00000187266	breast cancer						0.09132		
2521	EPOR	ENSG00000187266	carcinoid								
2522	EPOR	ENSG00000187266	cervical cancer								0.07137
2523	EPOR	ENSG00000187266	colorectal cancer								0.0145
2524	EPOR	ENSG00000187266	endometrial cancer								0.1044
2525	EPOR	ENSG00000187266	glioma								0.1875
2526	EPOR	ENSG00000187266	head and neck cancer								0.1115
2527	EPOR	ENSG00000187266	liver cancer						0.3704		
2528	EPOR	ENSG00000187266	lung cancer						0.01501		
2529	EPOR	ENSG00000187266	lymphoma								
2530	EPOR	ENSG00000187266	melanoma						0.05603		
2531	EPOR	ENSG00000187266	ovarian cancer								0.09002
2532	EPOR	ENSG00000187266	pancreatic cancer					3.171e-05			
2533	EPOR	ENSG00000187266	prostate cancer								0.006375
2534	EPOR	ENSG00000187266	renal cancer								0.0159
2535	EPOR	ENSG00000187266	skin cancer								
2536	EPOR	ENSG00000187266	stomach cancer								0.2078
2537	EPOR	ENSG00000187266	testis cancer								0.1999
2538	EPOR	ENSG00000187266	thyroid cancer						0.07485		
2539	EPOR	ENSG00000187266	urothelial cancer						0.001012		
2540	CHEK2	ENSG00000183765	breast cancer	5.0	7.0	0.0	0.0		0.154		
2541	CHEK2	ENSG00000183765	carcinoid	1.0	0.0	3.0	0.0				
2542	CHEK2	ENSG00000183765	cervical cancer	8.0	1.0	0.0	0.0				0.2204
2543	CHEK2	ENSG00000183765	colorectal cancer	10.0	1.0	0.0	0.0		0.05833		
2544	CHEK2	ENSG00000183765	endometrial cancer	9.0	1.0	1.0	0.0				0.02931
2545	CHEK2	ENSG00000183765	glioma	2.0	6.0	3.0	0.0		0.2416		
2546	CHEK2	ENSG00000183765	head and neck cancer	4.0	0.0	0.0	0.0				0.03828
2547	CHEK2	ENSG00000183765	liver cancer	6.0	2.0	1.0	1.0				0.001486
2548	CHEK2	ENSG00000183765	lung cancer	9.0	1.0	1.0	1.0		0.005078		
2549	CHEK2	ENSG00000183765	lymphoma	6.0	4.0	0.0	2.0				
2550	CHEK2	ENSG00000183765	melanoma	5.0	5.0	1.0	0.0				0.003329
2551	CHEK2	ENSG00000183765	ovarian cancer	8.0	2.0	2.0	0.0		0.009621		
2552	CHEK2	ENSG00000183765	pancreatic cancer	4.0	3.0	1.0	2.0				0.01285
2553	CHEK2	ENSG00000183765	prostate cancer	4.0	1.0	3.0	1.0				0.3133
2554	CHEK2	ENSG00000183765	renal cancer	0.0	3.0	4.0	4.0			7.805e-09	
2555	CHEK2	ENSG00000183765	skin cancer	8.0	0.0	1.0	0.0				
2556	CHEK2	ENSG00000183765	stomach cancer	5.0	5.0	2.0	0.0		0.02381		
2557	CHEK2	ENSG00000183765	testis cancer	11.0	0.0	1.0	0.0				0.1785
2558	CHEK2	ENSG00000183765	thyroid cancer	1.0	1.0	1.0	1.0		0.07266		
2559	CHEK2	ENSG00000183765	urothelial cancer	8.0	3.0	0.0	0.0		0.006788		
2560	PPP5C	ENSG00000011485	breast cancer	2.0	10.0	0.0	0.0				0.08247
2561	PPP5C	ENSG00000011485	carcinoid	2.0	2.0	0.0	0.0				
2562	PPP5C	ENSG00000011485	cervical cancer	3.0	8.0	1.0	0.0		0.07901		
2563	PPP5C	ENSG00000011485	colorectal cancer	11.0	1.0	0.0	0.0		0.1438		
2564	PPP5C	ENSG00000011485	endometrial cancer	3.0	8.0	0.0	1.0				0.06299
2565	PPP5C	ENSG00000011485	glioma	0.0	5.0	5.0	0.0		0.0592		
2566	PPP5C	ENSG00000011485	head and neck cancer	1.0	3.0	0.0	0.0		0.02617		
2567	PPP5C	ENSG00000011485	liver cancer	7.0	5.0	0.0	0.0			3.451e-06	
2568	PPP5C	ENSG00000011485	lung cancer	1.0	7.0	0.0	0.0				0.1292
2569	PPP5C	ENSG00000011485	lymphoma	0.0	8.0	3.0	1.0				
2570	PPP5C	ENSG00000011485	melanoma	2.0	9.0	0.0	0.0				0.01037
2571	PPP5C	ENSG00000011485	ovarian cancer	4.0	7.0	0.0	0.0				0.08249
2572	PPP5C	ENSG00000011485	pancreatic cancer	5.0	5.0	1.0	0.0		0.05559		
2573	PPP5C	ENSG00000011485	prostate cancer	1.0	11.0	0.0	0.0				0.02199
2574	PPP5C	ENSG00000011485	renal cancer	1.0	9.0	0.0	1.0		0.03243		
2575	PPP5C	ENSG00000011485	skin cancer	1.0	8.0	0.0	1.0				
2576	PPP5C	ENSG00000011485	stomach cancer	5.0	7.0	0.0	0.0		0.1138		
2577	PPP5C	ENSG00000011485	testis cancer	5.0	7.0	0.0	0.0		0.1349		
2578	PPP5C	ENSG00000011485	thyroid cancer	3.0	1.0	0.0	0.0		0.005923		
2579	PPP5C	ENSG00000011485	urothelial cancer	6.0	5.0	0.0	0.0				0.1374
2580	IL32	ENSG00000008517	breast cancer	0.0	11.0	0.0	0.0		0.01995		
2581	IL32	ENSG00000008517	carcinoid	0.0	3.0	1.0	0.0				
2582	IL32	ENSG00000008517	cervical cancer	1.0	11.0	0.0	0.0		0.0289		
2583	IL32	ENSG00000008517	colorectal cancer	1.0	10.0	1.0	0.0				0.2863
2584	IL32	ENSG00000008517	endometrial cancer	1.0	11.0	0.0	0.0	0.0001328			
2585	IL32	ENSG00000008517	glioma	0.0	8.0	3.0	0.0				0.02951
2586	IL32	ENSG00000008517	head and neck cancer	0.0	3.0	1.0	0.0		0.1316		
2587	IL32	ENSG00000008517	liver cancer	7.0	4.0	0.0	0.0		0.08022		
2588	IL32	ENSG00000008517	lung cancer	0.0	10.0	2.0	0.0				0.02582
2589	IL32	ENSG00000008517	lymphoma	1.0	3.0	7.0	1.0				
2590	IL32	ENSG00000008517	melanoma	0.0	10.0	1.0	0.0		0.00173		
2591	IL32	ENSG00000008517	ovarian cancer	2.0	7.0	2.0	0.0		0.02188		
2592	IL32	ENSG00000008517	pancreatic cancer	4.0	7.0	0.0	0.0				0.003323
2593	IL32	ENSG00000008517	prostate cancer	5.0	7.0	0.0	0.0		0.3513		
2594	IL32	ENSG00000008517	renal cancer	0.0	7.0	5.0	0.0				0.03298
2595	IL32	ENSG00000008517	skin cancer	0.0	12.0	0.0	0.0				
2596	IL32	ENSG00000008517	stomach cancer	1.0	7.0	0.0	0.0		0.08079		
2597	IL32	ENSG00000008517	testis cancer	0.0	12.0	0.0	0.0				0.03858
2598	IL32	ENSG00000008517	thyroid cancer	0.0	4.0	0.0	0.0		0.03163		
2599	IL32	ENSG00000008517	urothelial cancer	0.0	7.0	4.0	0.0		0.004291		
2600	SAT2	ENSG00000141504	breast cancer	0.0	0.0	4.0	5.0		0.02613		
2601	SAT2	ENSG00000141504	carcinoid	0.0	1.0	2.0	1.0				
2602	SAT2	ENSG00000141504	cervical cancer	0.0	0.0	2.0	8.0		0.01271		
2603	SAT2	ENSG00000141504	colorectal cancer	0.0	0.0	0.0	11.0				0.03228
2604	SAT2	ENSG00000141504	endometrial cancer	0.0	0.0	0.0	10.0	8.759e-06			
2605	SAT2	ENSG00000141504	glioma	0.0	1.0	1.0	7.0				0.02177
2606	SAT2	ENSG00000141504	head and neck cancer	0.0	0.0	2.0	2.0				0.2317
2607	SAT2	ENSG00000141504	liver cancer	0.0	2.0	4.0	6.0		0.072		
2608	SAT2	ENSG00000141504	lung cancer	0.0	0.0	0.0	12.0	0.0006707			
2609	SAT2	ENSG00000141504	lymphoma	0.0	0.0	0.0	11.0				
2610	SAT2	ENSG00000141504	melanoma	0.0	0.0	2.0	10.0				0.04136
2611	SAT2	ENSG00000141504	ovarian cancer	0.0	0.0	0.0	10.0		0.2752		
2612	SAT2	ENSG00000141504	pancreatic cancer	0.0	0.0	3.0	9.0	6.047e-05			
2613	SAT2	ENSG00000141504	prostate cancer	0.0	0.0	1.0	9.0		0.1828		
2614	SAT2	ENSG00000141504	renal cancer	0.0	2.0	5.0	5.0				0.00666
2615	SAT2	ENSG00000141504	skin cancer	0.0	1.0	3.0	8.0				
2616	SAT2	ENSG00000141504	stomach cancer	0.0	0.0	0.0	9.0		0.2488		
2617	SAT2	ENSG00000141504	testis cancer	0.0	0.0	1.0	10.0				0.1865
2618	SAT2	ENSG00000141504	thyroid cancer	0.0	2.0	2.0	0.0				0.15
2619	SAT2	ENSG00000141504	urothelial cancer	0.0	0.0	2.0	8.0		0.03124		
2620	NR2E1	ENSG00000112333	breast cancer	0.0	0.0	0.0	11.0				0.3429
2621	NR2E1	ENSG00000112333	carcinoid	0.0	0.0	0.0	4.0				
2622	NR2E1	ENSG00000112333	cervical cancer	0.0	0.0	0.0	12.0		0.1413		
2623	NR2E1	ENSG00000112333	colorectal cancer	0.0	0.0	0.0	12.0				
2624	NR2E1	ENSG00000112333	endometrial cancer	0.0	0.0	0.0	12.0				
2625	NR2E1	ENSG00000112333	glioma	0.0	0.0	0.0	11.0				0.1774
2626	NR2E1	ENSG00000112333	head and neck cancer	0.0	0.0	0.0	3.0		0.09601		
2627	NR2E1	ENSG00000112333	liver cancer	0.0	0.0	0.0	10.0				0.06275
2628	NR2E1	ENSG00000112333	lung cancer	0.0	0.0	0.0	10.0		0.6		
2629	NR2E1	ENSG00000112333	lymphoma	0.0	0.0	0.0	11.0				
2630	NR2E1	ENSG00000112333	melanoma	0.0	0.0	0.0	12.0				0.0178
2631	NR2E1	ENSG00000112333	ovarian cancer	0.0	0.0	0.0	12.0				
2632	NR2E1	ENSG00000112333	pancreatic cancer	0.0	0.0	0.0	10.0				0.07307
2633	NR2E1	ENSG00000112333	prostate cancer	0.0	0.0	0.0	11.0				0.08637
2634	NR2E1	ENSG00000112333	renal cancer	0.0	0.0	0.0	10.0				9.593e-08
2635	NR2E1	ENSG00000112333	skin cancer	0.0	0.0	0.0	10.0				
2636	NR2E1	ENSG00000112333	stomach cancer	0.0	0.0	0.0	11.0				0.2867
2637	NR2E1	ENSG00000112333	testis cancer	0.0	0.0	0.0	12.0		0.2486		
2638	NR2E1	ENSG00000112333	thyroid cancer	0.0	0.0	0.0	4.0				
2639	NR2E1	ENSG00000112333	urothelial cancer	0.0	0.0	0.0	12.0		0.307		
2640	NEDD8	ENSG00000129559	breast cancer	1.0	6.0	4.0	0.0		0.0126		
2641	NEDD8	ENSG00000129559	carcinoid	2.0	2.0	0.0	0.0				
2642	NEDD8	ENSG00000129559	cervical cancer	0.0	6.0	6.0	0.0				0.2549
2643	NEDD8	ENSG00000129559	colorectal cancer	0.0	4.0	7.0	0.0				0.114
2644	NEDD8	ENSG00000129559	endometrial cancer	0.0	5.0	7.0	0.0				0.1077
2645	NEDD8	ENSG00000129559	glioma	5.0	6.0	1.0	0.0		0.169		
2646	NEDD8	ENSG00000129559	head and neck cancer	0.0	3.0	1.0	0.0				0.003344
2647	NEDD8	ENSG00000129559	liver cancer	0.0	0.0	12.0	0.0				0.00183
2648	NEDD8	ENSG00000129559	lung cancer	1.0	5.0	5.0	1.0		0.09186		
2649	NEDD8	ENSG00000129559	lymphoma	0.0	4.0	8.0	0.0				
2650	NEDD8	ENSG00000129559	melanoma	0.0	7.0	5.0	0.0				0.4661
2651	NEDD8	ENSG00000129559	ovarian cancer	0.0	6.0	5.0	0.0		0.01347		
2652	NEDD8	ENSG00000129559	pancreatic cancer	0.0	1.0	11.0	0.0				0.02658
2653	NEDD8	ENSG00000129559	prostate cancer	0.0	11.0	1.0	0.0		0.1406		
2654	NEDD8	ENSG00000129559	renal cancer	0.0	3.0	8.0	0.0		0.00178		
2655	NEDD8	ENSG00000129559	skin cancer	0.0	6.0	5.0	0.0				
2656	NEDD8	ENSG00000129559	stomach cancer	0.0	4.0	7.0	0.0				0.02757
2657	NEDD8	ENSG00000129559	testis cancer	0.0	5.0	7.0	0.0		0.1307		
2658	NEDD8	ENSG00000129559	thyroid cancer	0.0	3.0	0.0	0.0		0.02786		
2659	NEDD8	ENSG00000129559	urothelial cancer	0.0	5.0	6.0	0.0				0.005251
2660	MAP3K1	ENSG00000095015	breast cancer	2.0	8.0	2.0	0.0		0.1768		
2661	MAP3K1	ENSG00000095015	carcinoid	1.0	2.0	1.0	0.0				
2662	MAP3K1	ENSG00000095015	cervical cancer	4.0	6.0	2.0	0.0		0.01708		
2663	MAP3K1	ENSG00000095015	colorectal cancer	7.0	4.0	1.0	0.0				0.4094
2664	MAP3K1	ENSG00000095015	endometrial cancer	5.0	6.0	0.0	0.0		0.2176		
2665	MAP3K1	ENSG00000095015	glioma	8.0	4.0	0.0	0.0		0.03481		
2666	MAP3K1	ENSG00000095015	head and neck cancer	2.0	2.0	0.0	0.0		0.005388		
2667	MAP3K1	ENSG00000095015	liver cancer	4.0	8.0	0.0	0.0				0.005197
2668	MAP3K1	ENSG00000095015	lung cancer	3.0	9.0	0.0	0.0		0.02523		
2669	MAP3K1	ENSG00000095015	lymphoma	3.0	8.0	1.0	0.0				
2670	MAP3K1	ENSG00000095015	melanoma	2.0	8.0	2.0	0.0				0.1353
2671	MAP3K1	ENSG00000095015	ovarian cancer	8.0	4.0	0.0	0.0		0.141		
2672	MAP3K1	ENSG00000095015	pancreatic cancer	2.0	8.0	2.0	0.0				0.01051
2673	MAP3K1	ENSG00000095015	prostate cancer	2.0	9.0	1.0	0.0		0.06726		
2674	MAP3K1	ENSG00000095015	renal cancer	0.0	5.0	7.0	0.0		0.001971		
2675	MAP3K1	ENSG00000095015	skin cancer	0.0	7.0	5.0	0.0				
2676	MAP3K1	ENSG00000095015	stomach cancer	3.0	8.0	1.0	0.0		0.02178		
2677	MAP3K1	ENSG00000095015	testis cancer	3.0	6.0	3.0	0.0				0.1577
2678	MAP3K1	ENSG00000095015	thyroid cancer	3.0	0.0	0.0	0.0		0.009918		
2679	MAP3K1	ENSG00000095015	urothelial cancer	1.0	8.0	2.0	0.0				0.1106
2680	PRKDC	ENSG00000253729	breast cancer	12.0	0.0	0.0	0.0				0.03142
2681	PRKDC	ENSG00000253729	carcinoid	3.0	1.0	0.0	0.0				
2682	PRKDC	ENSG00000253729	cervical cancer	10.0	1.0	0.0	0.0				0.003017
2683	PRKDC	ENSG00000253729	colorectal cancer	10.0	0.0	0.0	0.0		0.01564		
2684	PRKDC	ENSG00000253729	endometrial cancer	7.0	3.0	1.0	0.0			0.000103	
2685	PRKDC	ENSG00000253729	glioma	9.0	2.0	0.0	0.0		0.08952		
2686	PRKDC	ENSG00000253729	head and neck cancer	3.0	1.0	0.0	0.0		0.1339		
2687	PRKDC	ENSG00000253729	liver cancer	8.0	3.0	0.0	1.0				0.007696
2688	PRKDC	ENSG00000253729	lung cancer	4.0	6.0	0.0	0.0				0.05735
2689	PRKDC	ENSG00000253729	lymphoma	11.0	1.0	0.0	0.0				
2690	PRKDC	ENSG00000253729	melanoma	10.0	1.0	0.0	0.0				0.01118
2691	PRKDC	ENSG00000253729	ovarian cancer	11.0	1.0	0.0	0.0		0.01603		
2692	PRKDC	ENSG00000253729	pancreatic cancer	8.0	3.0	0.0	1.0				0.007757
2693	PRKDC	ENSG00000253729	prostate cancer	11.0	1.0	0.0	0.0				0.0777
2694	PRKDC	ENSG00000253729	renal cancer	4.0	3.0	0.0	4.0				0.02836
2695	PRKDC	ENSG00000253729	skin cancer	12.0	0.0	0.0	0.0				
2696	PRKDC	ENSG00000253729	stomach cancer	8.0	4.0	0.0	0.0		0.2324		
2697	PRKDC	ENSG00000253729	testis cancer	10.0	2.0	0.0	0.0				0.2199
2698	PRKDC	ENSG00000253729	thyroid cancer	3.0	1.0	0.0	0.0				0.006765
2699	PRKDC	ENSG00000253729	urothelial cancer	9.0	3.0	0.0	0.0				0.02153
2700	PIK3R1	ENSG00000145675	breast cancer	0.0	9.0	2.0	0.0		0.05737		
2701	PIK3R1	ENSG00000145675	carcinoid	0.0	1.0	3.0	0.0				
2702	PIK3R1	ENSG00000145675	cervical cancer	1.0	7.0	4.0	0.0		0.06577		
2703	PIK3R1	ENSG00000145675	colorectal cancer	1.0	10.0	1.0	0.0		0.2012		
2704	PIK3R1	ENSG00000145675	endometrial cancer	2.0	8.0	1.0	0.0		0.01312		
2705	PIK3R1	ENSG00000145675	glioma	3.0	7.0	1.0	0.0		0.1178		
2706	PIK3R1	ENSG00000145675	head and neck cancer	0.0	4.0	0.0	0.0		0.0133		
2707	PIK3R1	ENSG00000145675	liver cancer	0.0	7.0	4.0	0.0	0.0008088			
2708	PIK3R1	ENSG00000145675	lung cancer	0.0	5.0	6.0	1.0		0.003778		
2709	PIK3R1	ENSG00000145675	lymphoma	9.0	3.0	0.0	0.0				
2710	PIK3R1	ENSG00000145675	melanoma	2.0	9.0	1.0	0.0				0.1779
2711	PIK3R1	ENSG00000145675	ovarian cancer	0.0	7.0	4.0	0.0		0.2715		
2712	PIK3R1	ENSG00000145675	pancreatic cancer	0.0	4.0	8.0	0.0		0.06103		
2713	PIK3R1	ENSG00000145675	prostate cancer	0.0	9.0	3.0	0.0		0.1318		
2714	PIK3R1	ENSG00000145675	renal cancer	0.0	4.0	4.0	3.0		0.004585		
2715	PIK3R1	ENSG00000145675	skin cancer	0.0	11.0	1.0	0.0				
2716	PIK3R1	ENSG00000145675	stomach cancer	1.0	7.0	3.0	0.0				0.005662
2717	PIK3R1	ENSG00000145675	testis cancer	0.0	5.0	5.0	2.0				0.1269
2718	PIK3R1	ENSG00000145675	thyroid cancer	0.0	4.0	0.0	0.0		0.05919		
2719	PIK3R1	ENSG00000145675	urothelial cancer	0.0	12.0	0.0	0.0				0.1538
2720	CDK4	ENSG00000135446	breast cancer	2.0	5.0	1.0	3.0				0.08884
2721	CDK4	ENSG00000135446	carcinoid	0.0	1.0	1.0	2.0				
2722	CDK4	ENSG00000135446	cervical cancer	6.0	3.0	1.0	2.0		0.2529		
2723	CDK4	ENSG00000135446	colorectal cancer	2.0	2.0	4.0	4.0		0.05273		
2724	CDK4	ENSG00000135446	endometrial cancer	0.0	0.0	5.0	7.0				0.09007
2725	CDK4	ENSG00000135446	glioma	0.0	4.0	4.0	3.0		0.2212		
2726	CDK4	ENSG00000135446	head and neck cancer	2.0	1.0	1.0	0.0				0.1097
2727	CDK4	ENSG00000135446	liver cancer	1.0	1.0	2.0	7.0			2.087e-07	
2728	CDK4	ENSG00000135446	lung cancer	1.0	6.0	3.0	2.0				0.0739
2729	CDK4	ENSG00000135446	lymphoma	1.0	5.0	2.0	4.0				
2730	CDK4	ENSG00000135446	melanoma	3.0	4.0	5.0	0.0				0.003231
2731	CDK4	ENSG00000135446	ovarian cancer	6.0	0.0	5.0	1.0		0.02926		
2732	CDK4	ENSG00000135446	pancreatic cancer	0.0	2.0	4.0	5.0		0.03186		
2733	CDK4	ENSG00000135446	prostate cancer	0.0	4.0	4.0	3.0				0.09096
2734	CDK4	ENSG00000135446	renal cancer	0.0	2.0	5.0	4.0			3.152e-05	
2735	CDK4	ENSG00000135446	skin cancer	3.0	3.0	4.0	2.0				
2736	CDK4	ENSG00000135446	stomach cancer	0.0	3.0	1.0	8.0		0.3325		
2737	CDK4	ENSG00000135446	testis cancer	2.0	2.0	6.0	2.0				0.1674
2738	CDK4	ENSG00000135446	thyroid cancer	1.0	2.0	1.0	0.0				0.3637
2739	CDK4	ENSG00000135446	urothelial cancer	3.0	4.0	2.0	3.0				0.01567
2740	TSC1	ENSG00000165699	breast cancer	0.0	6.0	5.0	0.0				0.1878
2741	TSC1	ENSG00000165699	carcinoid	0.0	3.0	0.0	1.0				
2742	TSC1	ENSG00000165699	cervical cancer	0.0	9.0	3.0	0.0		0.1507		
2743	TSC1	ENSG00000165699	colorectal cancer	0.0	7.0	4.0	0.0				0.01401
2744	TSC1	ENSG00000165699	endometrial cancer	0.0	6.0	6.0	0.0		0.2559		
2745	TSC1	ENSG00000165699	glioma	1.0	7.0	2.0	2.0		0.06674		
2746	TSC1	ENSG00000165699	head and neck cancer	1.0	3.0	0.0	0.0		0.004229		
2747	TSC1	ENSG00000165699	liver cancer	0.0	4.0	6.0	2.0			6.027e-06	
2748	TSC1	ENSG00000165699	lung cancer	2.0	6.0	2.0	2.0				0.01957
2749	TSC1	ENSG00000165699	lymphoma	0.0	5.0	7.0	0.0				
2750	TSC1	ENSG00000165699	melanoma	0.0	11.0	1.0	0.0				0.03481
2751	TSC1	ENSG00000165699	ovarian cancer	0.0	6.0	6.0	0.0				0.1236
2752	TSC1	ENSG00000165699	pancreatic cancer	0.0	2.0	5.0	3.0	0.000801			
2753	TSC1	ENSG00000165699	prostate cancer	0.0	3.0	9.0	0.0				0.01841
2754	TSC1	ENSG00000165699	renal cancer	0.0	1.0	2.0	8.0	0.0007911			
2755	TSC1	ENSG00000165699	skin cancer	0.0	10.0	1.0	0.0				
2756	TSC1	ENSG00000165699	stomach cancer	0.0	4.0	5.0	1.0		0.09488		
2757	TSC1	ENSG00000165699	testis cancer	1.0	9.0	1.0	0.0		0.1459		
2758	TSC1	ENSG00000165699	thyroid cancer	0.0	4.0	0.0	0.0		0.2351		
2759	TSC1	ENSG00000165699	urothelial cancer	0.0	4.0	7.0	1.0		0.1159		
2760	CHEK1	ENSG00000149554	breast cancer								0.06743
2761	CHEK1	ENSG00000149554	carcinoid								
2762	CHEK1	ENSG00000149554	cervical cancer						0.3625		
2763	CHEK1	ENSG00000149554	colorectal cancer					0.0003617			
2764	CHEK1	ENSG00000149554	endometrial cancer								0.05536
2765	CHEK1	ENSG00000149554	glioma								0.2169
2766	CHEK1	ENSG00000149554	head and neck cancer						0.1028		
2767	CHEK1	ENSG00000149554	liver cancer							3.703e-06	
2768	CHEK1	ENSG00000149554	lung cancer								0.00395
2769	CHEK1	ENSG00000149554	lymphoma								
2770	CHEK1	ENSG00000149554	melanoma								0.001259
2771	CHEK1	ENSG00000149554	ovarian cancer						0.02544		
2772	CHEK1	ENSG00000149554	pancreatic cancer							3.1e-06	
2773	CHEK1	ENSG00000149554	prostate cancer								0.1746
2774	CHEK1	ENSG00000149554	renal cancer							1.036e-08	
2775	CHEK1	ENSG00000149554	skin cancer								
2776	CHEK1	ENSG00000149554	stomach cancer						0.02895		
2777	CHEK1	ENSG00000149554	testis cancer								0.2644
2778	CHEK1	ENSG00000149554	thyroid cancer						0.08165		
2779	CHEK1	ENSG00000149554	urothelial cancer								0.133
2780	APC	ENSG00000134982	breast cancer	4.0	6.0	1.0	0.0				0.04798
2781	APC	ENSG00000134982	carcinoid	0.0	3.0	1.0	0.0				
2782	APC	ENSG00000134982	cervical cancer	2.0	5.0	4.0	1.0				0.1189
2783	APC	ENSG00000134982	colorectal cancer	1.0	8.0	3.0	0.0		0.03719		
2784	APC	ENSG00000134982	endometrial cancer	0.0	7.0	4.0	1.0				0.114
2785	APC	ENSG00000134982	glioma	0.0	0.0	0.0	11.0		0.1095		
2786	APC	ENSG00000134982	head and neck cancer	0.0	3.0	1.0	0.0		0.007095		
2787	APC	ENSG00000134982	liver cancer	2.0	4.0	5.0	0.0				0.1625
2788	APC	ENSG00000134982	lung cancer	0.0	5.0	7.0	0.0		0.008103		
2789	APC	ENSG00000134982	lymphoma	0.0	0.0	2.0	10.0				
2790	APC	ENSG00000134982	melanoma	1.0	2.0	6.0	3.0				0.2353
2791	APC	ENSG00000134982	ovarian cancer	2.0	3.0	7.0	0.0				0.004845
2792	APC	ENSG00000134982	pancreatic cancer	6.0	4.0	2.0	0.0		0.1275		
2793	APC	ENSG00000134982	prostate cancer	6.0	3.0	2.0	0.0		0.04176		
2794	APC	ENSG00000134982	renal cancer	0.0	1.0	4.0	6.0		0.01023		
2795	APC	ENSG00000134982	skin cancer	0.0	8.0	4.0	0.0				
2796	APC	ENSG00000134982	stomach cancer	3.0	4.0	5.0	0.0				0.1073
2797	APC	ENSG00000134982	testis cancer	3.0	6.0	2.0	1.0		0.3353		
2798	APC	ENSG00000134982	thyroid cancer	0.0	3.0	1.0	0.0				0.02233
2799	APC	ENSG00000134982	urothelial cancer	5.0	5.0	1.0	0.0				0.1964
2800	CDKN1B	ENSG00000111276	breast cancer	0.0	0.0	7.0	4.0		0.05673		
2801	CDKN1B	ENSG00000111276	carcinoid	1.0	1.0	1.0	1.0				
2802	CDKN1B	ENSG00000111276	cervical cancer	0.0	1.0	3.0	8.0		0.09762		
2803	CDKN1B	ENSG00000111276	colorectal cancer	0.0	2.0	4.0	2.0	0.0005149			
2804	CDKN1B	ENSG00000111276	endometrial cancer	0.0	0.0	4.0	7.0				0.006899
2805	CDKN1B	ENSG00000111276	glioma	1.0	7.0	2.0	0.0		0.005842		
2806	CDKN1B	ENSG00000111276	head and neck cancer	0.0	2.0	0.0	1.0		0.01028		
2807	CDKN1B	ENSG00000111276	liver cancer	0.0	1.0	2.0	3.0			0.0003248	
2808	CDKN1B	ENSG00000111276	lung cancer	0.0	2.0	3.0	4.0		0.04042		
2809	CDKN1B	ENSG00000111276	lymphoma	0.0	0.0	2.0	10.0				
2810	CDKN1B	ENSG00000111276	melanoma	0.0	4.0	6.0	0.0				0.1107
2811	CDKN1B	ENSG00000111276	ovarian cancer	0.0	0.0	3.0	8.0				0.002855
2812	CDKN1B	ENSG00000111276	pancreatic cancer	0.0	0.0	2.0	6.0		0.009231		
2813	CDKN1B	ENSG00000111276	prostate cancer	0.0	2.0	6.0	2.0				0.2957
2814	CDKN1B	ENSG00000111276	renal cancer	0.0	0.0	1.0	11.0			0.0008389	
2815	CDKN1B	ENSG00000111276	skin cancer	0.0	0.0	1.0	10.0				
2816	CDKN1B	ENSG00000111276	stomach cancer	0.0	0.0	6.0	5.0		0.1232		
2817	CDKN1B	ENSG00000111276	testis cancer	0.0	0.0	1.0	10.0				0.08684
2818	CDKN1B	ENSG00000111276	thyroid cancer	0.0	2.0	1.0	0.0		0.2885		
2819	CDKN1B	ENSG00000111276	urothelial cancer	0.0	0.0	0.0	10.0		0.115		
2820	KDM5C	ENSG00000126012	breast cancer								0.1193
2821	KDM5C	ENSG00000126012	carcinoid								
2822	KDM5C	ENSG00000126012	cervical cancer						0.1129		
2823	KDM5C	ENSG00000126012	colorectal cancer								0.01562
2824	KDM5C	ENSG00000126012	endometrial cancer						0.071		
2825	KDM5C	ENSG00000126012	glioma						0.09754		
2826	KDM5C	ENSG00000126012	head and neck cancer								0.2194
2827	KDM5C	ENSG00000126012	liver cancer							0.0002107	
2828	KDM5C	ENSG00000126012	lung cancer						0.02084		
2829	KDM5C	ENSG00000126012	lymphoma								
2830	KDM5C	ENSG00000126012	melanoma								0.2107
2831	KDM5C	ENSG00000126012	ovarian cancer								0.124
2832	KDM5C	ENSG00000126012	pancreatic cancer						0.05448		
2833	KDM5C	ENSG00000126012	prostate cancer								0.01583
2834	KDM5C	ENSG00000126012	renal cancer								0.005045
2835	KDM5C	ENSG00000126012	skin cancer								
2836	KDM5C	ENSG00000126012	stomach cancer						0.01957		
2837	KDM5C	ENSG00000126012	testis cancer						0.06906		
2838	KDM5C	ENSG00000126012	thyroid cancer						0.1301		
2839	KDM5C	ENSG00000126012	urothelial cancer						0.1001		
2840	FGFR3	ENSG00000068078	breast cancer	0.0	1.0	0.0	10.0		0.1343		
2841	FGFR3	ENSG00000068078	carcinoid	0.0	1.0	0.0	2.0				
2842	FGFR3	ENSG00000068078	cervical cancer	0.0	2.0	4.0	5.0		0.00529		
2843	FGFR3	ENSG00000068078	colorectal cancer	0.0	0.0	4.0	6.0				0.149
2844	FGFR3	ENSG00000068078	endometrial cancer	0.0	1.0	5.0	6.0			0.000377	
2845	FGFR3	ENSG00000068078	glioma	0.0	2.0	3.0	7.0				0.05898
2846	FGFR3	ENSG00000068078	head and neck cancer	1.0	1.0	1.0	1.0		0.001242		
2847	FGFR3	ENSG00000068078	liver cancer	0.0	3.0	2.0	7.0				0.07219
2848	FGFR3	ENSG00000068078	lung cancer	1.0	1.0	3.0	7.0		0.2542		
2849	FGFR3	ENSG00000068078	lymphoma	0.0	0.0	0.0	12.0				
2850	FGFR3	ENSG00000068078	melanoma	0.0	0.0	0.0	12.0				0.1987
2851	FGFR3	ENSG00000068078	ovarian cancer	0.0	1.0	2.0	8.0				0.2172
2852	FGFR3	ENSG00000068078	pancreatic cancer	0.0	1.0	1.0	10.0		0.1382		
2853	FGFR3	ENSG00000068078	prostate cancer	0.0	0.0	3.0	8.0				0.02876
2854	FGFR3	ENSG00000068078	renal cancer	0.0	0.0	0.0	11.0		0.1305		
2855	FGFR3	ENSG00000068078	skin cancer	0.0	6.0	3.0	3.0				
2856	FGFR3	ENSG00000068078	stomach cancer	0.0	0.0	0.0	11.0		0.009112		
2857	FGFR3	ENSG00000068078	testis cancer	3.0	4.0	2.0	3.0				0.198
2858	FGFR3	ENSG00000068078	thyroid cancer	0.0	0.0	0.0	4.0				0.04735
2859	FGFR3	ENSG00000068078	urothelial cancer	2.0	1.0	3.0	5.0		0.1973		
2860	ARID2	ENSG00000189079	breast cancer								0.08407
2861	ARID2	ENSG00000189079	carcinoid								
2862	ARID2	ENSG00000189079	cervical cancer						0.1028		
2863	ARID2	ENSG00000189079	colorectal cancer						0.04023		
2864	ARID2	ENSG00000189079	endometrial cancer								0.03943
2865	ARID2	ENSG00000189079	glioma						0.04152		
2866	ARID2	ENSG00000189079	head and neck cancer					0.000575			
2867	ARID2	ENSG00000189079	liver cancer								0.01258
2868	ARID2	ENSG00000189079	lung cancer								0.09708
2869	ARID2	ENSG00000189079	lymphoma								
2870	ARID2	ENSG00000189079	melanoma								0.09037
2871	ARID2	ENSG00000189079	ovarian cancer						0.05574		
2872	ARID2	ENSG00000189079	pancreatic cancer								0.1341
2873	ARID2	ENSG00000189079	prostate cancer						0.247		
2874	ARID2	ENSG00000189079	renal cancer								0.01123
2875	ARID2	ENSG00000189079	skin cancer								
2876	ARID2	ENSG00000189079	stomach cancer								0.09212
2877	ARID2	ENSG00000189079	testis cancer						0.3021		
2878	ARID2	ENSG00000189079	thyroid cancer						0.2004		
2879	ARID2	ENSG00000189079	urothelial cancer						0.0653		
2880	SMARCB1	ENSG00000099956	breast cancer	12.0	0.0	0.0	0.0				0.2146
2881	SMARCB1	ENSG00000099956	carcinoid	4.0	0.0	0.0	0.0				
2882	SMARCB1	ENSG00000099956	cervical cancer	12.0	0.0	0.0	0.0		0.05623		
2883	SMARCB1	ENSG00000099956	colorectal cancer	12.0	0.0	0.0	0.0		0.006604		
2884	SMARCB1	ENSG00000099956	endometrial cancer	10.0	1.0	1.0	0.0		0.01633		
2885	SMARCB1	ENSG00000099956	glioma	12.0	0.0	0.0	0.0		0.004008		
2886	SMARCB1	ENSG00000099956	head and neck cancer	4.0	0.0	0.0	0.0				0.2139
2887	SMARCB1	ENSG00000099956	liver cancer	6.0	3.0	0.0	2.0			0.0006524	
2888	SMARCB1	ENSG00000099956	lung cancer	11.0	0.0	0.0	0.0				0.4101
2889	SMARCB1	ENSG00000099956	lymphoma	12.0	0.0	0.0	0.0				
2890	SMARCB1	ENSG00000099956	melanoma	12.0	0.0	0.0	0.0				0.1863
2891	SMARCB1	ENSG00000099956	ovarian cancer	12.0	0.0	0.0	0.0		0.01026		
2892	SMARCB1	ENSG00000099956	pancreatic cancer	7.0	4.0	1.0	0.0		0.02096		
2893	SMARCB1	ENSG00000099956	prostate cancer	8.0	1.0	0.0	0.0		0.004433		
2894	SMARCB1	ENSG00000099956	renal cancer	8.0	4.0	0.0	0.0	1.142e-06			
2895	SMARCB1	ENSG00000099956	skin cancer	11.0	0.0	0.0	0.0				
2896	SMARCB1	ENSG00000099956	stomach cancer	12.0	0.0	0.0	0.0		0.1241		
2897	SMARCB1	ENSG00000099956	testis cancer	10.0	2.0	0.0	0.0		0.04575		
2898	SMARCB1	ENSG00000099956	thyroid cancer	4.0	0.0	0.0	0.0		0.04568		
2899	SMARCB1	ENSG00000099956	urothelial cancer	9.0	2.0	0.0	0.0		0.07042		
2900	CDK6	ENSG00000105810	breast cancer	0.0	0.0	2.0	10.0		0.1288		
2901	CDK6	ENSG00000105810	carcinoid	1.0	0.0	1.0	1.0				
2902	CDK6	ENSG00000105810	cervical cancer	1.0	2.0	2.0	6.0				0.005982
2903	CDK6	ENSG00000105810	colorectal cancer	0.0	3.0	2.0	5.0				0.09065
2904	CDK6	ENSG00000105810	endometrial cancer	1.0	1.0	0.0	10.0				0.002785
2905	CDK6	ENSG00000105810	glioma	1.0	1.0	6.0	4.0				0.02557
2906	CDK6	ENSG00000105810	head and neck cancer	2.0	1.0	1.0	0.0				0.0324
2907	CDK6	ENSG00000105810	liver cancer	1.0	1.0	0.0	10.0				0.339
2908	CDK6	ENSG00000105810	lung cancer	0.0	1.0	2.0	8.0				0.002423
2909	CDK6	ENSG00000105810	lymphoma	1.0	2.0	5.0	4.0				
2910	CDK6	ENSG00000105810	melanoma	0.0	2.0	3.0	6.0				0.07189
2911	CDK6	ENSG00000105810	ovarian cancer	2.0	1.0	2.0	7.0				0.007782
2912	CDK6	ENSG00000105810	pancreatic cancer	3.0	2.0	1.0	5.0			3.857e-06	
2913	CDK6	ENSG00000105810	prostate cancer	0.0	1.0	1.0	8.0		0.04056		
2914	CDK6	ENSG00000105810	renal cancer	0.0	0.0	0.0	11.0				0.004093
2915	CDK6	ENSG00000105810	skin cancer	1.0	2.0	1.0	6.0				
2916	CDK6	ENSG00000105810	stomach cancer	1.0	6.0	2.0	2.0				0.1086
2917	CDK6	ENSG00000105810	testis cancer	0.0	4.0	0.0	8.0				0.07879
2918	CDK6	ENSG00000105810	thyroid cancer	0.0	0.0	0.0	4.0				0.1932
2919	CDK6	ENSG00000105810	urothelial cancer	1.0	3.0	4.0	4.0			2.329e-05	
2920	PDGFRA	ENSG00000134853	breast cancer	0.0	0.0	0.0	11.0				0.1666
2921	PDGFRA	ENSG00000134853	carcinoid	0.0	0.0	0.0	4.0				
2922	PDGFRA	ENSG00000134853	cervical cancer	0.0	0.0	0.0	12.0				0.09353
2923	PDGFRA	ENSG00000134853	colorectal cancer	0.0	0.0	0.0	11.0		0.004592		
2924	PDGFRA	ENSG00000134853	endometrial cancer	0.0	0.0	0.0	12.0		0.16		
2925	PDGFRA	ENSG00000134853	glioma	0.0	2.0	2.0	8.0		0.08921		
2926	PDGFRA	ENSG00000134853	head and neck cancer	0.0	0.0	0.0	3.0	0.0009332			
2927	PDGFRA	ENSG00000134853	liver cancer	0.0	0.0	0.0	11.0				0.1245
2928	PDGFRA	ENSG00000134853	lung cancer	0.0	0.0	0.0	11.0				0.02
2929	PDGFRA	ENSG00000134853	lymphoma	0.0	0.0	0.0	12.0				
2930	PDGFRA	ENSG00000134853	melanoma	0.0	1.0	0.0	9.0				0.1461
2931	PDGFRA	ENSG00000134853	ovarian cancer	0.0	1.0	0.0	11.0				0.02175
2932	PDGFRA	ENSG00000134853	pancreatic cancer	0.0	0.0	0.0	11.0				0.2185
2933	PDGFRA	ENSG00000134853	prostate cancer	0.0	0.0	0.0	12.0		0.07009		
2934	PDGFRA	ENSG00000134853	renal cancer	0.0	0.0	0.0	12.0			9.794e-06	
2935	PDGFRA	ENSG00000134853	skin cancer	0.0	0.0	0.0	12.0				
2936	PDGFRA	ENSG00000134853	stomach cancer	0.0	0.0	0.0	11.0				0.00958
2937	PDGFRA	ENSG00000134853	testis cancer	0.0	0.0	1.0	6.0				0.09866
2938	PDGFRA	ENSG00000134853	thyroid cancer	0.0	0.0	0.0	4.0				0.02158
2939	PDGFRA	ENSG00000134853	urothelial cancer	0.0	0.0	1.0	10.0				0.001718
2940	BRAF	ENSG00000157764	breast cancer	3.0	7.0	0.0	0.0		0.00298		
2941	BRAF	ENSG00000157764	carcinoid	3.0	1.0	0.0	0.0				
2942	BRAF	ENSG00000157764	cervical cancer	5.0	7.0	0.0	0.0		0.05663		
2943	BRAF	ENSG00000157764	colorectal cancer	6.0	4.0	1.0	0.0				0.02198
2944	BRAF	ENSG00000157764	endometrial cancer	6.0	5.0	0.0	0.0				0.00266
2945	BRAF	ENSG00000157764	glioma	5.0	6.0	0.0	0.0				0.2437
2946	BRAF	ENSG00000157764	head and neck cancer	1.0	3.0	0.0	0.0		0.01478		
2947	BRAF	ENSG00000157764	liver cancer	1.0	3.0	3.0	4.0				0.02069
2948	BRAF	ENSG00000157764	lung cancer	1.0	7.0	2.0	1.0		0.04234		
2949	BRAF	ENSG00000157764	lymphoma	11.0	1.0	0.0	0.0				
2950	BRAF	ENSG00000157764	melanoma	11.0	1.0	0.0	0.0				0.04069
2951	BRAF	ENSG00000157764	ovarian cancer	3.0	7.0	1.0	0.0		0.01582		
2952	BRAF	ENSG00000157764	pancreatic cancer	0.0	8.0	4.0	0.0		0.06534		
2953	BRAF	ENSG00000157764	prostate cancer	11.0	1.0	0.0	0.0				0.01908
2954	BRAF	ENSG00000157764	renal cancer	1.0	7.0	2.0	1.0		0.003795		
2955	BRAF	ENSG00000157764	skin cancer	4.0	8.0	0.0	0.0				
2956	BRAF	ENSG00000157764	stomach cancer	1.0	2.0	5.0	4.0				0.2076
2957	BRAF	ENSG00000157764	testis cancer	8.0	4.0	0.0	0.0		0.1761		
2958	BRAF	ENSG00000157764	thyroid cancer	4.0	0.0	0.0	0.0				0.08015
2959	BRAF	ENSG00000157764	urothelial cancer	5.0	7.0	0.0	0.0		0.05464		
2960	RRM2	ENSG00000171848	breast cancer	0.0	0.0	4.0	8.0				0.02101
2961	RRM2	ENSG00000171848	carcinoid	0.0	0.0	0.0	4.0				
2962	RRM2	ENSG00000171848	cervical cancer	0.0	0.0	2.0	10.0				0.1625
2963	RRM2	ENSG00000171848	colorectal cancer	0.0	2.0	6.0	4.0		0.006402		
2964	RRM2	ENSG00000171848	endometrial cancer	0.0	0.0	0.0	12.0				0.004422
2965	RRM2	ENSG00000171848	glioma	0.0	0.0	2.0	9.0				0.05703
2966	RRM2	ENSG00000171848	head and neck cancer	0.0	0.0	0.0	3.0		0.1693		
2967	RRM2	ENSG00000171848	liver cancer	0.0	2.0	0.0	8.0			1.392e-05	
2968	RRM2	ENSG00000171848	lung cancer	0.0	0.0	3.0	8.0				0.001038
2969	RRM2	ENSG00000171848	lymphoma	0.0	1.0	1.0	9.0				
2970	RRM2	ENSG00000171848	melanoma	0.0	0.0	2.0	9.0				0.006673
2971	RRM2	ENSG00000171848	ovarian cancer	0.0	0.0	0.0	12.0		0.0453		
2972	RRM2	ENSG00000171848	pancreatic cancer	0.0	0.0	3.0	7.0			0.0001616	
2973	RRM2	ENSG00000171848	prostate cancer	0.0	0.0	1.0	11.0				0.005106
2974	RRM2	ENSG00000171848	renal cancer	0.0	0.0	0.0	10.0			0.0	
2975	RRM2	ENSG00000171848	skin cancer	0.0	0.0	0.0	8.0				
2976	RRM2	ENSG00000171848	stomach cancer	0.0	2.0	1.0	8.0		0.03048		
2977	RRM2	ENSG00000171848	testis cancer	0.0	0.0	0.0	12.0				0.2236
2978	RRM2	ENSG00000171848	thyroid cancer	0.0	0.0	0.0	4.0		0.1382		
2979	RRM2	ENSG00000171848	urothelial cancer	0.0	1.0	0.0	8.0				0.02089
2980	ROR1	ENSG00000185483	breast cancer						0.0515		
2981	ROR1	ENSG00000185483	carcinoid								
2982	ROR1	ENSG00000185483	cervical cancer								0.01193
2983	ROR1	ENSG00000185483	colorectal cancer								0.03649
2984	ROR1	ENSG00000185483	endometrial cancer						0.01033		
2985	ROR1	ENSG00000185483	glioma						0.06242		
2986	ROR1	ENSG00000185483	head and neck cancer						0.1611		
2987	ROR1	ENSG00000185483	liver cancer								0.007107
2988	ROR1	ENSG00000185483	lung cancer								0.141
2989	ROR1	ENSG00000185483	lymphoma								
2990	ROR1	ENSG00000185483	melanoma						0.4056		
2991	ROR1	ENSG00000185483	ovarian cancer						0.3839		
2992	ROR1	ENSG00000185483	pancreatic cancer								0.03204
2993	ROR1	ENSG00000185483	prostate cancer						0.02025		
2994	ROR1	ENSG00000185483	renal cancer						0.003637		
2995	ROR1	ENSG00000185483	skin cancer								
2996	ROR1	ENSG00000185483	stomach cancer								0.0148
2997	ROR1	ENSG00000185483	testis cancer								0.1521
2998	ROR1	ENSG00000185483	thyroid cancer						0.05873		
2999	ROR1	ENSG00000185483	urothelial cancer								0.05147
3000	CASP8	ENSG00000064012	breast cancer	9.0	3.0	0.0	0.0		0.005206		
3001	CASP8	ENSG00000064012	carcinoid	2.0	2.0	0.0	0.0				
3002	CASP8	ENSG00000064012	cervical cancer	5.0	7.0	0.0	0.0		0.2099		
3003	CASP8	ENSG00000064012	colorectal cancer	10.0	2.0	0.0	0.0		0.01833		
3004	CASP8	ENSG00000064012	endometrial cancer	9.0	2.0	1.0	0.0				0.00969
3005	CASP8	ENSG00000064012	glioma	1.0	2.0	2.0	6.0				0.2091
3006	CASP8	ENSG00000064012	head and neck cancer	2.0	2.0	0.0	0.0				0.05605
3007	CASP8	ENSG00000064012	liver cancer	5.0	2.0	5.0	0.0			0.0003016	
3008	CASP8	ENSG00000064012	lung cancer	1.0	9.0	2.0	0.0		0.2098		
3009	CASP8	ENSG00000064012	lymphoma	3.0	7.0	2.0	0.0				
3010	CASP8	ENSG00000064012	melanoma	0.0	8.0	2.0	0.0				0.04792
3011	CASP8	ENSG00000064012	ovarian cancer	5.0	5.0	2.0	0.0	0.0001245			
3012	CASP8	ENSG00000064012	pancreatic cancer	10.0	0.0	1.0	0.0				0.07754
3013	CASP8	ENSG00000064012	prostate cancer	1.0	6.0	4.0	1.0				0.05111
3014	CASP8	ENSG00000064012	renal cancer	3.0	7.0	1.0	1.0			1.271e-06	
3015	CASP8	ENSG00000064012	skin cancer	0.0	8.0	3.0	1.0				
3016	CASP8	ENSG00000064012	stomach cancer	7.0	4.0	1.0	0.0		0.007672		
3017	CASP8	ENSG00000064012	testis cancer	5.0	2.0	5.0	0.0				0.2429
3018	CASP8	ENSG00000064012	thyroid cancer	0.0	2.0	2.0	0.0		0.2525		
3019	CASP8	ENSG00000064012	urothelial cancer	6.0	5.0	1.0	0.0		0.004527		
3020	PBRM1	ENSG00000163939	breast cancer	0.0	0.0	5.0	6.0		0.1866		
3021	PBRM1	ENSG00000163939	carcinoid	0.0	0.0	1.0	3.0				
3022	PBRM1	ENSG00000163939	cervical cancer	1.0	3.0	8.0	0.0		0.1727		
3023	PBRM1	ENSG00000163939	colorectal cancer	0.0	2.0	0.0	8.0		0.01905		
3024	PBRM1	ENSG00000163939	endometrial cancer	2.0	3.0	5.0	2.0		0.2001		
3025	PBRM1	ENSG00000163939	glioma	0.0	2.0	1.0	9.0		0.06155		
3026	PBRM1	ENSG00000163939	head and neck cancer	0.0	2.0	0.0	2.0		0.01339		
3027	PBRM1	ENSG00000163939	liver cancer	1.0	3.0	4.0	4.0				0.01017
3028	PBRM1	ENSG00000163939	lung cancer	1.0	5.0	4.0	2.0		0.09544		
3029	PBRM1	ENSG00000163939	lymphoma	0.0	2.0	5.0	5.0				
3030	PBRM1	ENSG00000163939	melanoma	1.0	1.0	8.0	2.0				0.01865
3031	PBRM1	ENSG00000163939	ovarian cancer	0.0	8.0	4.0	0.0		0.1434		
3032	PBRM1	ENSG00000163939	pancreatic cancer	0.0	0.0	2.0	8.0				0.01988
3033	PBRM1	ENSG00000163939	prostate cancer	0.0	0.0	2.0	9.0				0.04319
3034	PBRM1	ENSG00000163939	renal cancer	0.0	0.0	1.0	10.0		0.002895		
3035	PBRM1	ENSG00000163939	skin cancer	0.0	0.0	4.0	8.0				
3036	PBRM1	ENSG00000163939	stomach cancer	0.0	0.0	5.0	7.0				0.3061
3037	PBRM1	ENSG00000163939	testis cancer	0.0	1.0	2.0	9.0				0.1961
3038	PBRM1	ENSG00000163939	thyroid cancer	0.0	3.0	0.0	1.0				0.01527
3039	PBRM1	ENSG00000163939	urothelial cancer	0.0	1.0	3.0	8.0		0.1055		
3040	RPS6KB1	ENSG00000108443	breast cancer	3.0	9.0	0.0	0.0				0.2249
3041	RPS6KB1	ENSG00000108443	carcinoid	1.0	3.0	0.0	0.0				
3042	RPS6KB1	ENSG00000108443	cervical cancer	1.0	10.0	0.0	0.0		0.04523		
3043	RPS6KB1	ENSG00000108443	colorectal cancer	2.0	9.0	0.0	0.0		0.00191		
3044	RPS6KB1	ENSG00000108443	endometrial cancer	1.0	11.0	0.0	0.0				0.01346
3045	RPS6KB1	ENSG00000108443	glioma	4.0	8.0	0.0	0.0		0.09813		
3046	RPS6KB1	ENSG00000108443	head and neck cancer	1.0	3.0	0.0	0.0		0.1126		
3047	RPS6KB1	ENSG00000108443	liver cancer	4.0	8.0	0.0	0.0				0.003716
3048	RPS6KB1	ENSG00000108443	lung cancer	0.0	8.0	2.0	0.0				0.1698
3049	RPS6KB1	ENSG00000108443	lymphoma	3.0	8.0	1.0	0.0				
3050	RPS6KB1	ENSG00000108443	melanoma	2.0	9.0	0.0	0.0				0.05861
3051	RPS6KB1	ENSG00000108443	ovarian cancer	1.0	11.0	0.0	0.0				0.1661
3052	RPS6KB1	ENSG00000108443	pancreatic cancer	1.0	10.0	0.0	0.0		0.3668		
3053	RPS6KB1	ENSG00000108443	prostate cancer	4.0	6.0	0.0	0.0				0.01759
3054	RPS6KB1	ENSG00000108443	renal cancer	2.0	9.0	0.0	0.0			5.087e-07	
3055	RPS6KB1	ENSG00000108443	skin cancer	3.0	8.0	0.0	0.0				
3056	RPS6KB1	ENSG00000108443	stomach cancer	0.0	11.0	0.0	0.0		0.3453		
3057	RPS6KB1	ENSG00000108443	testis cancer	8.0	2.0	0.0	0.0				0.2086
3058	RPS6KB1	ENSG00000108443	thyroid cancer	1.0	3.0	0.0	0.0				0.03978
3059	RPS6KB1	ENSG00000108443	urothelial cancer	3.0	8.0	0.0	0.0		0.001523		
3060	FLT3	ENSG00000122025	breast cancer						0.002189		
3061	FLT3	ENSG00000122025	carcinoid								
3062	FLT3	ENSG00000122025	cervical cancer						0.00316		
3063	FLT3	ENSG00000122025	colorectal cancer						0.006544		
3064	FLT3	ENSG00000122025	endometrial cancer						0.09957		
3065	FLT3	ENSG00000122025	glioma								0.3876
3066	FLT3	ENSG00000122025	head and neck cancer						3.961e-07		
3067	FLT3	ENSG00000122025	liver cancer						0.007988		
3068	FLT3	ENSG00000122025	lung cancer						0.01652		
3069	FLT3	ENSG00000122025	lymphoma								
3070	FLT3	ENSG00000122025	melanoma						0.05365		
3071	FLT3	ENSG00000122025	ovarian cancer						0.01011		
3072	FLT3	ENSG00000122025	pancreatic cancer						0.1957		
3073	FLT3	ENSG00000122025	prostate cancer						0.1034		
3074	FLT3	ENSG00000122025	renal cancer								0.04558
3075	FLT3	ENSG00000122025	skin cancer								
3076	FLT3	ENSG00000122025	stomach cancer								0.3653
3077	FLT3	ENSG00000122025	testis cancer								0.03908
3078	FLT3	ENSG00000122025	thyroid cancer						0.2513		
3079	FLT3	ENSG00000122025	urothelial cancer						0.2216		
3080	ARID1A	ENSG00000117713	breast cancer	0.0	3.0	6.0	2.0				0.2829
3081	ARID1A	ENSG00000117713	carcinoid	1.0	2.0	0.0	1.0				
3082	ARID1A	ENSG00000117713	cervical cancer	2.0	8.0	0.0	1.0		0.1812		
3083	ARID1A	ENSG00000117713	colorectal cancer	3.0	4.0	1.0	2.0		0.0748		
3084	ARID1A	ENSG00000117713	endometrial cancer	2.0	3.0	2.0	4.0				0.1409
3085	ARID1A	ENSG00000117713	glioma	3.0	4.0	1.0	3.0				0.2442
3086	ARID1A	ENSG00000117713	head and neck cancer	2.0	1.0	0.0	1.0		0.01892		
3087	ARID1A	ENSG00000117713	liver cancer	2.0	2.0	2.0	5.0			0.0004179	
3088	ARID1A	ENSG00000117713	lung cancer	2.0	3.0	6.0	1.0		0.3018		
3089	ARID1A	ENSG00000117713	lymphoma	2.0	9.0	0.0	1.0				
3090	ARID1A	ENSG00000117713	melanoma	2.0	4.0	2.0	4.0				0.03658
3091	ARID1A	ENSG00000117713	ovarian cancer	0.0	4.0	3.0	2.0				0.134
3092	ARID1A	ENSG00000117713	pancreatic cancer	2.0	5.0	3.0	0.0		0.09688		
3093	ARID1A	ENSG00000117713	prostate cancer	5.0	6.0	0.0	0.0				0.07762
3094	ARID1A	ENSG00000117713	renal cancer	0.0	3.0	3.0	6.0		0.01012		
3095	ARID1A	ENSG00000117713	skin cancer	3.0	6.0	2.0	1.0				
3096	ARID1A	ENSG00000117713	stomach cancer	0.0	2.0	6.0	1.0		0.01621		
3097	ARID1A	ENSG00000117713	testis cancer	4.0	4.0	3.0	0.0		0.06046		
3098	ARID1A	ENSG00000117713	thyroid cancer	1.0	3.0	0.0	0.0				0.2656
3099	ARID1A	ENSG00000117713	urothelial cancer	5.0	3.0	3.0	1.0		0.06536		
3100	VEGFA	ENSG00000112715	breast cancer	4.0	6.0	0.0	1.0				0.1125
3101	VEGFA	ENSG00000112715	carcinoid	2.0	1.0	1.0	0.0				
3102	VEGFA	ENSG00000112715	cervical cancer	4.0	6.0	1.0	0.0			0.00045	
3103	VEGFA	ENSG00000112715	colorectal cancer	11.0	1.0	0.0	0.0				0.02424
3104	VEGFA	ENSG00000112715	endometrial cancer	7.0	4.0	1.0	0.0			0.0002097	
3105	VEGFA	ENSG00000112715	glioma	4.0	2.0	2.0	3.0				0.04347
3106	VEGFA	ENSG00000112715	head and neck cancer	2.0	2.0	0.0	0.0				0.1485
3107	VEGFA	ENSG00000112715	liver cancer	11.0	1.0	0.0	0.0			2.339e-05	
3108	VEGFA	ENSG00000112715	lung cancer	11.0	1.0	0.0	0.0				0.051
3109	VEGFA	ENSG00000112715	lymphoma	0.0	5.0	2.0	5.0				
3110	VEGFA	ENSG00000112715	melanoma	6.0	6.0	0.0	0.0				0.00527
3111	VEGFA	ENSG00000112715	ovarian cancer	4.0	4.0	2.0	2.0		0.02304		
3112	VEGFA	ENSG00000112715	pancreatic cancer	5.0	6.0	0.0	0.0				0.14
3113	VEGFA	ENSG00000112715	prostate cancer	7.0	4.0	0.0	0.0				0.01002
3114	VEGFA	ENSG00000112715	renal cancer	4.0	7.0	1.0	0.0			1.762e-05	
3115	VEGFA	ENSG00000112715	skin cancer	8.0	1.0	2.0	1.0				
3116	VEGFA	ENSG00000112715	stomach cancer	6.0	4.0	2.0	0.0		0.2199		
3117	VEGFA	ENSG00000112715	testis cancer	1.0	4.0	1.0	6.0				0.1802
3118	VEGFA	ENSG00000112715	thyroid cancer	1.0	3.0	0.0	0.0				0.1434
3119	VEGFA	ENSG00000112715	urothelial cancer	3.0	6.0	1.0	1.0	0.0002727			
3120	MAP2K1	ENSG00000169032	breast cancer	0.0	8.0	3.0	0.0				0.04052
3121	MAP2K1	ENSG00000169032	carcinoid	0.0	4.0	0.0	0.0				
3122	MAP2K1	ENSG00000169032	cervical cancer	0.0	4.0	6.0	2.0				0.01234
3123	MAP2K1	ENSG00000169032	colorectal cancer	0.0	5.0	4.0	2.0		0.2072		
3124	MAP2K1	ENSG00000169032	endometrial cancer	0.0	3.0	3.0	5.0				0.0492
3125	MAP2K1	ENSG00000169032	glioma	0.0	1.0	1.0	7.0			0.0001946	
3126	MAP2K1	ENSG00000169032	head and neck cancer	0.0	3.0	1.0	0.0				0.001814
3127	MAP2K1	ENSG00000169032	liver cancer	0.0	0.0	1.0	11.0				0.05778
3128	MAP2K1	ENSG00000169032	lung cancer	0.0	0.0	0.0	9.0				0.009911
3129	MAP2K1	ENSG00000169032	lymphoma	0.0	3.0	3.0	6.0				
3130	MAP2K1	ENSG00000169032	melanoma	0.0	4.0	0.0	6.0				0.1111
3131	MAP2K1	ENSG00000169032	ovarian cancer	0.0	8.0	3.0	0.0				0.1772
3132	MAP2K1	ENSG00000169032	pancreatic cancer	0.0	4.0	3.0	3.0				0.1448
3133	MAP2K1	ENSG00000169032	prostate cancer	0.0	5.0	5.0	0.0				0.007618
3134	MAP2K1	ENSG00000169032	renal cancer	0.0	0.0	4.0	7.0				0.1205
3135	MAP2K1	ENSG00000169032	skin cancer	0.0	5.0	3.0	3.0				
3136	MAP2K1	ENSG00000169032	stomach cancer	0.0	2.0	3.0	7.0		0.2713		
3137	MAP2K1	ENSG00000169032	testis cancer	0.0	2.0	5.0	5.0				0.1962
3138	MAP2K1	ENSG00000169032	thyroid cancer	0.0	1.0	1.0	1.0				0.1145
3139	MAP2K1	ENSG00000169032	urothelial cancer	0.0	4.0	6.0	2.0				0.009397
3140	NEK1	ENSG00000137601	breast cancer	11.0	0.0	0.0	0.0		0.04097		
3141	NEK1	ENSG00000137601	carcinoid	1.0	3.0	0.0	0.0				
3142	NEK1	ENSG00000137601	cervical cancer	5.0	6.0	0.0	0.0				0.2966
3143	NEK1	ENSG00000137601	colorectal cancer	11.0	1.0	0.0	0.0		0.0159		
3144	NEK1	ENSG00000137601	endometrial cancer	11.0	1.0	0.0	0.0		0.1974		
3145	NEK1	ENSG00000137601	glioma	4.0	7.0	1.0	0.0		0.06978		
3146	NEK1	ENSG00000137601	head and neck cancer	2.0	2.0	0.0	0.0		0.3102		
3147	NEK1	ENSG00000137601	liver cancer	4.0	8.0	0.0	0.0		0.3946		
3148	NEK1	ENSG00000137601	lung cancer	5.0	4.0	1.0	0.0				0.3292
3149	NEK1	ENSG00000137601	lymphoma	2.0	4.0	2.0	3.0				
3150	NEK1	ENSG00000137601	melanoma	8.0	4.0	0.0	0.0				0.1126
3151	NEK1	ENSG00000137601	ovarian cancer	12.0	0.0	0.0	0.0		0.2775		
3152	NEK1	ENSG00000137601	pancreatic cancer	5.0	4.0	0.0	0.0		0.004056		
3153	NEK1	ENSG00000137601	prostate cancer	7.0	5.0	0.0	0.0		0.2206		
3154	NEK1	ENSG00000137601	renal cancer	0.0	9.0	2.0	1.0	0.000142			
3155	NEK1	ENSG00000137601	skin cancer	4.0	7.0	1.0	0.0				
3156	NEK1	ENSG00000137601	stomach cancer	6.0	6.0	0.0	0.0		0.1067		
3157	NEK1	ENSG00000137601	testis cancer	9.0	2.0	0.0	0.0		0.1028		
3158	NEK1	ENSG00000137601	thyroid cancer	2.0	2.0	0.0	0.0				0.02101
3159	NEK1	ENSG00000137601	urothelial cancer	2.0	9.0	0.0	0.0				0.3461
3160	PRMT1	ENSG00000126457	breast cancer	0.0	11.0	1.0	0.0		0.0188		
3161	PRMT1	ENSG00000126457	carcinoid	0.0	4.0	0.0	0.0				
3162	PRMT1	ENSG00000126457	cervical cancer	0.0	7.0	3.0	1.0		0.01284		
3163	PRMT1	ENSG00000126457	colorectal cancer	1.0	10.0	0.0	0.0		0.03004		
3164	PRMT1	ENSG00000126457	endometrial cancer	5.0	3.0	2.0	0.0		0.3844		
3165	PRMT1	ENSG00000126457	glioma	0.0	2.0	3.0	4.0		0.0413		
3166	PRMT1	ENSG00000126457	head and neck cancer	0.0	3.0	0.0	0.0				0.03333
3167	PRMT1	ENSG00000126457	liver cancer	3.0	1.0	1.0	6.0			8.035e-05	
3168	PRMT1	ENSG00000126457	lung cancer	0.0	5.0	1.0	3.0				0.03425
3169	PRMT1	ENSG00000126457	lymphoma	0.0	4.0	5.0	3.0				
3170	PRMT1	ENSG00000126457	melanoma	2.0	3.0	4.0	1.0				0.1818
3171	PRMT1	ENSG00000126457	ovarian cancer	0.0	4.0	6.0	2.0				0.1772
3172	PRMT1	ENSG00000126457	pancreatic cancer	1.0	7.0	2.0	2.0		0.03586		
3173	PRMT1	ENSG00000126457	prostate cancer	1.0	8.0	1.0	2.0				0.1051
3174	PRMT1	ENSG00000126457	renal cancer	0.0	0.0	4.0	8.0				0.00719
3175	PRMT1	ENSG00000126457	skin cancer	4.0	4.0	3.0	0.0				
3176	PRMT1	ENSG00000126457	stomach cancer	0.0	4.0	3.0	2.0		0.2215		
3177	PRMT1	ENSG00000126457	testis cancer	1.0	8.0	2.0	1.0		0.03661		
3178	PRMT1	ENSG00000126457	thyroid cancer	2.0	2.0	0.0	0.0		0.04734		
3179	PRMT1	ENSG00000126457	urothelial cancer	5.0	4.0	1.0	2.0		0.011		
3180	PRMT5	ENSG00000100462	breast cancer	7.0	4.0	0.0	0.0				0.08339
3181	PRMT5	ENSG00000100462	carcinoid	1.0	2.0	0.0	1.0				
3182	PRMT5	ENSG00000100462	cervical cancer	1.0	0.0	6.0	4.0				0.005138
3183	PRMT5	ENSG00000100462	colorectal cancer	5.0	5.0	2.0	0.0		0.01194		
3184	PRMT5	ENSG00000100462	endometrial cancer	0.0	4.0	6.0	2.0				0.219
3185	PRMT5	ENSG00000100462	glioma	7.0	2.0	2.0	1.0		0.004563		
3186	PRMT5	ENSG00000100462	head and neck cancer	0.0	2.0	0.0	2.0			0.000182	
3187	PRMT5	ENSG00000100462	liver cancer	3.0	2.0	2.0	5.0			4.773e-05	
3188	PRMT5	ENSG00000100462	lung cancer	0.0	3.0	3.0	6.0				0.03642
3189	PRMT5	ENSG00000100462	lymphoma	1.0	7.0	3.0	1.0				
3190	PRMT5	ENSG00000100462	melanoma	3.0	5.0	1.0	2.0		0.06795		
3191	PRMT5	ENSG00000100462	ovarian cancer	2.0	5.0	5.0	0.0				0.1484
3192	PRMT5	ENSG00000100462	pancreatic cancer	6.0	2.0	2.0	1.0			0.0002612	
3193	PRMT5	ENSG00000100462	prostate cancer	2.0	10.0	0.0	0.0				0.04689
3194	PRMT5	ENSG00000100462	renal cancer	0.0	1.0	5.0	6.0		0.001992		
3195	PRMT5	ENSG00000100462	skin cancer	0.0	2.0	6.0	3.0				
3196	PRMT5	ENSG00000100462	stomach cancer	5.0	4.0	2.0	1.0		0.1207		
3197	PRMT5	ENSG00000100462	testis cancer	3.0	5.0	2.0	1.0		0.0704		
3198	PRMT5	ENSG00000100462	thyroid cancer	0.0	0.0	2.0	1.0				0.06284
3199	PRMT5	ENSG00000100462	urothelial cancer	1.0	3.0	6.0	1.0			0.0001038	
3200	MAP1LC3B	ENSG00000140941	breast cancer	0.0	3.0	5.0	4.0				0.004702
3201	MAP1LC3B	ENSG00000140941	carcinoid	0.0	0.0	3.0	1.0				
3202	MAP1LC3B	ENSG00000140941	cervical cancer	0.0	2.0	5.0	3.0				0.2886
3203	MAP1LC3B	ENSG00000140941	colorectal cancer	0.0	0.0	3.0	7.0				0.3208
3204	MAP1LC3B	ENSG00000140941	endometrial cancer	0.0	0.0	0.0	12.0		0.009702		
3205	MAP1LC3B	ENSG00000140941	glioma	5.0	2.0	4.0	1.0		0.4275		
3206	MAP1LC3B	ENSG00000140941	head and neck cancer	0.0	1.0	0.0	2.0				0.01788
3207	MAP1LC3B	ENSG00000140941	liver cancer	0.0	0.0	1.0	10.0				0.004983
3208	MAP1LC3B	ENSG00000140941	lung cancer	0.0	0.0	2.0	10.0				0.02502
3209	MAP1LC3B	ENSG00000140941	lymphoma	0.0	0.0	2.0	10.0				
3210	MAP1LC3B	ENSG00000140941	melanoma	0.0	4.0	2.0	5.0		0.1204		
3211	MAP1LC3B	ENSG00000140941	ovarian cancer	0.0	2.0	6.0	4.0		0.07262		
3212	MAP1LC3B	ENSG00000140941	pancreatic cancer	0.0	0.0	2.0	8.0				0.1045
3213	MAP1LC3B	ENSG00000140941	prostate cancer	0.0	4.0	3.0	2.0				0.1696
3214	MAP1LC3B	ENSG00000140941	renal cancer	0.0	1.0	4.0	6.0	2.774e-07			
3215	MAP1LC3B	ENSG00000140941	skin cancer	0.0	1.0	3.0	7.0				
3216	MAP1LC3B	ENSG00000140941	stomach cancer	0.0	0.0	4.0	5.0			0.0008971	
3217	MAP1LC3B	ENSG00000140941	testis cancer	0.0	0.0	1.0	10.0				0.09657
3218	MAP1LC3B	ENSG00000140941	thyroid cancer	0.0	0.0	3.0	1.0		0.1145		
3219	MAP1LC3B	ENSG00000140941	urothelial cancer	0.0	1.0	3.0	6.0				0.1599
